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Thesis Abstract 
Bronchiectasis is a chronic lung disease that can create significant symptom and 
treatment burdens for those affected, and significant costs to the National Health 
Service. Treatment concordance can be problematic and improvements in 
interventions are urgently required. There is little patient information available, yet 
information and education could support patients to self-manage, improve 
understanding and optimise engagement with treatment. This in turn could facilitate 
reductions in unscheduled presentations to healthcare services and improvements in 
longer-term health-related outcomes.   
A mixed methods approach was taken to this work. Qualitative interviews were 
conducted with patients and carers to explore and understand their unmet 
information needs. Using thematic analysis, a core mediating issue emerged: what it 
means to learn to live your life with bronchiectasis. Embedded within this journey 
were issues around developing support and coping mechanisms, learning to connect 
with information, taking back control and developing active partnerships with the 
medical team.  
Using the interview findings, a novel information resource was co-developed during a 
series of workshops with patients and carers. Potential designs, formats and content 
were discussed and prototypes developed, reviewed and refined. A booklet and a 
website featuring video content (www.bronchiectasis.me) were produced. 
A feasibility study (The BRIEF Study, ISRCTN84229105) was subsequently 
conducted comparing use of this novel information resource to usual care. Feasibility 
outcomes included recruitment and retention rates and questionnaire completion 
rates. 62 participants were randomised; 60 completed the study. Recruitment and 
questionnaire completion rates were excellent. Resource evaluation conducted within 
the trial was positive and demands for access worldwide were high.  
By understanding what it means to live with bronchiectasis, a resource that meets 
users’ needs has been co-developed. The feasibility study indicates that a definitive 
trial establishing effect on understanding, self-management and health-related 
outcomes would be feasible and that the resource is credible and of high quality.
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Chapter 1 Introduction to thesis: Context, Overview and Structure 
Bronchiectasis is a chronic lung condition that leads to a significant symptom and 
treatment burden for those affected, and significant costs to the National Health 
Service. Statistics show us that prevalence is increasing, both in the UK and 
worldwide (Seitz et al., 2012; Ringshausen et al., 2015; Quint et al., 2016), yet still 
the evidence base for treatments and management remains poor. Historically there 
has been relatively little research conducted in this field and it is only in the recent 
past that more attention has been paid to this previously somewhat neglected 
disease. Improvements in interventions are urgently required. 
Interventions for bronchiectasis are likely to include advancements in medical 
therapies, yet we also know that bronchiectasis is a ‘model’ chronic disease in terms 
of its potential for self-management. If patients and their carers know how to 
recognise their own symptoms of deterioration or exacerbation, and know how and 
when to take action, this could facilitate improvements in self-management. This in 
turn could potentially facilitate increases in disease stability, reductions in 
unscheduled presentations to acute health care services and improvements in 
longer-term health related outcomes.   
In 2011, I carried out a pilot study during a Master of Clinical Research degree in 
order to begin to explore the health information and education needs within this 
patient group (Hester, 2012; Hester et al., 2012a). I will describe this in more depth in 
Chapter two, yet key messages emerging from interviews were that patients felt there 
was a lack of credible information available to them and that they believed 
information could be key to them learning to live with and manage their condition. On 
the basis of these findings I developed a research proposal to further investigate the 
unmet information needs of patients with bronchiectasis and their carers, and to then 
use this data to develop and evaluate an intervention that would address the 
identified issues. In 2012, I was awarded a Doctoral Research Fellowship by the 
National Institute for Health Research in order to carry out this work, which comprises 
the contents of this thesis.  
The overall aims at the outset were to explore, describe and understand the 
information and education needs of patients with bronchiectasis and their carers; and 
to produce and evaluate a novel, effective and practical educational resource. The 
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resource was to be patient-driven in both format and content, feasibly deliverable 
within the NHS setting and accessible at users’ convenience. In order to effectively 
meet these aims, a mixed methodological approach combining a variety of qualitative 
and quantitative methods was required. I will discuss this in depth in Chapter 3. The 
approach taken for the qualitative aspects of the work falls within the realist 
paradigm. Specifically, a subtle realist standpoint was taken, acknowledging the fact 
that we can aim for an objective reality, but we can only really know reality from 
individuals’ perspectives of it. I will further describe methodological considerations 
and strategies used to ensure credibility and rigour for each aspect of this work in 
Chapter 3. 
For the purposes of study sponsor and ethics committee approvals, the work was 
subdivided into two stages as follows:- 
Stage 1: Information and education provision for patients with bronchiectasis: a 
qualitative investigation of patients’ needs and development of a patient-driven 
resource. (The BRIE study, REC Ref 12/SC/0585.)  
The aim of this section of work was firstly to identify, understand and describe in 
detail the information and education needs within this patient group; and secondly to 
co-develop a high-quality, patient-driven information resource for patients with 
bronchiectasis in accordance with themes identified in qualitative interviews and 
workshops. One of the major outputs of this research is the resource itself (Appendix 
1, Appendix 2). The website can also be viewed at www.bronchiectasis.me.  
Stage 2: Bronchiectasis Information and Education: Feasibility Study and Evaluation 
of a Novel Resource. (The BRIEF Study, ISRCTN registration: ISRCTN84229105, 
REC Ref: 14/NE/0119.) 
The aim of this stage was to conduct a feasibility study that would inform the decision 
process concerning whether to proceed to a definitive randomised controlled trial and 
whether any refinements to the design or conduct of that trial are warranted. Further 
aims were to evaluate and refine the patient information resources and collect 
information on patient preferences and resource use. 
As this work was carried out in distinct yet interlinking stages, I have presented it 
within this thesis as the stages progressed chronologically. The background and 
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review of literature in Chapter 2 pertains to all aspects of this work, as do the 
methods and methodology in Chapter 3. Three results chapters detail the findings of 
the interviews, the outcomes of the resource development process and the findings 
of the BRIEF study respectively. There is some discussion within each results 
chapter, and a unifying discussion and conclusions chapter of the entire body of work 
is presented at the end of the thesis, drawing together outcomes, impacts and 
considerations for future work. 
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Chapter 2 Background and review of literature: Bronchiectasis, 
information and self-management 
In the introduction, I gave a broad description of why it was important that this 
research was conducted, and presented an overview of the research undertaken. In 
this chapter I will discuss the context of this work and the literature relevant to it in 
more depth. Given the paucity of data available on information and education in 
bronchiectasis specifically, a formal systematic review was not possible. In order to 
ensure that a thorough review of the relevant literature was conducted, I performed 
detailed searches with robust search strategies using multiple databases including 
Medline, Ovid, Scopus and Web of Science. Searches of PubMed, Cochrane and 
NICE were also carried out. Searches were additionally performed in interlinking 
areas to include data on information and education in other chronic respiratory and 
medical conditions where comparisons could be drawn, and other bronchiectasis 
data that could have an impact upon the need for patient information. 
I will begin with some background information about bronchiectasis and its 
management; and introduce the importance of patient information for people who 
have this condition. I will go on to describe information provision and self-
management, both in bronchiectasis and other chronic conditions, as comparison 
examples. I will also discuss information seeking and the development and 
evaluation of information resources; concluding with a summary of the main issues 
and the aims and objectives for the work described within this thesis.  
2.1 Bronchiectasis 
2.1.1 Bronchiectasis pathogenesis and prevalence 
Bronchiectasis is a chronic lung condition, characterised by dilated bronchi. It leads 
to symptoms of breathlessness, cough and a chronic infective syndrome, with 
inevitable additional infective exacerbations. Bronchiectasis has various potential 
aetiologies including immune-deficiency syndromes, chronic asthma, chronic 
obstructive pulmonary disease (COPD), ciliary dysfunction and post-infection. In 
addition, studies have found that between a quarter and half of cases are idiopathic 
(Pasteur et al., 2000; Shoemark et al., 2007). Patients often have recurrent, costly 
hospital admissions, a poorer quality of life (Wilson et al., 1997; O'Leary et al., 2002) 
and clinically significant fatigue (Macfarlane et al., 2010; Hester et al., 2012b). 
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Patients with bronchiectasis are at increased risk of anxiety and depression (Olveira 
et al., 2013; Boussoffara et al., 2014; Ozgun Niksarlioglu et al., 2016). New data has 
also shown a greater risk of coronary heart disease and stroke in patients with 
bronchiectasis (Navaratman et al., 2017).  
Recent UK statistics indicate a prevalence of between 43.4/100,000 in those aged 
18-30 and 1239.7/100,000 in those aged 70-79. This equates to an estimated 
300,000 in the UK with bronchiectasis, and up to 20,000 new cases being identified 
each year (Quint et al., 2016; Navaratman et al., 2017). In the North East of England 
there are over 1,100 patients with a diagnosis of bronchiectasis. Approximately 450 
of these attend a specialist clinic at a central hospital. Overall prevalence is 
increasing in the UK (Quint et al., 2016), and the USA (Seitz et al., 2012). Higher 
than expected numbers were also recently reported from Europe (Ringshausen et al., 
2015). Importantly, studies have demonstrated that up to 50% of patients with COPD 
have evidence of co-existent bronchiectasis (O'Brien et al., 2000; Patel et al., 2004). 
It has been suggested more recently that COPD and bronchiectasis can co-exist as 
‘bronchiectasis COPD overlap syndrome’ (BCOS) (Hurst et al., 2015). With over 
1,000,000 patients with a diagnosis of COPD in the UK (Shahab et al., 2006), there is 
potential for a significant increase in case-finding of BCOS, and consequently a 
continued rise in bronchiectasis prevalence, over the coming years.  
Bronchiectasis mortality rates have been reported in the UK to be twice that of the 
general population (Quint et al., 2016) and approximately 50% higher than that of 
uncomplicated COPD (calculated at 3% per annum) (Office for National Statistics, 
2004). Rates are increasing, with up to 1000 people dying each year from 
bronchiectasis (Roberts and Hubbard, 2010). The presence of BCOS also leads to 
increased mortality rates (Gatheral et al., 2014; Goeminne et al., 2014). Prognosis 
varies, with a study of 91 patients finding that the primary cause of death was usually 
respiratory, with survival rates of 91% at 4 years and 68.3% at 12.3 years (Loebinger 
et al., 2009). The same study found factors such as chronic infection with 
Pseudomonas aeruginosa increase mortality. In addition, infective exacerbations 
lead to significant morbidity. The national British Thoracic Society (BTS) 
bronchiectasis audit reported that 38% of patients had three or more exacerbations 
per year (Hill et al., 2013). Within a cohort of patients attending the aforementioned 
specialist clinic, average exacerbation rate was 4 per year (twice the rate of 
exacerbations in uncomplicated COPD) (McDonnell et al., 2015) with an increase in 
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hospital bed days in recent years from 400 to 2,000 per annum. This is consistent 
with American data on the increasing burden of bronchiectasis (Seitz et al., 2010). 
Previously published UK data also emphasises the burden of bronchiectasis, 
uncertainties in aetiology and lack of evidence for the treatments that are often used 
(Kelly et al., 2003). Improved interventions in bronchiectasis are clearly required. 
2.1.2 Management of bronchiectasis 
There are national guidelines for investigation, diagnosis and management of 
bronchiectasis produced by the BTS (Pasteur et al., 2010). There is no cure for 
bronchiectasis and many therapies are empiric and not evidence based. In terms of 
managing bronchiectasis, there are two main therapeutic streams: maintenance 
therapy and exacerbation management. Maintenance therapy aims to improve or 
maintain a patient’s baseline condition, reducing both their everyday symptoms and 
the frequency of their exacerbations. Exacerbation management is treatment of 
episodic worsening with an aim of returning to baseline condition as quickly as 
possible.  
Examples of the treatments used include mucolytics (tablets or nebulised solutions to 
aid sputum expectoration), physiotherapy, and antibiotics (Pasteur et al., 2010). 
Regular use of mucolytics and physiotherapy aids sputum clearance both as 
maintenance therapy and as part of exacerbation management. Current modalities of 
antimicrobial treatment include oral, inhaled or intravenous antibiotics; both regularly 
and with additional courses for exacerbations. With some exceptions, treatments are 
broadly similar regardless of the aetiology of bronchiectasis, but specific treatment 
plans are tailored to the individual. These can range from no regular treatments at all, 
to daily use of nebulisers, physiotherapy, inhalers and tablets that can be significantly 
burdensome for patients and their families. 
Treatments can be a cause for concern for patients which can be further complicated 
by any uncertainty around the specific ‘type’ of bronchiectasis they have. To be 
labelled as having ‘idiopathic bronchiectasis’, which has no identifiable cause, can be 
quite confusing for patients. It can be equally as confusing for those who, for 
example, have a longstanding diagnosis of COPD and then go on to develop 
bronchiectasis. In this situation, having a new or additional diagnosis raises 
questions about whether the original diagnosis was incorrect, and also whether their 
symptoms at any one time are attributable to bronchiectasis or COPD. Although we 
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have said that treatments for bronchiectasis are broadly similar regardless of 
aetiology, uncertainties regarding the origin of symptoms naturally leads to 
uncertainties for patients around what action to take and how the symptoms should 
be treated. For example, an exacerbation of COPD may not require antibiotics, yet 
an exacerbation of bronchiectasis would require a 2 week course of antimicrobial 
treatment (Pasteur et al., 2010). Failure to commence antibiotics promptly can result 
in a more severe exacerbation of bronchiectasis which could require hospital 
admission. This would clearly lead to significant additional costs to the NHS, and a 
much bigger physical, psychological and social impact upon patients and their 
families. Conversely, inappropriately excessive antibiotic use can lead to antibiotic 
resistance which can also have problematic repercussions in terms of response to 
future treatments and longer term health outcomes. If a patient does not fully 
understand their diagnosis, symptom recognition and self-management are bound to 
be problematic. 
Bronchiectasis differs from some chronic diseases in that appropriate, timely 
recognition of exacerbation symptoms and improved management of infections can 
lead to increased disease stability. Although largely not evidenced, this is the general 
approach towards management. Adherence to regular maintenance treatments is 
expected to reduce the frequency of exacerbations, yet adherence is known to be an 
issue. A recent trial looked at treatment adherence over a one year period and found 
that 41% adhered to airway clearance, and 53% inhaled antibiotics (McCullough et 
al., 2014). When looking at adherence to all treatments, this fell to 16% of the cohort 
studied. Adhering to inhaled antibiotics led to a decreased exacerbation rate. 
Importantly, it is known that those with more frequent exacerbations suffer not only 
the physical effects, but also a reduction in quality of life (Wilson et al., 1997). To 
expect patients to understand their condition, the treatments used and the 
implications of not taking them appropriately is quite a tall order; yet is clearly 
necessary. In order to facilitate such self-management, patients need to have 
accurate and accessible information about their condition, enabling them to 
recognise and respond to changes, and understand how their actions could 
potentially alter their prognosis. Adequate education could lead to a level of self-
management that results in clinically and biologically important endpoints in 
bronchiectasis. 
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2.2 Information and self-management 
2.2.1 Information provision in bronchiectasis 
The BTS guidelines for management of bronchiectasis (Pasteur et al., 2010) 
recommend education of patients; including explanations of the disease, recognition 
and importance of exacerbations and treatment approaches. The BTS Quality 
Standards for clinically significant bronchiectasis in adults also advocate a personal 
management plan for each patient (Bronchiectasis Quality Standards Working 
Group, 2012). Although patients with bronchiectasis gain information through 
discussion with their clinician, there is little additional information available to them in 
comparison to the number of resources available for other chronic conditions such as 
COPD or Cystic Fibrosis. Charitable organisations such as the British Lung 
Foundation (BLF) recognise the need for information and education for patients with 
chronic lung disease. They produce a range of paper and online information 
resources for patients with respiratory conditions. Their leaflet about bronchiectasis, 
however, is just one A4 page in length. The BLF recognise the need for 
improvements in information provision for patients with bronchiectasis and have 
supported this research.  
If one performs an online search for information about bronchiectasis, there are 
resources available. However, in addition to being limited in number when compared 
to other conditions, many are either very brief, with little information provided, or 
lengthy and not patient-friendly. There are currently no widely available audio-visual 
information resources relevant to bronchiectasis. The BTS have a short self-
management tool for bronchiectasis that is available to download (Bronchiectasis 
Quality Standards Working Group, 2012). This does not serve as an information 
resource as such, however, but a 1 page reference guide to exacerbation 
management. Other sources of online information include forums or ‘chat rooms’. 
There are a limited number available that are specific to bronchiectasis (Angel, 
2015). These do not necessarily serve as information resources, but can be a way for 
patients to gain from either looking at conversations between others, or engaging in 
discussion with other people who have had similar experiences. The lack of ‘expert’ 
opinion contained within these discussions however could be a deterrent to some 
users. Likewise, the need to share one’s own story may not be something users are 
willing to engage with. Attendance at local support groups is another way for patients 
to gain information and a sense of community. An example for those with chronic 
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lung disease would be the Breathe Easy support groups (British Lung Foundation, 
2017). These are run by the British Lung Foundation and are held nationwide. The 
opportunity to meet with others who also have chronic lung disease may be of 
interest to some, yet others may not wish to engage with something that involves 
them openly discussing their diagnosis. For patients with bronchiectasis, it is also 
less likely that others in the group would have the same diagnosis, with groups more 
likely to be predominated by people with more prevalent conditions such as COPD or 
asthma. A more detailed review of the resources currently available is detailed in 
chapter 5 of this thesis, where I describe the development of the novel patient 
information resource. This includes how knowledge of these existent resources 
alongside the interview data additionally influenced its design.  
In a survey of 104 patients attending a specialist bronchiectasis clinic in the North 
East of England, 98% felt more confident with managing their condition following 
information and education about their treatment (Hester et al., 2011). Moreover, a 
pilot study carried out prior to the work contained within this thesis identified the 
importance of patient information in the process of developing the skills and 
confidence to manage and live with bronchiectasis (Hester, 2012; Hester et al., 
2012a). I carried out this pilot study as part of a Master of Clinical Research Degree. 
This was an exploratory study and I recruited patients with bronchiectasis via a 
specialist bronchiectasis clinic. Sampling was pragmatic and essentially formed a 
convenience sample. The aims of the study were to begin to explore patients’ views 
on information provision for people who have bronchiectasis and begin to identify any 
unmet needs. I conducted in depth, semi-structured interviews and used thematic 
analysis to look for emergent themes. In total, 8 patients were recruited, 6 female, 2 
male with a median age of 66 years (range 33-67). The majority of participants had 
been living with bronchiectasis for many years. Four interlinking core themes arose 
from the analysis of the interview data:- 
1. Information: There was a strong feeling amongst participants that there was a 
lack of trustworthy information (from a reliable source such as their hospital, from 
trusted specialists or organisations such as the BLF) available beyond that obtained 
in clinic. Patients felt they would benefit from a credible information resource that 
they could continue to access outside of a clinic setting. Timing of information was 
important, with users wanting information at diagnosis. Patients also indicated that a 
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useable resource would have to be presented in a format that met their needs and 
those of their carers and families. 
2. Experience at diagnosis: There was often a lack of information and support at 
diagnosis, which patients felt impacted on their ability to cope with their condition, 
both at diagnosis and beyond. 
3. Ongoing medical care and support: Patients felt that when they transferred to 
the care of a specialist bronchiectasis clinic, they had a source of help, support and 
information. Receiving such information empowered patients, yet they felt there was 
a need for accessible resources outside of this setting.  
4. Living with bronchiectasis and its impact: Patients acknowledged the impacts 
of the condition and the support needed. They considered knowledge and 
information to be critical in developing the skills and confidence to live with and 
manage bronchiectasis.  
Limitations of this study included the small sample size and the lack of within-sample 
variation. The majority of patients were female, in their sixth decade, and all 
participants were attending a specialist bronchiectasis service. The ways in which 
this has influenced sampling for the work contained within this thesis is described in 
Chapter 3, section 3.2.1.This pilot exploratory work demonstrated the importance of 
the lack of information provision for people with bronchiectasis to the patient group 
and provided further evidence that this was a worthwhile area of research. 
Information is an essential commodity to facilitate better patient understanding and 
disease management; yet is clearly under-provided in bronchiectasis. There is an 
obvious requirement for further research into the unmet information needs of affected 
individuals and their carers, and for appropriate resource development.  
2.2.2 Information provision in chronic conditions 
The Department of Health and the NHS recognise the importance of information 
provision for patients with long-term conditions and their carers. The NHS refer to 
longstanding evidence that patients want to access information (Bunker, 1983) and 
that its provision can reduce anxiety (George et al., 1983). The Audit Commission 
previously identified that information can improve patient outcomes (Audit 
Commission, 1993) and improvements in information provision have been a priority 
for over a decade (The NHS Plan, 2000). Information provision being key to 
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facilitating self-care is highlighted by the UK Government as fundamental to 
promoting patient choice and shared decision making (Department of Health, 2006). 
It is proposed in this document that all people with long-term conditions, and their 
carers, should receive information and services that will help them to manage their 
condition. The NHS Outcomes Framework 2012/13 (Annex A) has a domain entitled 
‘enhancing quality of life for people with long-term conditions’ which details an area 
for improvement as ‘ensuring people feel supported to manage their condition’ 
(Department of Health, 2011). The Department of Health also published a policy 
document in 2012, entitled ‘The power of information: Putting us all in control of the 
health and care information we need’. This described a ten year strategy framework 
to transform information for health and care, including both patient care information 
and health information resources for use by patients (Department of Health, 2012). 
The Patient Information Forum, an organisation that campaigns for improvements in 
health information, also put forward their evidence for the need to make 
improvements in health information for patients (Patient Information Forum, 2013). 
They emphasise that information is an intervention, its production is a highly skilled 
process and that it should be user tested, co-designed and co-produced where 
possible. Information provision is known to play an important role in supporting self-
management and active participation in care remains a priority area of health 
research for all chronic conditions. 
Although provision of information is clearly seen as an essential part of management 
of chronic conditions, it is argued that information itself does not automatically 
translate into behavioural change (Becker, 1990). Theoretical constructs and 
behavioural change techniques beyond information delivery (Michie et al., 2005; 
Abraham and Michie, 2008) are important to consider in development of any 
intervention that aims to produce changes in behaviour. The use of such techniques, 
however, are not the only approach to optimising effectiveness of information 
provision. It has been proposed that information seeking is a necessary stage for 
action to be taken by patients and that specific information on help available may 
improve chances of patients taking action (Catania et al., 1990). In a review of the 
role of education in asthma it was recognised that information about asthma should 
not simply be factual but allow patients to acquire skills (Partridge and Hill, 2000). 
Again in asthma, it is preferable to teach patients about their asthma treatments and 
inflammation rather than the structure and function of the lungs for example 
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(Takakura et al., 1998). Asthma education alone does not necessarily improve 
outcomes but needs to be delivered in combination with medical review and written 
action plans (Gibson et al., 2002a).  
It would seem to be clear that providing patients with something as simple as a 
factsheet on their condition is unlikely to result in any major tangible benefits. Indeed, 
the currently available BLF leaflet about bronchiectasis provides no intervention 
details that a patient could implement as part of a self-management plan. Thinking 
beyond this simplistic and traditional version of an information resource and 
establishing what information is relevant to the patient group, and how it could be 
delivered in order to achieve the desired effects is therefore essential.  
2.2.3 Self-management in chronic disease 
Self-management and patient information provision are seemingly inextricably linked. 
Self-management is increasingly recognised as an important part of chronic disease 
management and is recommended by the World Health Organisation (WHO) 
(Epping-Jordan et al., 2004). Information, as discussed, plays a key role in patients’ 
ability to self-manage. The Wanless Report (Wanless, 2004) identified inadequacies 
in information provision as a reason for people managing their health poorly. In 
primary care, self-management has been referred to as patients with chronic disease 
making day to day decisions about their illnesses (Bodenheimer et al., 2002) and the 
everyday tasks and activities that a person living with a chronic condition needs to 
carry out (Eaton et al., 2015). The authors proposed self-management education 
rather than traditional information alone improves clinical outcomes, in keeping with 
the aforementioned literature. The aim in supporting self-management is to allow 
people to gain not only the knowledge but also the confidence and relevant skills to 
manage their condition; promoting patient ‘activation’ (Hibbard and Greene, 2013; 
Eaton, 2016). An important concept embedded within this is self-efficacy: the 
confidence that one can carry out a behaviour necessary to achieve a desired goal 
(Bandura, 1977). Using self-efficacy as a measurable outcome, however, is not 
without flaws, as was shown when trialling the expert patient programme (EPP). This 
was developed by Lorig, and used self-efficacy as an outcome measure (Lorig et al., 
1985; Lorig and Holman, 1993; Lorig et al., 2001). The EPP has been used in a 
variety of conditions, but was initially developed for patients with arthritis. The EPP 
was designed to enhance disease specific information rather than replace it, as the 
programme is generic in nature. They found improvements in symptom control, pain 
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and hospitalisations as well as gains in self-efficacy. There are, however, many 
criticisms of the EPP. These include self-efficacy gains not leading to improvements 
in self-management and not necessarily reducing hospital presentations. Additionally, 
it has been suggested that participants in EPPs were not representative of the 
general population and were possibly better at self-managing than most (Gately et 
al., 2007; Taylor and Bury, 2007; Lindsay and Vrijhoef, 2009). A UK study using a 
lay-led EPP (n=629) showed an increase in participant self-efficacy and energy, yet 
no reduction in health care utilisation (Kennedy et al., 2007).  
A recent systematic review and meta-analysis of self-management interventions 
concluded that they can be implemented without a detrimental effect on health 
outcomes and that they do reduce service utilisation (Panagioti et al., 2014). 
Although the effect sizes were small overall, it is of note that respiratory conditions 
were amongst the two groups that had the strongest evidence. Systematic reviews of 
self-management education in chronic lung disease specifically, however, have been 
less conclusive. A review in COPD revealed inconclusive evidence of any benefits 
(Monninkhof et al., 2003). In asthma, as discussed previously, a Cochrane review 
reported that self-management education could improve health outcomes only when 
delivered in conjunction with medical reviews and a written action plan (Gibson et al., 
2002b). In cystic fibrosis, an inherited multi-system disease with similar respiratory 
features to bronchiectasis, there was again too little data to draw firm conclusions 
about recommendations for self-management (Savage et al., 2011). A protocol for a 
systematic review of self-management in non-cystic fibrosis bronchiectasis has 
recently been published, (Kelly et al., 2017). Conclusions are likely to be limited, 
however, reflecting the current lack of an evidence-base for self-management in 
bronchiectasis.  
A meta-synthesis of qualitative studies additionally highlights the importance of social 
networks (family, friends, communities) in the self-management of chronic illnesses 
(Vassilev et al., 2014). A longitudinal study of patients with heart disease and 
diabetes also acknowledges the role of social networks in supporting self-
management (Reeves et al., 2014). A large international observational study 
explored the roles of individual support networks and community organisations within 
self-management of diabetes (Koetsenruijter et al., 2014; Koetsenruijter et al., 2015). 
Participation in community organisations (including online communities and health 
education groups) was associated with better physical and mental health. It is 
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apparent that when considering educational and self-management support 
interventions they need to be tailored to the users’ approaches. Establishing users’ 
needs and preferences and taking into account their use of social networks is 
therefore critical. This will enable development of suitable information and education 
resources and lay the groundwork for establishing their effects on numerous aspects 
of patients’ lives and disease course. 
2.2.4 Self-management in bronchiectasis 
A small number of self-management resources have been produced for chronic lung 
diseases. The British Lung Foundation, for example, produced a document in 
conjunction with NHS Improvement to assist patients with the self-management of 
COPD (British Lung Foundation, 2012). Another self-management educational 
resource, SPACE for COPD, was developed by a group in Leicester (Mitchell-Wagg 
et al., 2012). This was designed as a six week intervention. At 6 months, although 
there were gains in disease knowledge, anxiety and performance levels, the primary 
outcome measure of dyspnoea had not improved (Mitchell et al., 2014). Living Well 
with COPD (McGill University Health Centre and Quebec Asthma and COPD 
Network, 2013) is a website with information and videos and requires a password 
obtained by patients from their physician in order to access the full material. A two 
year randomised controlled trial conducted in primary care did not show long term 
benefits over usual care when using measures of self-efficacy and quality of life. The 
group with access to the living well programme, however, did seem more able to 
manage their exacerbations (Bischoff et al., 2012). It is possible that self-efficacy, as 
discussed, may not necessarily be the optimal outcome measure in such studies. In 
asthma, a study using an educational programme based on repeated short 
interventions (face to face sessions at 3 month intervals over 1 year, a personalised 
action plan and inhaler technique training) saw improvements in asthma control in 
the intervention group, yet they did note a degree of improvement within the control 
group too (Plaza et al., 2015). Cost effectiveness was not examined and although the 
intervention was brief, it would involve staff time at considerable cost, and user 
information needs at other time points were not taken into account.   
There still remains to be an evidence-based intervention for use in bronchiectasis. 
Perhaps unsurprisingly, there is very little evidence for self-management in 
bronchiectasis, yet there are rational arguments for its use. One study began to 
explore how self-management could be facilitated in bronchiectasis. Using focus 
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groups with patients who had bronchiectasis, they were able to explore patients’ 
perspectives on what was required. Participants perceived lack of information and 
confidence as barriers to self-management and felt that disease specific information 
would be useful (Lavery et al., 2007). The same group investigated the use of an 
EPP as part of a self-management programme for patients with bronchiectasis 
(Lavery et al., 2011). The programme consisted of two sessions of disease-specific 
information followed by a standard, generic EPP for six weeks. Improvement was 
found in six of ten domains of a self-efficacy scale, including managing symptoms 
and depression. The intervention group, however, also reported more symptoms and 
reduced quality of life post intervention. The educational sessions about 
bronchiectasis were not patient-driven in terms of content or format of delivery, and 
participants commented that the sessions should be condensed and be attended by 
physicians. Costs, staffing, time and patient commitment involved with such a course 
are considerable, making it potentially unfeasible to deliver within a clinical setting. 
The centre that carried out this study is not using this routinely following the trial. 
(J.S. Elborn, December 2012, personal communication.) A successful intervention for 
bronchiectasis would need to meet patients’ needs, be easily accessible and be 
feasibly deliverable within a resource constrained NHS on a long-term basis. 
Another recent study has taken a different approach to aiding self-management in 
patients with bronchiectasis, using a novel tool, the Bronchiectasis Empowerment 
Tool (ISRCTN Registry, 2015). The tool consisted of a one page action plan, within a 
pack containing information and optional notepads. The reported aim of the study 
was to work alongside existing care in order to improve self-management. At the time 
of writing the study is closed to recruitment but no published results are available.  
Self-management includes making day to day decisions about your management. In 
bronchiectasis, this would include making decisions surrounding adherence to 
treatments. As noted above, adherence to some treatments in bronchiectasis can 
result in fewer exacerbations (McCullough et al., 2014), yet less than 20% of the 
cohort studied were adherent to all prescribed treatments. In a study of an inhaled 
antibiotic in bronchiectasis, a delay to first exacerbation was only demonstrated in 
patients adherent to ≥81% of treatment (Haworth et al., 2014). Factors predicting 
adherence to treatments could include beliefs about treatments and burden of 
treatment (McCullough et al., 2015b). Based on these findings, further work has been 
done by the same group using a theoretical approach to work towards a behaviour 
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change intervention to promote treatment adherence (McCullough et al., 2015a). 
Interestingly, the message about need for information came across again in this 
study, as interviews identified that patients felt knowledge about bronchiectasis and 
treatments improved adherence. Addressing the issue of treatment adherence would 
therefore seem to be important when delivering an educational or self-management 
intervention for bronchiectasis. It is not however, the only aspect of the patient 
experience to be considered. Common to all aspects of day to day management is 
the need for information. Having an in depth understanding of the information and 
education needs of both patients and their carers, and how these could be met is 
fundamental to the development and execution of novel interventions.  
2.3 Information seeking 
Information seeking is another important aspect to consider in developing an 
understanding of patients’ information needs and how they might go about meeting 
them. Knowing how, why and when patients seek information, in addition to what 
information they seek, is key to the development of a successful resource.  
In prior exploratory interviews with patients who have bronchiectasis (Hester, 2012; 
Hester et al., 2012a) participants reported that they had often not persisted in 
information seeking beyond the clinic setting due to a lack of trust in the available 
online resources. Participants did state that if they had been directed to information 
(by their physician for example) that originated from a credible source, they would be 
interested in accessing it. Information from clinicians was reported to be credible 
information. Interestingly, there is evidence in COPD, which may well be applicable 
to other conditions, that gaps in knowledge of health care professionals can impact 
upon patients’ knowledge and understanding of their condition (Edwards and Singh, 
2012). Patients who have bronchiectasis may not attend a specialist bronchiectasis 
clinical service. Respiratory or general physicians, although they may understand the 
disease process, are likely to have less disease-specific experience and knowledge 
than a specialist delivering a bronchiectasis service. In addition, they may not have 
sufficient exposure to have developed a comparable practice in exchanging disease-
specific information in a patient-focussed manner. With this relative lack of exposure 
to patients who have bronchiectasis, further development of such skills in an area 
outside their main expertise is likely to be problematic. Given that credibility of 
information received is important to patients, and that patients may not all be 
18 
 
receiving the same standard of information from their clinicians, there is clearly a 
need for high-quality resources beyond a specialist bronchiectasis clinic. Having a 
trustworthy and patient-driven resource that is widely available has the potential to 
engage patients and enable both dissemination of good practice and equity of 
information access amongst the patient group.  
Within the aforementioned exploratory interviews, some patients indicated that their 
carers, partners, friends and family members played a key role in the day to day 
management of their condition (Hester, 2012; Hester et al., 2012a). For some, this 
was practical assistance with treatments or other activities and for others their carers 
were actually the main seekers of information about their condition. Patients use 
information to aid their decision-making about various aspects of their management 
and its use can be a key coping strategy (Lambert and Loiselle, 2007). Significant 
others are also frequently involved in shared decision-making in a variety of different 
ways and that patients are rarely entirely autonomous in these processes (Ohlen et 
al., 2006; Rapley, 2008). Previous work has also emphasised the importance of the 
role of family or carers in the adaptation of patients and coping with chronic illness 
(Anderson and Bury, 1988; Heijmans et al., 1999) in keeping with the importance of 
social networks in self-management (Koetsenruijter et al., 2014; Reeves et al., 2014; 
Vassilev et al., 2014; Koetsenruijter et al., 2015). It would seem clear, therefore, that 
significant others are just as likely to engage with information resources as patients. 
As such, any newly developed resource would need to also accommodate carers 
and families of patients with bronchiectasis. 
Another common reason identified for not seeking information in the prior pilot 
interviews (Hester, 2012; Hester et al., 2012a) was fear of what may be found. This 
potential for information to worsen rather than reduce anxiety has been proposed by 
Lambert and Loiselle (Lambert and Loiselle, 2007), and the concept of information 
avoidance is recognised (Maslow, 1963; Case et al., 2005). Reviews of health 
information seeking behaviour have concluded that a better understanding of this 
concept will enable the provision of better information, and that information should 
meet patients’ individual needs (Case et al., 2005; Lambert and Loiselle, 2007). 
Previous work looking into why patients with cancer may not want or seek information 
about their condition also identified that patients’ attitudes and coping strategies are 
sometimes what limits their seeking of information (Leydon et al., 2000). Leydon also 
demonstrates the importance of identifying the needs of the patient group in order to 
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tailor resources to suit them rather than assuming a ‘one size fits all’ approach will 
work.  
Building on this, another theory is that information seeking behaviour is based upon 
personal traits rather than situational triggers (Rokeach, 1960). Again, this links with 
individual coping strategies and has relevance to patients with both terminal and 
chronic illnesses. Clear parallels can be drawn with bronchiectasis, as prognosis 
remains a crucial question and different patients vary in how much information they 
need (or want) on a personal level, as well as at different time points. A discussion of 
approaches to looking at information is presented by Lee (Lee et al., 2016) which 
goes on to describe the pros and cons of a number of methods of interviewing with a 
view to understanding such seeking. This is all the more important when talking 
about how people access online information, and which sites are deemed credible, 
useful or easy to understand. Having an understanding of how, when and why 
patients seek information is clearly crucial prior to development of such an 
information resource. By identifying information needs using appropriate techniques 
and delivering an intervention that has been designed, in conjunction with patients, to 
complement their learning approaches, a resource can be tailored to meet needs. 
2.4 Development of patient information resources: processes and formats 
When suitable information resources are already felt to be in existence, patient 
signposting has been used for information delivery purposes. In a scheme aiming to 
provide patients with chronic conditions, including COPD, with patient specific 
information; patients were given an ‘information prescription’ based on their 
information needs identified by the patients and clinicians (McShane et al., 2014). 
The majority of users and professionals were satisfied with the service, which 
facilitated access to information that was already available rather than creating novel 
resources. Establishing whether there is a need for novel resources prior to 
embarking upon development processes is essential.   
Health information resources are developed in a variety of ways. A study reviewing 
information behaviours of carers of patients with dementia explored the differences 
between system-centred and user-centred approaches to developing information 
resources (Harland and Bath, 2008). Their conclusions were that user-centred 
approaches take into account individual needs which are not taken into account in 
system centred approaches. This further highlights the argument for co-development 
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of such resources, based on users’ needs. Different formats and contents suit 
different people, and identifying the preferences and needs within the patient group 
must therefore be a critical part of ensuring good uptake. In addition to specific 
details of content, layout and information presentation, fundamentals such as 
whether the resource will be paper based, online, or a DVD for example, must be 
considered.  
Paper-based information resources remain an important format. The NHS has 
created a toolkit for producing paper-based patient information, which provides a 
synopsis of the recommended processes and principles for developing basic 
information leaflets in line with service provision requirements (The Department of 
Health, 2003). It does allude to the fact that patients could be consulted and that 
other formats of information delivery could be considered, but it is primarily a 
resource to aid the production of paper leaflets written by healthcare professionals for 
patients. Signposting to other organisations such as the Patient Information Forum is 
included for those developers wanting to find out more.  
Online and audio-visual formats also need to be considered when developing 
information resources. For some users, the use of audio-visual information is 
preferable to written information, whereas for others it could complement the more 
traditional format. Papers published in oncology, for example, have described the 
process of development and evaluation of audio-visual materials to prepare patients 
for procedures and promote self-management (Carey et al., 2006; Carey et al., 
2007). The authors describe the principles used in development of such resources 
and the positive evaluations made by both patients and professionals. This group 
also report how their DVD led to a reduction in supportive care needs and 
improvements in self-efficacy (Schofield et al., 2008). A group based in Newcastle 
described their production of an informative DVD for patients who had been newly 
diagnosed with Primary Biliary Cirrhosis, a chronic liver disease. They used 
interviews to identify what patients’ needs were and consequently developed a DVD 
that focussed mainly on the diagnosis experience and information that would benefit 
patients at that time (Pearce et al., 2011). This received positive feedback when 
shown to a group of 10 patients and carers who were asked to complete a 
questionnaire with free text about the DVD. The DVD has since been made available 
free of charge via the charity Liver North. 
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Although videos and now DVDs are becoming outdated, the use of the internet is 
now commonplace and audio-visual information can easily be accessed online. One 
example of information delivery using the internet is the use of ‘YouTube’ to access 
videos. This has been done to provide access to videos about pulmonary 
rehabilitation for example (King's College Hospital, 2007). Healthtalkonline.org 
provides a series of video interviews with patients and practitioners surrounding a 
number of health issues (Health Experience Research Group, 2013). This is based 
upon patients wanting to learn about other people’s similar experiences when faced 
with health issues. This was also a sentiment expressed by patients in my prior 
exploratory study, yet for bronchiectasis, there are no such online resources. Not all 
patients, however, have the resources or ability to access information via this route, 
and paper resources are likely to remain in existence for some time to come.  
With all potential information formats it is important to consider how accessible the 
resource will be to those with additional literacy or language barriers. More 
specifically, ‘health literacy’ is a term used to describe a person’s ability to both read 
and understand information related to health. This requires a user to be able to read 
the information easily, understand it and be engaged with their health care. In order 
to optimise this, developers of resources need to ensure the absence of any potential 
barriers to user interaction and understanding (Raynor, 2012). These approaches 
should be adopted universally; producing high quality, clear information and 
communication for all users rather than screening for health literacy issues (Kronzer, 
2016). There are online resources available to guide production of accessible 
information materials (Department of Health, 2010). Using plain and simple language 
is a key example, but there are many more ways to try to facilitate uptake. Co-
developing a resource based on users’ needs and reviews would facilitate production 
of an accessible information resource that could be readily engaged with.   
2.5 Summary 
People who have bronchiectasis and their carers remain poorly provided for in terms 
of health information and self-management guidance. This is despite clear potential 
for such interventions to produce tangible benefits for patients and the NHS. The 
prevalence of bronchiectasis is rising and makes this issue ever more pressing. 
Information has been identified in the literature as a requirement to enable self-
management and treatment adherence. The need for improvements in information 
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and self-management education are widely recognised and an NHS priority for all 
chronic diseases. Bronchiectasis is a chronic disease in which advancements in 
information and self-management education could result in significant improvements 
in health and health service utilisation. In order to develop a resource that is well-
received, engaged with and influences users’ knowledge and actions, users must be 
involved in its production. I aimed to address this lack of provision with a patient-
centred approach; incorporating what we already know about information seeking, 
needs and self-management in chronic disease, and exploring for the first time the 
specific unmet needs of those with bronchiectasis and their carers.  
2.6 Aims and objectives 
The specific aims and objectives of the work contained within this thesis were as 
follows:- 
1. To identify, understand and describe the information and education needs of 
patients who have bronchiectasis and their carers. 
2. To co-develop a high-quality, patient-driven information resource for patients 
with bronchiectasis in accordance with themes identified in qualitative 
interviews, focus groups and workshops. 
3. To evaluate the resource and conduct a feasibility study to inform the decision 
of whether to proceed to a definitive randomised controlled trial examining the 
impact of the resource on users understanding, self-management, use of 
health care services and disease stability. 
The methods used to achieve these aims and objectives are described in the 
following chapter. 
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Chapter 3 Methods and methodology: An exploration of unmet 
needs; development of a patient-driven information resource 
and the BRIEF Study protocol 
This chapter provides a description of the methods used to achieve the outlined aims 
and objectives. I discuss the methodological approach taken to exploring and 
describing the information needs of patients with bronchiectasis and their carers; and 
to using this data to develop, trial and evaluate a novel information resource. I 
describe methods used for the interviews, detailing sampling, recruitment and 
analysis. The methods used within the resource development process are then 
described and lastly the design and conduct of the Bronchiectasis Information and 
Education: Feasibility study and evaluation of a novel resource (BRIEF) study 
(ISRCTN registration: ISRCTN84229105). The protocol for the BRIEF study has also 
been published as an open access article in Trials (Hester et al., 2016) and is 
included as an appendix at the end of the thesis (Appendix 3).  
3.1 Overall Methodology 
A mixed methods approach has been taken for the work included in this thesis. If the 
interlinking stages of this research are considered as an overall research question to 
be answered: ‘what are the unmet information needs of patients with bronchiectasis, 
and can we develop and trial a resource that meets those needs and has the 
potential to improve understanding and self-management?’ the need for mixed 
methods becomes apparent. The information resource developed would be classed 
as a complex intervention due to its multiple components and the interactional 
behaviours required by those receiving the intervention in order for it to produce 
change (Medical Research Council, 2006). A mixed methodological approach to its 
development and evaluation is appropriate as outlined in the Medical Research 
Council (MRC) guidelines for developing and evaluating complex interventions 
(Campbell et al., 2000; Medical Research Council, 2000; Medical Research Council, 
2006). The revision of the MRC guidance in 2006 highlighted that the multiple phases 
of developing and evaluating a complex intervention are not necessarily sequential, 
and that the understanding of processes, whilst important, does not replace 
evaluation (Medical Research Council, 2006; Craig et al., 2008). With the work 
described in this thesis, all phases were interlinked and an emphasis has been 
placed on evaluation of the intervention itself alongside the evaluation of processes 
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used during development and trialling of the intervention. An understanding of the 
evidence base is of course deemed essential by the MRC in undertaking the 
development and evaluation of such an intervention: the review and critique of the 
relevant literature has been described in chapter 2. The approach taken to this work 
is in keeping with these MRC guidelines, and was considered in great depth prior to 
the commencement of this work.  
Only relatively recently has mixed methods (rather than a purist approach of either 
qualitative or quantitative methods alone) been considered to be a methodology in 
itself; the so-called ‘third research paradigm’ (Teddlie and Tashakkori, 2003; Johnson 
and Onwuegbuzie, 2004). Its development in the health sciences has since been 
acknowledged and described (O'Cathain and Thomas, 2006; O'Cathain, 2009). The 
specific mixed methods approach taken here was tailored to the research questions 
posed. The use of differing methods to answer a research question more completely 
can be regarded as triangulation in this context, a process advocated in ensuring 
high quality data (Sandelowski, 1995; O'Cathain et al., 2010). It has been proposed 
that such methodological pluralism and selection of methods to suit the scenario is 
essential for high quality research and to obtain useful answers (Sechrest and Sidani, 
1995; Johnson and Onwuegbuzie, 2004). By using a mixed methods approach for 
this work, my aim was to explore and answer the research questions as completely 
as possible.  
The overall term of ‘mixed methods’ might be regarded as being rather vague. If 
looking to label the typology of mixed methods used for this work, the approach taken 
would probably be best described as a sequential exploratory strategy (Cresswell et 
al., 2003). The qualitative data analysis in the first stage of work (exploration of 
unmet information needs) informed the development of the novel resource (which 
used further qualitative methods) and then this resource was used as the intervention 
in the randomised controlled trial (primarily quantitative methods). When looking at 
the RCT in separation, a further typology of mixed methods used within the feasibility 
study could be described as a concurrent nested approach (Cresswell et al., 2003). 
Qualitative methods were additionally integrated into the feasibility trial design (a 
randomised controlled trial with end of study focus group) to allow evaluation of the 
resource and trial process that could not be obtained using quantitative methods 
alone. A relatively complex mixed methodological approach has therefore been used 
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overall, in order to best answer the research questions in a reliable, valid and 
rigorous way.  
Adopting such mixed methodology in order to answer research questions seems to 
be an obvious example of pragmatism. Pragmatism has been described as allowing 
the researcher to avoid the ‘forced choice dichotomy between positivism and 
constructivism’ (Cresswell and Plano-Clark, 2007, p. 27); ending the divide between 
quantitative and qualitative research methods to focus on answering the research 
question (Hanson, 2008). As such, pragmatism seems to go hand in hand with mixed 
methods research (Feilzer, 2010) and is in keeping with the overall methodological 
approach taken to this work. It is important to note that an additional (yet 
complementary) philosophical approach was taken when analysing the qualitative 
components of this work: subtle realism. Subtle realism assumes we only know 
reality from our experience of it. A realist approach aims to achieve an objective 
reality or knowledge through rigorous methodology, based on the theory that 
phenomena exist independently of human knowledge of them. Subtle realism 
additionally acknowledges the individuality, or ‘situatedness’, of a person’s 
experiences and knowledge. Although first described in the context of ethnography, 
this can be applied to qualitative research more widely (Hammersley, 1992; Banfield, 
2004; Maxwell, 2012). By interviewing a wide variety of patients with bronchiectasis 
and their carers, I aimed to gain a rich dataset in order to understand the experiences 
of people living with bronchiectasis and how their information needs might be met. 
This approach provided a wealth of descriptions and viewpoints. These descriptions 
of experiences are individual, yet they were not simply studied in isolation. Methods 
were carefully considered to ensure the validity and reliability of the resultant data 
when looking across cases to identify similarities and differences. The methods used 
for sampling and data analysis take into account the requirement for methodological 
rigour in order to produce credible data. This included careful purposive sampling, 
peer and supervisor review and code checking, deviant case analysis and reflexivity.  
The feasibility study in the main used quantitative methods, and as such scientific 
rigor in terms of randomisation, analysis and reporting of results was paramount. 
Although the three elements of work cannot be entirely separated given their 
interlinking nature, to ensure clarity, I have detailed the specific methods and results 
for each stage distinctly. 
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3.2 Methods: The Qualitative interviews  
For the first stage of work, in order to fully explore the information needs of patients 
and carers with bronchiectasis, and obtain rich, experiential data to inform 
subsequent resource development, qualitative methods were the obvious choice. 
Using qualitative interviews allowed new and emergent ideas to develop and these 
ideas could then be tested and further explored over subsequent interviews. To use 
data collection methods such as questionnaires would not have facilitated such depth 
of data and transfer of views between the participants and myself, nor would it have 
enabled the detailed exploration of emergent ideas. Semi-structured, in-depth 
interviews were therefore selected as the method of choice to gain a detailed 
understanding of participants’ experiences. This first stage of the work builds upon 
my prior exploratory interviews (Hester et al., 2012a) which documented the need for 
disease-specific information for patients who have bronchiectasis, and began to 
explore those needs. This prior pilot study, however, had obvious limitations. To 
address these limitations and improve upon this groundwork, methods used for 
sampling and for exploring the needs within the patient group were subject to further 
methodological considerations.  
3.2.1 Sampling 
In the previously described pilot study (Hester, 2012; Hester et al., 2012a) the 
majority of patients interviewed regarding their unmet information needs had very 
similar characteristics; in part due to the nature of the sampling approach used. 
Specifically, in the pilot study, all participants were attending a specialist 
bronchiectasis outpatient service in a tertiary referral centre and all had the same 
consultant delivering their care. All were listed on a database that indicated their 
interest in taking part in research and the majority were female patients in their sixth 
decade who had longstanding disease. Upon reflection, many of these factors had 
potential to influence information needs, access to information and information 
seeking behaviour. One would anticipate that those attending a specialist service 
would have access to information via their clinician that may surpass that routinely 
delivered in general clinics. Supporting this assumption, during pilot interviews, 
participants often referred to the fact that they had obtained very little information 
about their condition until they started attending the specialist clinic (Hester et al., 
2012a). 
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In the prior pilot study, the sample was in essence a ‘convenience sample’ (Patton, 
1990). All potential participants were approached via a specialist bronchiectasis 
clinic, and all were known to be interested in being approached about research 
studies. Potential participants were therefore identified by the consultant as people 
likely to be interested in talking about their experiences. In order to address this prior 
lack of within-sample variation, rigorously explore emerging concepts and improve 
upon pilot work, purposive sampling was used to recruit participants to the interviews 
reported within this thesis.  
Numerous different subtypes of purposive sampling have been described (Patton, 
1990) and maximum variation sampling was the method used for this study. The 
purpose of this technique is to ensure description of themes that cut across a wide 
participant variation and also to specifically seek participants likely to generate the 
most useful data (Green and Thorogood, 2009b). Potential participants were sought 
with the following characteristics:- 
 
 Attending different general respiratory clinics 
 Attending a specialist bronchiectasis clinic  
 Variety of ages  
 Variety of social and cultural backgrounds 
 Patients with a new diagnosis (within 6 months) 
 Patients with a longstanding diagnosis 
 Patients with additional diagnoses 
 Variation in disease severity 
 Patients with carers 
 
The following inclusion and exclusion criteria were also applied:- 
Inclusion Criteria: Clinical and radiological diagnosis of bronchiectasis 
Age 18 years and over 
Capacity to give informed consent 
Exclusion Criteria: Cognitive impairment 
Sampling and analysis were conducted concurrently in order to focus on particular 
aspects of data, emerging concepts, and potential influencing factors that were felt to 
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be important. For example, the first ‘round’ (Rapley, 2010; Rapley, 2013) of sampling 
aimed to concentrate on individuals who attended a general respiratory clinic rather 
than a specialist bronchiectasis clinic. The intention in this round was to explore how 
information needs may differ for those who do not attend a specialist service, hence 
building on the knowledge gained from the previous exploratory interviews. After 
analysis of this round, I focussed on sampling patients who had less severe disease, 
as this was an area that emerged as not having been explored. Further rounds 
focussed on the characteristics listed above and emerging data and ideas from 
ongoing interviews, which can also be referred to as theoretical sampling (Glaser, 
1978).  
This process obviously had to involve some flexibility, and participants wanting to 
take part who met criteria known to be of interest were not asked to wait until their 
‘round’. Sampling, as per recruitment and analysis, was an iterative process. An 
example of this would be sampling patients who had a more recent diagnosis of 
bronchiectasis. The first four participants had longstanding disease. In keeping with 
the findings from the pilot study, they often referred to how little information they had 
when first diagnosed in a non-specialist clinic. Whilst this may be an entirely correct 
recollection, specifically sampling patients who had received a recent diagnosis 
potentially allowed for more accurate descriptions of their experiences. This also 
enabled me to explore reactions to diagnosis when these feelings were fresh in 
people’s minds. Ultimately I was able to recruit four patients who had received a 
diagnosis within the past six months, with some having a diagnosis of bronchiectasis 
made within just a few weeks of their interview date. Clearly this needed to be 
opportunistic sampling when new patients were referred to clinic and was ongoing 
throughout the sampling process.  
In terms of sample size, an estimate was made in advance of commencement of 
recruitment of up to 20 patients and between 5 to 10 carers. This was flexible and the 
aim was to continue to interview until no new major issues relevant to the project 
were identified from the data. As qualitative studies aim to obtain a richness of data 
as opposed to simply a large number of participants, there is no definitive guidance 
as to how many interviews are ‘enough’. The term most frequently used to guide 
researchers as to when they have completed an effective sample size is ‘saturation’ 
or ‘data saturation’ (Hennink et al., 2016). Theoretical saturation was its starting 
point, a term used originally in grounded theory to describe the point when there is no 
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further emerging insight when gathering data (Glaser and Strauss, 1967; Kvale, 
2007). The term data saturation is used widely in qualitative research to mean when 
continuing data collection does not lead to the identification of any new issues (Kerr 
et al., 2010). There is a lack of guidance, however, on qualifying saturation and 
establishing the sample sizes required to achieve it (Morse, 1995; Guest et al., 2006; 
Kerr et al., 2010; Hennink et al., 2016). A recent study attempted to provide guidance 
on numbers of interviews required to achieve saturation and found that for ‘code 
saturation’ (no new codes emerging) the number of interviews required was fairly low 
at 9 (Hennink et al., 2016). Their findings are in keeping with previous ranges 
identified between 8 and 16 (Namey et al., 2016) and 7 and 12 interviews (Guest et 
al., 2006). Hennink et al attempted to go further and identify when ‘meaning 
saturation’ was reached, which they defined as ‘the point when we fully understand 
issues, and when no further dimensions, nuances, or insights of issues can be found’ 
(Hennink et al., 2016, p. 4). Although code saturation had been reached by interview 
9, meaning saturation required up to 24 interviews, and was complex to predict, 
being affected by multiple factors including more conceptual codes needing more 
data to be fully understood. They proposed that a decision of whether a small, 
intermediate or large sample (absolute numbers not specified) would be required 
should be made based upon multiple factors: purpose of the study, sampling 
strategy, and aims such as capturing broad themes or developing new theory. 
Although this tells us that sample size is dependent upon the aims of the study and 
the sample and data obtained, it would not be possible to predict a definitive sample 
size for this work due to the number of influencing factors and the quality of data not 
being known in advance of study commencement. In practical terms, the aim in this 
study was to ensure that all the key questions and ideas had been as thoroughly 
explored as possible and further sampling rounds did not generate any significant 
new ideas or meaning (Rapley, 2010).  
The sample size for carers (5-10) was more of a pragmatic decision, yet still 
facilitating the inclusion of their views as a group. As described in Chapter 2, carers 
can be central to patients’ information needs and can in fact be the primary 
information seekers. It is also known that carers often play a significant role and as 
such are likely to have specific information needs of their own. Carers were included 
in this sample to explore their experiences directly, rather than solely seeking 
patients’ accounts of their role.  
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More detailed characteristics of those recruited to the study, including the order in 
which they were interviewed are summarised in Chapter 4, the interview findings.  
3.2.2 Recruitment 
Patient participants were recruited from The Newcastle upon Tyne Hospitals NHS 
Foundation Trust. This covered multiple respiratory clinics provided by different 
respiratory consultants over two different hospital sites. One of the clinics is run as a 
specific specialist bronchiectasis service which is led by a single consultant.  
First approach to potential participants was by their clinical care team. The sampling 
strategy outlined was applied when asking clinical care teams to identify and 
approach suitable potential participants. All respiratory consultants within the trust 
were made aware of the study and given patient information sheets by the research 
team which included research nurses based at the Sir William Leech Centre for 
Respiratory Research at the Freeman Hospital. If potential participants were 
interested in hearing more about the study their details were passed to the research 
team by their clinical care team with their consent. Patient information sheets and 
invitation letters were sent out in the post to them or handed to them in clinic 
(Appendix 4, Appendix 5). This was then followed up by a telephone call from me 
after a minimum time elapsing of twenty four hours. This process ensured all their 
questions were answered and enabled me to arrange a convenient meeting time and 
place if they were interested in taking part. Any patient who agreed to take part in the 
study was asked if they had someone who played a significant role in their lives that 
they would like to join them in the interview; such as a spouse, family member or 
close friend. These additional participants were identified as ‘carers’. Written, 
informed consent of both patient and carer participants was obtained in advance of 
the interviews and was done in person, usually immediately prior to the 
commencement of the interview (Appendix 6).   
3.2.3 Interview process 
Patients and carers were invited to take part in one semi-structured interview 
expected to last between 30 and 90 minutes. All carer interviews were carried out as 
joint interviews with ‘their’ patient participant.  
Participants were given the option of the place of interview and the majority chose 
their own homes. One interview took place in a participant’s place of work in a private 
office, one took place in a patient’s private room on a hospital inpatient ward, two in 
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private rooms at the research facility at the Freeman Hospital and one in a private 
room at Newcastle University. The remaining twelve interviews were conducted in the 
participants’ homes. Different settings can impact upon the atmosphere and how a 
patient reacts to an interview (Green and Thorogood, 2009b) and also upon the data 
obtained (Green and Hart, 1999). The aim in offering choice of venue was to ensure 
maximum comfort and convenience for participants and to endeavour to conduct the 
interview with an informal conversational style allowing participants to relax and feel 
at ease. 
All interviews were conducted by me, which raises the issue of my role as an 
interviewer and how this may have influenced the narratives and responses from the 
interview participants. All of the participants were aware that I am a respiratory 
doctor. I carefully considered whether I would attempt to avoid declaring my ‘medical 
identity’ and ultimately decided against it. It has been described in the literature that 
interviewees’ perceptions of the interviewer affect interview interactions, and that 
professional role can influence this (Hoddinott and Pill, 1997; Hoddinott and Pill, 
1999; Richards and Emslie, 2000). I felt that to be consistent I would need to declare 
my role as a doctor to all participants, prior to commencement of the interviews. 
When considering what influence this may or may not have upon the interviews, and 
on people’s decisions about taking part, I felt that I needed to be open about this. For 
example, I could have introduced myself to potential participants as a ‘researcher’. I 
wondered what I would then say if people asked me what I knew about 
bronchiectasis, or if I worked with their healthcare team, or knew their consultant. I 
also knew that there was a definite probability that some participants would have 
already have come into contact with me in a clinical capacity. In order to maintain 
consistency between participants, and to avoid being conservative with the truth, I felt 
that the best approach would be to simply present my actual identity: a trainee 
respiratory doctor, who has expertise in bronchiectasis, and is currently a researcher.  
There may well be assumptions or beliefs that I bring as a doctor that others 
wouldn’t. Obviously, how the interview data would have differed with a different 
researcher is unknown. This, however, would be the case regardless of my role as 
solely a researcher or as a doctor in addition. It was possible that my profession 
would influence what accounts participants were willing to give to a ‘doctor’ rather 
than a ‘researcher’. Arguably there may also have been answers that would only be 
given because I was a doctor. In order to maximise consistency and transparency, 
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another important aspect of methodological rigour, I opted to make my role as a 
doctor who knew about bronchiectasis clear. I did this during introductions in 
telephone calls prior to the interviews being arranged. I will go on to reflect upon my 
role as interviewer in the discussion of the interview findings in Chapter 4. 
Much consideration was given to the interview schedule. The original interview topic 
guide is provided as an appendix (Appendix 7). Note that this was developmental 
and interviews were tailored to the answers of each interviewee and adapted over 
the course of the project as new research questions emerged from the analysis of 
prior interviews. The content of the topic guide at the outset was developed by 
building upon areas of interest arising from the pilot study (Hester, 2012; Hester et 
al., 2012a) and by drawing on past literature surrounding information seeking 
(Leydon et al., 2000; Cotten and Gupta, 2004; Case et al., 2005; Lambert and 
Loiselle, 2007; Lee et al., 2016). Also influencing the topic guide was what is already 
known about self-management (as detailed in Chapter 2) as well as interview 
methods and practicalities (Kvale, 2007; Green and Thorogood, 2009b; Lee et al., 
2016). Discussion with supervisors regarding both content of the guide and style of 
questioning also shaped the interviews, by integrating both clinical and sociological 
content. 
The interviews aimed to cover 4 main topic areas:-  
‘Learning about bronchiectasis’ 
This was the opening topic for each interview, and was introduced very broadly by 
asking participants to talk about when they first found out that they (or the person 
they cared for) had bronchiectasis. Although this generally invited a response that 
detailed the patient’s ‘story’ I then led this towards an exploration of the information 
they had been given at the time of diagnosis, as this had been a subject that had 
arisen as an area of need in the pilot interviews. This then allowed conversation 
about whether or not they had gone in search of more information since diagnosis: 
why, where and when this may or may not have occurred. ‘Learning about 
bronchiectasis’ also covered what people wanted to know about their condition, or 
what they already knew. By allowing discussion very generally around these 
subjects, I was able to explore both factual knowledge about their condition and 
approaches or barriers to information seeking. It was important to be able to establish 
from the interview data what factual aspects were felt to be important or areas they 
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were lacking information about (i.e. more clinical details) and also how, why, where or 
when people may or may not need or want information (i.e. more sociological or 
behavioural details). Both these aspects of data were critical to being able to 
effectively inform the design of the information package.  
 
‘Managing bronchiectasis’  
Discussions in this area aimed to explore knowledge and practices surrounding self-
management to elicit details regarding perceived abilities, roles, confidence and 
support required. This too was important for the planned information resource. 
 
‘Future information formats’  
This section aimed to further explore participants’ views of different modes of 
information delivery. To facilitate discussions around this and prompt opinions on 
styles of information resource, examples were shown to participants within the 
interviews. They were shown different styles of written information leaflets, an 
information DVD and several information websites. In order not to cloud judgement 
with details of actual content, the examples used were relevant to conditions other 
than bronchiectasis. The approach of ‘talking whilst looking’ at the information 
resources was taken to try to best understand their online information seeking, likes 
and dislikes (Lee et al., 2016).  
 
‘About you’  
This was a section included to ensure that relevant details such as length of time 
since diagnosis, age and nature of bronchiectasis were recorded in case they had 
not already been discussed earlier in the interview.  
The topics as set out in the interview schedule were not covered in order, yet served 
as a guide for the interview to ensure inclusion of important points. As the interviews 
progressed and other topics of importance arose, these were included within 
subsequent interviews in order to cross-check and further explore them. For 
example, prognosis was a topic often raised by participants, along with wanting to 
relate to other people in similar situations. These then became topics that would be 
raised in subsequent interviews for discussion if not already raised spontaneously by 
the participants.        
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The interviews were recorded using a digital audio recorder so as to ensure accurate 
data and allow conversational flow. Additional field notes were made both during and 
immediately following the interviews. These were notes to myself taken during the 
interviews concerning points that I felt to be significant, or wanted to explore further.   
3.2.4 Handling of interview data 
The interviews were audio recorded and audio files were transcribed verbatim. All 
data was stripped of strong identifiers and only identifiable by a unique study number. 
Only authorised members of the research team, operating to written codes of 
confidentiality, had access to the link between anonymised data and patient or 
professional identifiable details. Patients and professionals were not identifiable in 
any publications emanating from the work described in this thesis. Data was handled, 
computerised and stored in accordance with the Data Protection Act 1998. No 
participant identifiable data left the study site. 
3.2.5 Analysis of data 
Thematic analysis was used for the analysis of interview data and field notes were 
reviewed in conjunction with the transcripts to inform analysis. The process of 
thematic analysis begins when the researcher begins to notice and look for patterns 
of meaning and issues of potential interest within the data. Analysis therefore started 
during the collection of the data, i.e. at the interviews. The end point was when the 
themes and their content and meaning were reported. There are several stages of 
thematic analysis (Grbich, 1999; Braun and Clarke, 2006; Gibbs, 2007):- 
1. Becoming familiar with the data by reading repeatedly to search for meanings 
2. Develop a list of ideas about the data, applying codes and organising into   
meaningful groups 
3. Looking for themes 
4. Reviewing the themes 
5. Defining and naming themes and a written detailed analysis of each theme 
6. Written report including all themes 
To give a little more detail on how the above process was applied to analysis of my 
data I will give some more specific examples. Firstly, as discussed in the sampling 
section, I carried out data analysis and sampling concurrently in ‘rounds’ (Rapley, 
2010). This approach involved carrying out the first few interviews, and then 
reflecting upon analysis of the data generated in order to aid further sampling and 
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highlight areas to focus on in future interviews. In order to do this, interviews were 
transcribed as soon as possible. Whilst this was taking place, interview audio 
recordings were listened to repeatedly to review the content of the interview and 
initial ideas. By reading and re-reading the interview transcripts and field notes, and 
re-listening to the audio-recordings, I became familiar with the data. A great deal of 
time was spent becoming familiar with the data so as to ensure accurate detail when 
conducting the analysis. When familiar with the data within the first few interviews, I 
began to develop a list of ideas about the key issues at that stage. Having used 
different codes to describe small sections of data within these initial transcripts, (e.g. 
impact of bronchiectasis) I then began to assimilate a list of codes (Appendix 8) and 
applied these codes to the data within the subsequent transcripts. I revised this list 
throughout the analysis process as ideas developed and evolved throughout further 
rounds of sampling and analysis. This was used for ease of updating and application 
of the generated codes and sub-codes (used to establish grouping of similar ideas, 
e.g. sub-codes of the code ‘impact of bronchiectasis’ include physical, emotional, 
role) to subsequent transcripts as the analysis progressed. This enabled me to 
document clearly when new codes were generated and to ensure no potentially 
confusing repetitions were made.  
When the first round of interviews had been coded in this way, I began to develop 
ideas about the themes within the data. Themes developed, changed and became 
more conceptual over time. Themes described the broader meanings within the data 
rather than coding specific small sections of data. As themes developed I wrote 
written analyses of individual themes (memos) which also changed over time. By 
dedicating large amounts of time to analysis during the time of the interviews and 
beyond, I was able to pay very careful attention to detail within the data. 
I referred previously to the consideration of methods to ensure the validity and 
reliability of the resultant data. There are differing views with regards to attaining 
rigour and validity in qualitative research and approaches obviously differ from that of 
quantitative research. Key components in qualitative work include peer and 
supervisor review and code checking, deviant case analysis and reflexivity. Ensuring 
such validity, reliability and generalisability started at the outset of this work. A basic 
yet important aspect of reliability is ensuring accuracy of transcripts and using audio-
recording to allow this (Green and Thorogood, 2009b). As described, careful 
checking of the transcripts was carried out and verbatim transcription was used.  
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Throughout the interviews, I used careful purposive sampling and concurrent data 
analysis. This iterative process, including writing memos alongside analysis 
throughout, allowed for the development, exploration and ‘testing’ of new ideas 
emerging from the data and adds to methodological rigour (Gibbs, 2007; Kvale, 
2007; Rapley, 2010; Rapley, 2013). Using this approach ensured optimisation of the 
validity and generalisability of the data. To add further to this validity, ensuring 
descriptions and emerging themes were genuinely representative of the data and 
participants’ experiences, I used both peer and supervisor review. Coding of 
randomly selected transcripts was checked by my PhD supervisor. Some data has 
also been analysed collectively in ‘data clinics’. Within these data clinics, members of 
the research team, including supervisors, postdoctoral researchers and doctoral 
students share and exchange interpretations of key issues emerging from the data. 
This is done by taking along sections of anonymised interview transcripts. This 
review and discussion with my peers and supervisory team has formed a vital part of 
ensuring methodological rigour and a more complete understanding of the data. This 
has added to both the validity and reliability of the data, with confirmation of 
reproducibility of findings with different investigators as well as different participants 
(Gibbs, 2007).  
Another method employed to maximise validity and hence rigour was searching for 
and the analysis of ‘deviant cases’ or ‘negative cases’ (Green and Thorogood, 
2009a; Rapley, 2010). Interestingly, the very first participant interviewed stood out as 
a ‘deviant case’ when describing his disinterest in hearing about other people’s 
similar health experiences. As I will describe in Chapter 4, this was an aspect of 
information that other participants found to be very helpful. Further analysis of such 
contradictory instances in fact added strength to the theme rather than disproving it, 
with this one participant highlighted as a marked exception to the norm.  
 
Finally, the use of reflexivity also played an important role within this analytical 
process (Gibbs, 2007; Green and Thorogood, 2009c). This involved both continuous 
reflection upon the data and the interviews themselves, and also reflection upon my 
role as interviewer and how my medical or social milieu potentially impacted upon the 
data and its analysis. As I referred to earlier, one specific example would be the 
impact of my role as a doctor (Hoddinott and Pill, 1997; Hoddinott and Pill, 1999; 
Richards and Emslie, 2000; McNair et al., 2008). I will discuss my reflections on the 
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potential influence of my day to day work role upon the interviews in Chapter 4, along 
with detailed results of the analysis of the interview data.  
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3.3 Methods: The resource development process 
Once interview analysis was complete, the process of developing the novel patient 
information resource based on the interview findings was commenced. How the 
findings of the interviews specifically influenced the resource will be described in 
Chapter 5. The methods used to develop the resource and ensure that it met users’ 
needs will be described here. By co-developing the resource with users, I aimed to 
ensure that interpretation of the interview findings and subsequent translation into a 
novel resource was an accurate representation of users’ requirements, and that it 
was developed in a way that would maximise potential uptake. The literature 
pertaining to the development of patient information has been discussed in the 
previous chapter.  
3.3.1 Sampling and recruitment 
The focus group style workshops used during the co-development process were 
detailed within the patient information leaflets given to potential interview participants 
(Appendix 4). It was stated that interview participants may be invited to attend a 
focus group to discuss the findings of the interviews and how these might inform the 
design of the new resource. Whilst all interviewees were invited to attend the focus 
groups, not all wished to or were able to attend and additional patients with 
bronchiectasis were also invited to join the groups. A purposive yet pragmatic 
approach was taken to this further sampling, and a mix of female, male, newly 
diagnosed and longstanding patients who had not taken part in the interviews were 
invited to attend, with or without their carers. For these additional participants, the 
same inclusion and exclusion criteria and recruitment processes were used as 
described previously for the interviews. A separate patient information leaflet and 
consent form was provided for those patients and carers taking part who had not 
been interviewed (Appendix 9, Appendix 10).  
3.3.2 The workshop sequence: Ideas, concepts, prototypes and refinements  
Once the main emergent themes had been identified and described, I developed 
some initial ideas about the resource based on those themes, and other important 
elements of the interview data relevant to the resource. In basic terms, this involved 
creating lists of themes and their descriptions to further explore and check, and also 
options as to what information may be included, what formats may be used and how 
it may be presented. Potential concepts for the new resource were drafted to get 
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further views and opinions. This enabled me to check the validity of the findings of 
the interviews and confirm how this could translate into a user-friendly resource.  
Workshop 1: ideas and concepts 
The aims for Workshop 1 were to establish agreement (or disagreement) with the 
main themes and ideas for contents and by doing so further refine the ideas for the 
resource. I additionally aimed to confirm what format the resource would be 
developed in, i.e. a booklet, website or DVD. The workshop was facilitated by me and 
a specialist bronchiectasis nurse. An extensive topic guide (Appendix 11) was used 
as a basis for discussion given the large volume of contents to be addressed, albeit 
at a preliminary level.  
Details of the main themes and their key components were printed out and placed on 
a central table to aid discussion (Appendix 12). Also printed out for discussion were 
ideas for the main contents and sections to be included within the information 
resource. Additionally, basic mock up booklet cover pages and website homepages 
were created with removable elements to establish priorities for these, ranging from 
what to include on a front page to what the title of the resource should be (Figure 1). 
The workshop sessions were audio recorded and still photographic images were 
taken with permission of participants.  
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Figure 1. Workshop 1 materials. 
 
 
Prototype development 
Once the ideas for the concept and design of the resource and its overall content 
were affirmed and refined, work began on the development of the resource. I did this 
with additional help from both the Freeman Hospital Adult Bronchiectasis Service 
team and a recommended media company specialising in website design. I held a 
series of discussions with potential contributors, including a specialist bronchiectasis 
nurse, bronchiectasis consultant, physiotherapists, dietitian, incontinence nurse, lung 
function technicians, patients and carers in order to establish who would have an 
input into which sections of content. I met with the media design company to 
establish what we envisaged for the end product – the information resource. In order 
to achieve this I needed to describe to them the purpose of the resource, the required 
content and format and the characteristics of a typical potential user.  
The vast majority of actual content was written by me and verified by my clinical 
supervisor, a bronchiectasis consultant. Specialist sections were written by their 
provider and then edited by me. For example, the bronchiectasis specialist 
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physiotherapist wrote the pages covering physiotherapy techniques and exercise 
advice, and the dietician wrote the content relevant to her expertise. By using the 
whole bronchiectasis multidisciplinary team’s expert knowledge and experience, I 
was able to create a resource offering credible, up to date and accurate advice and 
information from clinical experts. By inviting patients and carers to contribute to 
certain sections, elements identified as important to the final resource were also 
incorporated. The ways in which the contributions to and review of the prototype by 
users and the expert health care providers shaped the final product is described 
further in the results chapters. 
All written contents were edited by me and checked by other members of the 
contributing team. The Easy Read principles were taken into consideration when 
reviewing written content, to try to maximise accessibility (Department of Health, 
2010). I had extensively reviewed relevant literature and guidelines pertaining to this, 
and also attended a training workshop to further develop my skills in this area. 
Although this was not a resource specifically aimed at those with low literacy levels or 
learning disabilities, as highlighted in Chapter 2, it is important to adopt an aim of 
producing accessible information during the production of any new materials 
(Kronzer, 2016).  
All video content was filmed and edited by me, and permissions for any images 
included were obtained by me. Once the prototype content was finalised, this was 
sent on to the media company to build into the prototype website, the final version of 
which was hosted by Fasthosts, on a virtual server, at an annual cost. The 
contributory team, a respiratory consultant not involved with the project, and invited 
user reviewers (including a BLF user representative) commented on content in 
addition to initial styles and layouts developed as examples by the media team. 
Views were fed back in order to agree a final style and images for the website 
homepage and to refine content. As content was developed further following this, I 
undertook training to access to the content management system for the website and 
thus was able to add or amend any content, plus create user access logins and 
passwords. Once the content was completed for this first prototype version, the 
second and third workshops were held to review and refine this further, and to decide 
on the contents of a booklet version of the resource.  
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Workshops 2 and 3: Refinements 
The second workshop again had patient and carer participants and was facilitated by 
myself and the specialist bronchiectasis nurse. For this workshop the topic guide was 
much more concise (Appendix 13) as the aim of the session was to show the 
participants the current version of the website at that time to obtain feedback. I 
particularly wanted to get feedback about the appeal and credibility of the homepage, 
and navigation through the website. We also discussed the contents of relevant 
sections, including text, images and video, and the overall impression of the resource 
in comparison to others they may have seen. Additionally, this session was used as a 
forum to discuss thoughts about which sections should or should not be included 
within the short booklet version of the website. 
The third and final workshop followed the same guide as workshop 2, yet was a more 
focussed and detailed review of the website content with a much smaller group.  
3.3.3 Data handling 
The workshops were audio recorded and audio files were transcribed verbatim. All 
data was stripped of strong identifiers and only identifiable by a unique study number. 
Only authorised members of the research team, operating to written codes of 
confidentiality, had access to the link between anonymised data and 
patient/professional identifiable details. Patients and professionals were not 
identifiable in any publications emanating from the work described in this thesis. Data 
was handled, computerised and stored in accordance with the Data Protection Act 
1998. No participant identifiable data left the study site.  
3.3.4 Analysis of workshop data 
A pragmatic approach was taken to analysis of the data obtained through the 
workshops. A thematic analysis approach was used, yet the majority of the useful 
data was ‘real-time’ feedback. Notes were taken during the sessions, and 
discussions reviewed through subsequent reading and re-reading of the transcripts to 
ensure familiarity with the data. Discussions within and between the workshops 
tended to concur and as such ‘themes’ identified within the data were collective 
opinions. Any disagreements or deviations were usually discussed within the session 
and a common ground found. I used the transcripts to confirm workshop discussions 
and identify any further themes to aid resource refinement. Conclusions about 
alterations and refinements, sections that were liked or not, and how things should be 
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amended were directly applied to the resource development process. By using this 
iterative approach, a final working version of the resource, in website and booklet 
form, was produced to be used within the Bronchiectasis Information and Education 
Feasibility study. Results of the resource development are described in Chapter 5. 
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3.4 Methods: Bronchiectasis Information and Education: Feasibility study and 
evaluation of a novel resource (The BRIEF Study) 
Once the resource had been developed, its use as an intervention needed to be 
assessed. In order to go beyond a simple evaluation process, a feasibility study was 
conducted in order to both review the intervention itself, and to determine the 
feasibility of being able to conduct a future full randomised controlled trial (RCT). A 
definitive, multi-centre trial would address the research question: can the provision of 
patient-focussed information and education improve health outcomes in 
bronchiectasis? The rationale for the BRIEF study was, in advance of the definitive 
trial, it is necessary to assess whether the proposed design for the trial is practicable 
and will allow the proposed outcomes to be assessed. In addition the intervention 
was evaluated and further refined for use within the definitive trial. The full protocol is 
available as an appendix (Appendix 3) and has been published in Trials journal. 
(Hester et al., 2016). 
3.4.1 Study design and setting 
The BRIEF study was an unblinded single centre randomised controlled trial with two 
parallel groups, comparing a novel patient information resource to usual care in 
bronchiectasis. The BRIEF study took place in The Newcastle upon Tyne Hospitals 
NHS Foundation Trust. This consists of two teaching hospital sites: The Freeman 
Hospital and The Royal Victoria Infirmary. Study visits all took place within the 
Freeman Hospital. The running of the trial was based within the Freeman Hospital at 
the Sir William Leech Centre for Respiratory Research. Patients were recruited from 
either hospital site. 
Study duration for each participant was 3 months from study entry date. Due to 
variations in month length, this was calculated at 12 weeks (84 days). Study 
completion date was the date of the last assessment visit of the last entrant and 
completion of the end of study focus group. Study flow can also be seen in in the flow 
chart (Figure 2). 
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Figure 2. BRIEF study flow chart. 
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3.4.2 Study objectives 
Primary objective: To conduct a feasibility study that will inform the decision of 
whether to proceed to the definitive RCT and whether any refinements to the design 
or conduct of that trial are warranted. 
Secondary objectives: To evaluate and further refine the patient information 
resources and collect information on patient preferences. 
Definitive future trial objectives: To assess whether provision of a patient-focussed 
information and education resource can improve patient understanding, self-
management and health outcomes in bronchiectasis. 
3.4.3 Study Intervention details 
The BRIEF study compared the newly developed patient information resource 
(detailed in Chapter 5) with usual care. Those in the usual care arm did not receive 
any additional information but were able to obtain any information routinely acquired 
during their usual contacts with their healthcare team or their own information 
seeking. At the baseline visit, participants randomised to the intervention received the 
patient information resource: an overview booklet and website (password required for 
website access). Verbal and written instructions were given by appropriate members 
of the research team (as per delegation log) about how to access the website. The 
participants then had access to the intervention for the duration of the study. Their 
use or not of the information resource was down to individual choice, yet, through 
discussion with the research team member conducting each study visit, participants 
were encouraged to utilise the resource and to allow their families or carers to also 
utilise them should they so wish. Some participants may not have had direct access 
to a computer or internet use. This did not preclude them from entry as long as they 
could access the internet via their family, friends or local institutions such as libraries. 
For those who did not wish to or did not have the skills to access the website, 
participation using a PDF version of the information contained within the website was 
offered. This enabled them to view all the information content other than the video 
clips. At study completion, those randomised to the intervention group were allowed 
continued access to the resource. Those in the control group were offered access to 
the resource following completion of their study period so as to minimise potential 
disappointment due to their allocation to the control arm. This decision was made 
following discussions with the Trial Oversight Committee (TOC) and ethics committee 
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members. We felt this was a more acceptable way to conduct the trial as most 
potential participants had an interest in learning more about their condition. Any 
uptake of the resource following study completion did not form part of data collection.   
The intervention used in the BRIEF study was a non-clinical intervention and I did not 
expect any reasons for discontinuing the intervention other than participant 
preference. Any participant could choose to leave the study at any point with no 
effect on usual care. Potential participants currently participating in another trial were 
not approached for entry into the study.  
3.4.4 Study outcome measures 
The primary outcome measures for the BRIEF study were those measuring 
feasibility. These included:- 
• Participants’ willingness to enter the trial (consented participant to potentially 
eligible participants approached ratio). 
• Participant recruitment rate (as measured by the number of patients 
randomised divided by the length of the recruitment period).  
• Participants’ acceptability of study design (as measured by the completion rate 
of participants in each randomised group, ‘study completers’).  
• Participant completion of required study forms and visits as per protocol. 
Secondary outcome measures included the measures used to evaluate the 
information resource and the measures that would be used within a definitive trial to 
assess impact of the intervention upon health-related outcomes. For the purposes of 
this feasibility study, these measures contributed to the assessment of completion of 
study forms by participants and also to the resource evaluation process. Measures 
included:- 
Resource evaluation outcomes (unvalidated questionnaires):- 
 Resource Satisfaction Questionnaire (RSQ) 
 Monthly postal symptom questionnaire 
 Bronchiectasis Knowledge Questionnaire (BKQ) 
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Health-related and quality of life outcomes:- 
 Quality of Life-Bronchiectasis (QOL-B) (Quittner et al., 2014) 
 St George’s Respiratory Questionnaire (SGRQ) (Wilson et al., 1997) 
 Hospital Anxiety and Depression Scale (HADS) (Zigmond and Snaith, 1983) 
 Fatigue Impact Scale (FIS) (Fisk et al., 1994) 
 EuroQol 5 Dimensions 5 levels questionnaire (EQ-5D-5L) (Herdman et al., 
2011) 
 Number of unscheduled visits to primary or secondary care 
 Exacerbation frequency  
 Forced Expiratory Volume in 1 second (FEV1) 
All outcome measures were used in assessing feasibility of a future definitive trial, 
including recruitment, retention and study questionnaire completion rates. Participant 
evaluation of acceptability of the newly developed package was established through 
questionnaires and open questioning to include their satisfaction with the information 
provided, knowledge about their condition and management, and additional features 
that they felt may strengthen the intervention. Use of the resources provided and 
preferred formats identified within these questionnaires also informed feasibility of a 
future trial and allowed for refinement of intervention formats. A single focus group 
was held at study completion to strengthen data on the patient experience.  
Outcome measures were recorded at baseline (day 0) and then at 2 weeks (day 14) 
(i.e. shortly after initial viewing of information in order to facilitate obtaining first 
opinions), and 3 months (day 84) post recruitment. This was done during patient 
visits that were anticipated to take less than 1 hour each. Visit 2 could be conducted 
via telephone interview if participants preferred. Information was retrieved from the 
patient visits and patients' symptom and information sheets (patients were asked to 
complete a monthly postal record sheet, (week 4, 8 and 12) enabling identification of 
episodes of change in symptoms and actions taken, in addition to any information 
resource use, without the burden of a daily diary record) and also through GP and 
hospital recorded attendances if patients were unable to report or recollect.  
EQ-5D-5L was used to allow some estimate of health economic evaluation for a 
future RCT. It was anticipated that there could be potential health economic benefits 
if patients were empowered to self-manage thereby reducing service use. The 
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number of unscheduled presentations, exacerbation rate and FEV1 could potentially 
be used in a future full trial as a representation of the patients' ability to self-manage 
their condition and disease stability. Health related quality of life (HRQOL) measures 
were also felt to be important to include in a future definitive trial and were therefore 
recorded within this study. A recent review of their use in bronchiectasis has shown 
that they have good validity and repeatability. Specifically QOL-B and SGRQ were 
identified as having good psychometric properties, and QOL-B is the only disease-
specific HRQOL questionnaire available for bronchiectasis (Spinou et al., 2016). Of 
note, self-efficacy was not used as an outcome measure in the BRIEF study. As 
discussed in Chapter 2, self-efficacy is not always useful as an outcome measure per 
se, but is more a predictor of outcomes. There is no pre-defined minimal important 
clinical difference for example. In previous studies of self-management interventions, 
changes in self-efficacy do not necessarily produce measurable clinical differences. 
Having reviewed this at length, including discussion with Professor Lorig, who used 
this as a measure in the EPP studies (Lorig et al., 1985; Lorig and Holman, 1993; 
Lorig et al., 2001), it was concluded that it would not be appropriate to use this as an 
outcome measure for this study of an information provision intervention.  
3.4.5 Eligibility criteria 
Inclusion criteria 
1. Participant has capacity to provide written informed consent 
2. Aged 18 years or over 
3. Clinical and radiological diagnosis of bronchiectasis 
4. English speaking 
Exclusion criteria 
1. Cognitive impairment 
2. Non-English speaking 
3. Aged <18 years 
4. Participation in the preceding Bronchiectasis Information and Education 
(BRIE) study 
Due to the nature of the study, English language was a necessary inclusion criterion 
to ensure usability of the information provided. As this was a small feasibility study, 
resources were not available to produce the information in other languages, nor to 
 50 
 
provide a funded means of internet access. For those participants who did not have 
internet access, yet wished to take part in the study, the information within the 
website (excluding video clips) was provided in Portable Document Format (PDF). If 
a participant elected to enter the study as a ‘PDF participant’, this was recorded and 
the participants proceeded with the same visits and outcomes. Numbers requesting 
this mode of study entry were recorded to enable evaluation of resource format 
preferences.  
3.4.6 Participants 
Potential participants were identified by case-note review and attendance at 
outpatient clinics and were given or sent a letter of invitation to the study and a 
patient information sheet (Appendix 14, Appendix 15). Written informed consent was 
obtained from willing participants (Appendix 16). Patients could withdraw consent at 
any point with no effect on usual care. At the end of the study, some participants 
were invited to attend a focus group about their experience. Participants invited to 
attend the focus group were sampled purposively. The aim was to form a group that 
included participants of differing backgrounds and time since diagnosis, some from 
the control and some from the intervention group, and those that had differing 
preferences in terms of format used. Involvement in the focus group, however, was 
an optional extra and as such a pragmatic approach had to be taken. Anyone 
agreeing to take part in the focus group was invited to bring along their ‘carer’, who 
was then sent the appropriate information sheet to consider whether they would like 
to take part. Additional information sheets (Appendix 17) and consent forms 
(Appendix 18) were produced for those participants.  
3.4.7 Participant recruitment, identification and screening 
Patients were identified as described above. This was done on a sequential basis 
aiming to recruit 1 patient per weekly clinic. Eligible participants were invited to 
participate by their consultant, the Principal Investigator (PI) or the Chief Investigator 
(CI) who were part of the medical team. The study was explained to them further by 
the research team. A study participant information sheet was provided at this time 
and the patient could take this away for consideration. For those identified by case 
note review, a letter of invitation (Appendix 14) was sent in the post along with the 
patient information sheet and details of how to get in touch if interested. They were 
offered opportunity to discuss this further with the research team. 
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The details of the study were also discussed as part of a bronchiectasis open day 
held at the Freeman Hospital run by the Adult Bronchiectasis Service. This open day 
was advertised in the local press and on the trust intranet and was attended by both 
patients and staff. Patients who were interested in hearing more about the study 
could register interest using a form at the open day. A patient information sheet was 
then sent to their given address. In this setting there were a number of interested 
patients who were not attending clinics within the trust and therefore were not eligible 
for recruitment. This was explained to them and they were given general information 
about the study so that they could enquire about study results if they wished. 
A screening log was kept to document details of subjects invited to participate in the 
study. For subjects who declined participation, this documented any reasons 
available for non-participation. The log also ensured potential participants were only 
approached once. 
3.4.8 Sample size 
Sample size was up to 70, with a minimum of 30 being randomised to both the 
control and intervention groups. This was based on previous recommendations for 
good practice in feasibility studies (Lancaster et al., 2004). Due to this being a 
feasibility study, no formal power calculations were carried out. Up to 10 additional 
‘carer’ participants were anticipated to be recruited for the end of study focus group, 
as described above. 
I anticipated that 24 months would be adequate time to recruit 70 patients to this 
study, based on a clinic attendance of approximately 60 per month with an estimate 
of 50% of patients approached who were willing and able to enter. 70 patients 
recruited from approximately 140 patients approached would correspond to a 95% 
confidence interval for the recruitment rate of 41%-59% (an acceptable width of ± 
9%). I expected low attrition rates based on previous work and prior experience in 
this field. There was a 3 month additional period planned for follow up of the last 
recruited participants and time beyond for the focus group and analysis. 
3.4.9 Randomisation 
Participants were randomised to intervention or control groups in a 1:1 ratio, using 
random permuted blocks within strata. Because I knew there to be a disproportionate 
number of females within the potential study population and was uncertain of the 
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effect of gender on outcomes, randomisation was stratified by gender. The 
randomisation allocation schedule was generated by a statistician with no other 
involvement in the study. Randomisation was performed by the CI at site, or 
individual with delegated authority, using a secure password-protected web-based 
system administered by Newcastle Clinical Trials Unit. Randomisation generated a 
unique 3-digit Study identification (ID) number for each participant. Participants were 
informed of their allocated treatment group following randomisation. Blinding was not 
feasible for this study for patients or the research team conducting the study visits 
due to the nature of the intervention. Given that I, as the data analyst, was also 
involved directly with the study processes and data collection, blinding of the analyst 
was not possible.  
3.4.10 Data collection and handling 
Main study data 
Data was collected at study visits by the research team as per the delegation log and 
a summary is tabulated (Table 1). Visits 1 and 3 were done in person and visit 2 
could be either in person or on the telephone. Other than the spirometry performed at 
visits 1 and 3, all outcome measures were questionnaires and were either self-
completed by the participants or with the help of the research team member 
conducting the study visit. All answers were recorded in paper copies of each 
questionnaire within the participants’ files. The study team member conducting the 
visit checked for omissions after completion with the participant. All members of the 
delegate log were trained in the use of the questionnaires and lung function tests. 
The questionnaires completed are tabulated (Table 2) and also supplied as 
appendices (Appendix 19, Appendix 20, Appendix 21, Appendix 22, Appendix 23, 
Appendix 24, Appendix 25, Appendix 26).  
There was additional data collection through the use of monthly (week 4, 8, 12) 
postal symptom and resource use record sheets sent to participants (Appendix 19). 
This aimed to enable more accurate recollection of symptoms and information use 
than at the study visits alone, yet is a reduction in burden compared to completing a 
daily diary. Phone calls were made to encourage completion if the forms were not 
returned.  
Data on the use and attempted access to the online information resource was 
collected using Google Analytics. Basic data was collected to detail factors including 
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number of page views, most popular pages and navigation through the site. This was 
based on site access and use by individual participants was not monitored.  
Data collected on paper forms were entered by the CI or appropriately trained study 
research team members (as per delegation log) on a secure password protected 
study computer. Participants were identifiable on records only by a unique study 
identifier on all recorded data. Only authorised members of the research team, 
operating to written codes of confidentiality, had access to the link between 
anonymised data and patient identifiable details.  
Personal data was regarded as strictly confidential. To preserve anonymity, any data 
leaving the site identified participants by a unique study identification code only. The 
study complied with the Data Protection Act, 1998. All study records and Investigator 
Site Files were kept on site in a locked filing cabinet with restricted access. Only 
members of the research team had access to the final dataset, and that required for 
necessary audit and monitoring. 
Focus group data 
A single focus group was conducted after completion of the study. A brief topic guide 
(Appendix 27), in conjunction with the resource itself, was used to prompt discussion 
and the group was facilitated by me. The focus group was audio recorded and audio 
files were transcribed verbatim. All data was stripped of strong identifiers and only 
identifiable by a unique study number. Only authorised members of the research 
team, operating to written codes of confidentiality, had access to the link between 
anonymised data and patient/professional identifiable details. Patients and 
professionals were not identifiable in any publications emanating from the work 
described in this application. Data was handled, computerised and stored in 
accordance with the Data Protection Act 1998. No participant identifiable data left the 
study site.  
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Table 1. BRIEF Study data collection schedule. 
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Table 2. BRIEF Study data. 
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3.4.11 Compliance and withdrawal 
Compliance 
Where feasible, study visits were arranged to coincide with routine clinical follow-up, 
to enhance the likelihood of good compliance. Visit windows of +/- 1 week were 
allowed to aid visit attendance; non-attendance for study visits prompted follow-up by 
telephone. Participants were given the option of completing visit 2 by telephone 
interview to reduce the burden of travel for study visits. Non-return of monthly postal 
record sheets also prompted follow-up by telephone. 
Withdrawal of participants 
Participants had the right to withdraw from the study at any time without having to 
reveal a reason. The investigators also had the right to withdraw patients from the 
study intervention if judged to be in the patient’s best interests. As an excessive rate 
of withdrawals can render the study uninterpretable, unnecessary withdrawal of 
patients was avoided. If a patient decided to withdraw from the study, all efforts were 
made to report the reason for withdrawal (if given) as thoroughly as possible.   
There were two withdrawal options:   
1. Withdrawing completely (withdrawal from both the study intervention and provision 
of follow-up data) 
2. Withdrawing partially (withdrawal from study intervention but continuing to provide 
follow-up data by attending clinic and completing questionnaires). 
Consent was sought from participants choosing option 1 to retain data collected up to 
the point of withdrawal. Participants were asked if they would be happy for any given 
reason for the decision to withdraw to be recorded. 
3.4.12 Statistical analysis 
Statistical analysis was performed using SPSS 22.0. All analysis was carried out in 
keeping with a pre-written statistical analysis plan (Appendix 28). As this was a 
feasibility study, the analyses of the data collected were mainly descriptive. As the 
BRIEF study had a randomised controlled trial design, primary analysis was based 
on the intention to treat principle with analysis groups based on the groups allocated 
at randomisation and all randomised patients being included in the analysis. The 
extent of missing data was assessed and reported and analysis of outcomes carried 
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out on a complete-case basis. Rates were calculated as defined. At baseline and by 
intervention group the distribution of all numerical variables was examined 
graphically and summarised by measures of location and spread. Similarly, baseline 
categorical variables were tabulated and percentages reported. Change in the 
questionnaire outcomes from baseline to 2 weeks and 3 months was summarised. 
The difference in the mean change between the intervention groups from baseline to 
each of the two time points was explored for all validated outcome measures. Data 
was examined graphically and reported as appropriate for the distribution. The mean 
(SD) of the change data has also been presented given change data is most often 
symmetrical and this data could be used if calculating a sample size for a future 
definitive study based on this feasibility study design. No interpretation has been 
made of this basic change data nor of any apparent change within allocation groups 
given the fact that this cannot be meaningfully interpreted without further analysis 
and can be misleading (Vickers and Altman, 2001; Bland and Altman, 2011).  
All results were interpreted cautiously because of the size of the study and the 
possible imbalance in pre-randomisation baseline covariates. Data were examined 
graphically and analysed descriptively. No formal statistical testing was performed as 
this was a feasibility study, not powered to detect significant change within variables, 
and as such the reportable outcomes relate to feasibility. 
3.4.13 Analysis of focus group data 
The focus group conducted at the end of the study explored the experiences of 
participants and their carers. Topics covered both their views on the resource and 
their views on the trial itself. In a similar way to the analysis of the workshop data 
during the resource development process, a thematic analysis approach was taken. 
The group was audio-recorded and transcribed verbatim and transcripts were used to 
read and re-read and confirm issues identified during the focus group. Feedback 
themes were identified, summarised and reported. 
3.4.14 Monitoring 
This was a low risk trial and major safety issues were not anticipated. As agreed by 
Newcastle upon Tyne Hospitals NHS Foundation Trust, the Trial Oversight 
Committee (TOC) adopted the joint roles of Trial Steering Committee (TSC) and Data 
Monitoring & Ethics Committee (DMEC), with independent members meeting in 
closed session to fulfil the DMEC role. The TOC comprised an independent chair, an 
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independent consumer representative, a patient representative, a carer 
representative, CI, PI, data manager and statistician. The TOC met bi-annually. Their 
role was to monitor progress and supervise the trial to ensure it was conducted to 
high standards in accordance with the protocol, the principles of Good Clinical 
Practice (GCP), relevant regulations & guidelines and with regard to participant 
safety. Monitoring of study conduct and data collected was performed by site review 
to ensure the study was conducted in accordance with GCP. The main areas of focus 
included consent, serious adverse events and essential documents. 
The study was liable be subject to inspection and audit by Newcastle upon Tyne 
Hospitals NHS Foundation Trust under their remit as sponsor, and other regulatory 
bodies to ensure adherence to GCP. The investigator(s) / institutions would have 
permitted trial-related monitoring, audits, Research Ethics Committee (REC) review 
and regulatory inspection(s), and provided direct access to source data/documents. 
There was no interim analysis for this study. 
3.4.15 Ethics and regulatory issues 
The conduct of this study was in accordance with the recommendations for 
physicians involved in research on human subjects adopted by the 18th World 
Medical Assembly, Helsinki 1964 and later revisions. 
Favourable ethical opinion from NRES Committee North East - Sunderland (ref 
14/NE/0119) was granted and R&D approval (ref 7005) from the Newcastle upon 
Tyne Hospitals NHS Foundation Trust was granted prior to commencement of the 
study. Any protocol amendments were approved by R&D and the Sunderland REC 
and were communicated to all relevant parties: investigators, registries, participants.   
The study was registered with ISCTRN (ISRCTN84229105) on the 25/7/2014. The 
study was also accepted onto the CRN portfolio (UKCRN ID 16655).  
Information sheets were provided to all eligible subjects and written informed consent 
obtained prior to any study procedures.   
3.4.16 Informed consent procedures 
Informed consent discussions were undertaken by appropriately trained site staff (as 
per delegation log) involved in the study, including medical staff and research nurses, 
with opportunity for participants to ask any questions. Following receipt of information 
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about the study, participants were given reasonable time (with an aim of a minimum 
of 24 hours) to decide whether or not they would like to participate. Those wishing to 
take part provided written informed consent by signing and dating the study consent 
form, which was witnessed and dated by a member of the research team with 
documented, delegated responsibility to do so. Written informed consent was always 
obtained prior to randomisation and prior to study specific procedures and 
investigations. 
The original signed consent form was retained in the Investigator Site File, with a 
copy in the clinical notes and a copy provided to the participant. The participants 
specifically consented to their GP being informed of their participation in the study. 
The right to refuse to participate without giving reasons was respected. 
Due to the small subject population and the inclusion criteria, the information sheet 
and consent form for the study was available only in English.  
3.4.17 Insurance and finance 
The sponsor, Newcastle upon Tyne Hospitals NHS Foundation Trust, had liability for 
any clinical negligence that harmed individuals toward whom they have a duty of 
care. NHS Indemnity covered NHS staff and medical academic staff with honorary 
contracts conducting the trial for potential liability in respect of negligent harm arising 
from the conduct of the study. The Newcastle upon Tyne Hospitals NHS Trust was 
Sponsor and through the Sponsor, NHS indemnity was provided in respect of 
potential liability and negligent harm arising from study management. Indemnity in 
respect of potential liability arising from negligent harm related to study design was 
provided by NHS schemes for those protocol authors who have their substantive 
contracts of employment with the NHS and by Newcastle University Insurance 
schemes for those protocol authors who have their substantive contract of 
employment with the university. This was a non-commercial study and there were no 
arrangements for non-negligent compensation. Newcastle University provided 
insurance cover for the trial design. NIHR funded the study through a doctoral 
research fellowship awarded to the CI.  
Results of the BRIEF study are detailed in Chapter 6. 
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3.5 Summary 
As described within this chapter, this body of work has been conducted in three 
interlinking stages, using a mixed methods approach. The review of literature in 
Chapter 2 explained the need for improvements in information and education 
provision for patients with bronchiectasis and their carers and described how the 
nature of the resource and means of development are critical. By using qualitative 
methods to establish needs and involving patients and carers throughout the 
development process, I aimed to create a resource that met users’ requirements. By 
conducting the described feasibility study, I aimed to evaluate the resource and also 
establish the feasibility of conducting a future definitive trial to establish the impact of 
such an intervention and the refinements needed to both the intervention and 
protocol to facilitate such a trial.  
The results of the three stages of this work will be reported separately in the three 
subsequent results chapters. The results of the interviews are presented first, 
followed by the resource co-development process and subsequently the results of 
the BRIEF study. 
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Chapter 4 Results 1: Findings of the qualitative interviews 
In this chapter I begin with a summary of participant characteristics and recruitment 
and then describe the findings of the qualitative interviews with patients and carers. 
Within the interview data, four interlinking themes were identified, with the core 
emergent theme being ‘living your life with bronchiectasis’. This overarching theme 
describes the physical and non-physical impacts of living with bronchiectasis, and 
how these relate to the patient journey. The second theme, ‘developing support and 
coping mechanisms’ covers how both patients and carers learn to cope with this 
condition, and how they are supported in doing so. Thirdly, how patients ‘take back 
control and develop active partnerships with the medical team’ will be explored, 
describing how and when this process is facilitated. Lastly, this is linked with how 
patients and carers ‘connect with information’, the important features an information 
resource would require, and how this data could be used to inform the development 
of such a resource.  
4.1 Participant summary 
4.1.1 Participant characteristics 
Interviews with seventeen patients who have bronchiectasis took place, and nine of 
these interviews were conducted as joint interviews with the patient and their carer. 
Thus, there were twenty six participants in total. Of the nine carers that took part in 
the joint interviews, seven were spouses of the patient participant and two were 
siblings that co-habited with the patient they were interviewed with.  
The age range of participants was 33 to 78 years with a median age of 65 years. Ten 
patient participants were male and seven female. Of the carer participants, seven 
were female and 2 male. Time since diagnosis ranged from a few weeks to 65 years. 
Six of the patient participants attended a general respiratory outpatient clinic and 11 
were recruited from a ‘specialist’ bronchiectasis clinic. Of these eleven, four were 
newly diagnosed patients and as such had not received extensive information at the 
specialist clinic by the time of the interview.  
Whilst bronchiectasis has varying aetiologies, most participants had idiopathic 
disease. Of those who did not have idiopathic bronchiectasis, two had associated 
immune-deficiency syndromes and the remainder were thought to have been caused 
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by previous pneumonias. The majority of patients had additional medical diagnoses 
or comorbidities which varied in nature and severity.  
I recorded selected details on patients’ social circumstances, including who they lived 
with, current or previous occupations and age at which they left education. This was 
intended as a crude measure of socio-economic status, as factors including literacy 
levels could potentially influence the subject of interest: information needs. The 
majority of patients were retired, and jobs ranged from manual to professional with a 
wide variety of educational levels attained.  
The participants were sampled purposively as described in chapter two, in order to 
obtain a maximum variation sample and achieve a rich dataset. The participant 
characteristics relevant to the sampling strategy have been summarised (Table 3). 
Sampling was based upon patient characteristics rather than their carers hence the 
relative lack of detail about the carers. Carers’ details appear directly beneath ‘their’ 
patient in the table. 
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Table 3. Interview participant characteristics. 
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4.1.2 Participant recruitment rates 
There was a high rate of recruitment to the study amongst those identified as being 
interested in taking part. Four patients identified as potentially interested in taking 
part declined entry to the study when contacted by the researcher, stating poor 
health as their reason. One further patient cancelled their interview due to family 
commitments and was unable to rearrange. Recruitment and interviews took place 
over an eight month period of time.  
The recruitment flow chart summarises recruitment details (Figure 3).  
Figure 3. Interview recruitment flow chart 
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4.2 Main emergent theme: Living your life with bronchiectasis 
Living your life with bronchiectasis is the central issue emerging from the data. Note 
that the primary focus of the interviews at the outset was to establish unmet 
information needs. Interestingly, however, the overriding discussion within the 
interview data revolved around the impact that bronchiectasis has: what it means to 
live your life with this condition. Living your life with bronchiectasis encompasses 
experiences of diagnosis and the ongoing patient journey, and experiences of both 
the physical and emotional impacts of the condition.   
4.2.1 Diagnosis and prognosis: the patient journey 
Stories of diagnosis and concerns about prognosis were common throughout the 
interviews. Some recounted these tales from distant memory, whereas for others this 
was a very recent experience. The impact of the diagnosis itself varied between 
individuals, with multiple factors potentially influencing people’s reactions. One of 
these factors was timing of diagnosis. Some participants had received a diagnosis at 
a young age, others more advanced in years. Importantly, the way in which this 
influenced impact was not uniform. People’s experiences of living with the symptoms 
of bronchiectasis prior to diagnosis played an important role whatever their age. For 
example, several of those who were diagnosed later in life describe having not 
known any difference. Although they had recently received an official, clinical, 
diagnosis, they had had symptoms for as long as they could remember: 
‘I don’t feel any different than I have done for the last goodness knows how many 
years, it’s something that’s always been there and I guess I’ve just got used to it, but 
yeah, instead of me thinking it was asthma, which I thought it had been for years, now 
it has a name.’ (P17 26-32) 
‘I’ve had respiratory problems since 1967…and “bronchiectasis”…I just thought it was 
another word for ‘bronchitis’ really, I didn’t give it much more thought.’ (P15 9-16) 
These patients essentially describe their reaction as a ‘non-reaction’. The impact of 
their diagnosis, or the attribution of a name to their symptoms, was minimal. They 
now have a label, or a new label, for their symptoms, but nothing else has changed. 
Their symptoms are so much a part of their life that to be told they will continue is of 
little surprise to them. This continuance of their norm was exactly as expected.  
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There were also patients who had been living with the symptoms of undiagnosed 
bronchiectasis for many years, yet had a slightly different reaction. This patient 
described how he felt on receiving a diagnosis of bronchiectasis: 
‘I was shocked but sort of glad in a way, because it explained why I hadn’t been well 
for so long and, I mean, the littlest of coughs and colds I would be in bed for like a 
week because I couldn’t fight it basically, and now that explains why.’ (P10 16-19) 
Although this patient describes the element of shock at first that he actually did have 
a ‘condition’, he simultaneously experienced a positive reaction to the news. W ithin 
my data, this subgroup with undiagnosed symptoms tended to have a response of 
relief rather than despair when initially faced with the fact that they had a named 
chronic disease. Although their life would continue as they already knew it, they were 
not indifferent to the receipt of this diagnosis. Having this diagnosis enabled them to 
make sense of their experiences, and as such was well received.  
For some, however, receiving a diagnosis of bronchiectasis was a huge blow. Having 
‘more to lose’ seemed to magnify the impact of a diagnosis, as this patient and her 
husband described: 
‘I was pretty low. Wasn’t I? [C02: yes, totally] We were both pretty low because I 
thought well, you know, that’s it. Because I’d been such a busy, active person in the 
community I just feel that… I’m sorry.., I just feel as if my life, you know, has taken a 
bit of a downward spiral to be honest. It was quite emotional.’ (P05 C02 10-14) 
This lady’s reaction to receiving the diagnosis of bronchiectasis was one of finality: 
‘that’s it’. Being so active before the diagnosis, she felt she had a lot to lose, that this 
diagnosis would change her life as she knew it. Her previous experiences of illnesses 
had been conditions with surgical solutions, whereas this would be ongoing, an 
incurable illness. For this patient, amongst others, the point of receipt of diagnosis 
was a very negative experience; the end of their hopes that their symptoms could be 
explained away by ‘normal ageing’ and the start of their journey as a patient with a 
chronic disease. 
A patient’s ‘journey’ seemed to be directly linked with the presumed prognosis. 
Bronchiectasis differs from some other diagnoses in that there is often uncertainty 
surrounding prognosis. Patients are usually told that bronchiectasis is a chronic 
condition that can be managed, yet it cannot be cured. There is much variation in 
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terms of severity of symptoms. This uncertainty regarding prognosis was reflected in 
the interviews and clearly extends to the patients as well as the medical profession. 
One patient, with a very recent diagnosis, repeatedly led the conversation back to 
prognosis throughout the interview. Her primary concern was lack of information 
about the prognosis of bronchiectasis: 
‘I am interested in knowing about how progressive it is once you’ve got it, whether it’s 
got a grip on you and you’re never going to be released from this grip, so it’s a matter 
of containing what you’ve got?’ (P13 100-103)  
This lady wanted to be clear about the progressive nature of the condition and what 
this meant practically, which was a common feature of many interviews. How can 
someone plan for this patient journey without knowing what lies ahead? Having such 
a diagnosis without knowing a definite prognosis can be very hard to process, as 
another patient describes: 
‘Well I wasn’t aware what to expect. I knew I would deteriorate as time went on 
obviously, people get older, but not what path it would take, I know it’s not the same 
for every patient.’ (P03 163-165) 
As this patient demonstrated, knowing what to expect is important. Not knowing is a 
problem. It is a problem that continues beyond people’s initial reactions to their 
diagnosis.  
Centrally, time since diagnosis did not seem to influence desire for knowledge about 
prognosis. The continued focus upon prognosis of this incurable disease suggests 
that although patients may have had the initial diagnosis or ‘disruption’ many years 
ago, this biographical shift or change in trajectory is still laden with uncertainty. The 
shift is not a permanent and fixed new trajectory, but a move to an almost 
continuously or repeatedly disrupted one. A change from a presumed smooth life 
trajectory to the threat or reality of a constantly or periodically changing one. For 
those who had symptoms of bronchiectasis all their lives, their version of disruption 
could be likened to that of children with cystic fibrosis (an inherited multisystem 
disease with cystic bronchiectasis of the lungs): ‘non-difference’ (Williams et al., 
2009). For most, however, the diagnosis of a chronic illness such as bronchiectasis 
does not simply alter ones biography but opens the door to an uncertain future. 
Therefore one would imagine the process of acceptance, adjustment, or ‘learning to 
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live with’ the condition cannot be ‘completed’ at some point post diagnosis, as the 
symptoms or limitations that need to be accepted will be subject to change. This 
seems to lead to a lifelong adjustment process, requiring further work dependent on 
disease progression and changes in circumstance.    
How patients and their carers progressed on their ‘journey’ from diagnosis and dealt 
with the uncertainty of their prognosis varied, and those interviewed were at different 
stages of this journey. It was clear, however, that both the physical and psychological 
impacts of bronchiectasis directly influence the patient journey. Both are subject to 
change over time and both again are subject to much uncertainty.  
4.2.2 Living with the physical impacts of bronchiectasis  
Physically, symptoms of breathlessness, fatigue, cough and recurrent infections 
impose limitations on patients’ preferred lifestyles; affecting their ability to do things 
as they previously would have done. Adaptations needed to be made to allow for 
these new symptoms. These adaptations were not simply to physical activities, but 
also to people’s lifestyle, such as not going on aeroplanes, avoiding people with 
colds and changing drinking habits. This was all in an effort to reduce the impact of 
the physical symptoms, or reduce their chances of getting another infection and 
thereby not worsen their physical symptoms.  
Changes required to lessen the physical impacts of bronchiectasis were also affected 
by patient’s individual circumstances. For example, family commitments may dictate 
what changes to lifestyle are possible; lifestyle prior to symptom onset may influence 
the degree of change required; and factors such as a person’s level of social support 
or personal character traits also influenced impact and change. For some 
participants, changes also needed to be made to daily routines to allow for regular 
treatments. Patients often require more than simple oral medications. Nebulised 
antibiotics and physiotherapy regimes are often used which can be time consuming 
and socially restricting. Having bronchiectasis imposes change on one’s life. Due to 
the impacts it has, life is no longer ‘normal’.  
One might presume that any physical, or resultant practical, impacts (and indeed 
psychological impacts) may be directly proportional to the extent of disease. The 
degree to which symptoms impacted upon patients, however, did not consistently 
correlate with clinical severity. A medical diagnosis of ‘mild’ bronchiectasis was not 
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necessarily in keeping with the patients’ experience of their condition as this lady 
described:  
‘A mild case … I would hate to think anybody was worse than me, I think mine’s bad 
enough.’ (P04 63-163)   
Perception of severity is obviously subjective, highlighting the differences between a 
clinical label and a lived experience. Despite the classification of this patient’s 
condition as ‘mild’, this has had such an impact on her life that she can barely 
imagine how it could be worse. For her, this alleged ‘mildness’ provides little comfort 
or reassurance.  
Even when the clinical label does fit with the patients’ experience of their symptoms, 
there are still uncertainties. Another patient described how she felt about being told 
that her condition was classified as ‘mild’:   
‘mine fortunately is mild…it’s so mild that generally I’m feeling so well that it hasn’t 
made any impact on me, but I think it has had an emotional impact on me, to find that 
there is something wrong, but I need to discuss about the mildness of it, whether it 
could be milder.’ (P13 68-77)  
Although medical classification of this patient’s disease as physically ‘mild’ makes 
sense to her in terms of her symptoms, it is still important for her to make sense of 
whether it is modifiable. Having a label of ‘mild bronchiectasis’ is not necessarily 
reassuring, without putting it into context. This quote reinforces the uncertainties that 
patients are faced with when receiving such a diagnosis; not only is the absolute 
prognosis uncertain, but the symptoms one should expect are also uncertain.   
Part of the issue concerning uncertainty is the fact that the symptoms experienced 
are likely to change, both on a long and short term basis. Bronchiectasis is a 
condition that can deteriorate over time, and by its nature, there will be periods of 
exacerbation of symptoms. For example, one gentleman described how for many 
years he was not limited by his condition but that as his disease has progressed it 
has had a much greater impact on his lifestyle as a consequence of increasing 
physical symptoms:  
‘I (could) manage the bronchiectasis, cos I was working full-time, in fact sometimes I 
was working 50 hours a week when I was managing. 
 70 
 
…  
I’m leading a boring life at the moment, you know, not getting out much unless it’s in 
the car somewhere. I can’t go out for walks because…I’m struggling just to get to the 
end of the path.’ (P08 25-27; 614-617) 
This gentleman had bronchiectasis diagnosed as a young adult, and had spent the 
majority of his working life being able to cope with the physical impacts that 
bronchiectasis presented. The adaptations he needed to make to his life were 
minimal. However, as things have deteriorated more recently, his lifestyle bears little 
resemblance to the life he once had, despite the fact that he was also ‘living with 
bronchiectasis’ at that time too. Having bronchiectasis does not simply impose a 
single, permanent change to one’s life. 
As noted above, aside from the potential for progressive change over time, 
bronchiectasis also presents additional intermittent changes to the level of physical 
symptoms. This temporary worsening of symptoms during periods of exacerbation 
leads to extra changes having to be made to patients’ daily lives as this lady 
explained:  
‘The breathing gets a lot more difficult, I get a lot of pain, I’ve constantly got pain but it 
gets a lot worse if I’m having a flare-up, I get a lot more dependent on people…Some 
days I can’t even be bothered to get dressed, but I push myself to get dressed cos I 
want some normality in my life.’ (P03 228-230, 383-384) 
These periods of worsening of symptoms clearly result in physical limitations that 
make usual everyday activities become laborious and difficult, potentially changing a 
person’s ability to carry out their roles both in their work and personal life. Making it 
seem as though they no longer have a ‘normal’ life. For this patient, just carrying out 
these daily rituals in order to maintain a sense of normality took all of her efforts and 
required additional support.  
In order to present a comprehensive picture of the descriptions of change over time, 
it is important to include the fact that there were periods of time for some patients that 
were much easier to manage. As well as deteriorations and intermittent 
exacerbations, participants also described improvements in their condition as a result 
of changes to their treatment regimes:  
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‘I probably haven’t been as fit as I’ve ever been now (sic), since I’ve been diagnosed, 
which is a bit weird, I mean I haven’t had a…one (exacerbation) for about two 
years…which is great for me, so it’s something that I don’t think about, to be fair.’ 
(P10 26-31) 
This sentiment echoed the feelings of several participants. Patients talked about how 
they forgot about things when they were relatively well between exacerbations, when 
their physical symptoms were not enough to impact upon their lives to a significant 
degree. Without the physical symptoms to remind them of their diagnosis, little time 
was given over to thought or worry about it. Without the physical symptoms to impact 
upon their lifestyle, little effort was required to maintain their usual lifestyle. Whilst 
able to live their ‘normal’ life therefore, the psychological and psychosocial impact of 
bronchiectasis was also at a minimum. The link between the physical and 
psychological impacts of bronchiectasis was clear. 
4.2.3 Beyond the physical 
As noted above, the effects of bronchiectasis go beyond the physical impacts, and 
like the physical symptoms, the emotional impacts of having bronchiectasis can also 
be subject to change over time. Psychological effects are clearly linked with these 
physical symptoms, but are also influenced by other factors, such as passage of time 
and personal circumstances. Patients talked about the emotional impacts of the 
condition, and the conscious effort required to try to manage these impacts. This 
patient described the challenges of managing the emotional effects of bronchiectasis:   
‘Certain times if I’m busy, I sort of half forget about it…There’s some mind over matter 
going on in my head at the moment…but you can’t keep busy all day long, you know, 
you just can’t do it, you can’t focus your mind on something else all day long.’ (P05 
161-165)  
Trying to deal with these psychological impacts took considerable effort. Like the 
physical symptoms, these effects are seemingly an ever-present issue, yet she does 
refer to ‘half-forgetting’ about things when busy. Having to sustain this effort to 
eliminate the psychological impact however seems a burdensome task, almost 
unachievable. In addition, this constant ‘presence’ of bronchiectasis leads to 
psychological and social impacts that not only affect the patients but extend to others 
in their life as this patient and his wife explain:  
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‘C04: Your life is just…, well it’s just, I wouldn’t say it’s a routine but there’s just no 
end to it. 
P08: You can’t plan anything. 
C04: You can’t go away for two weeks and sort of like just unwind, it’s just there 
constantly isn’t it? It’s something that you’ve just got to live with.’ (C04 P08 294-297) 
It seems having bronchiectasis is at times all-consuming, it can rarely be forgotten 
about and impacts on lives to such an extent that patients and their carers can rarely 
plan ahead with any certainty. Those whose lives and lifestyles are interlinked also 
experience the effects of bronchiectasis first hand. There is no choice offered than to 
‘live with’ bronchiectasis for both patients and their carers.  
For the patients, the emotional impact of their condition not only included low mood, 
but went so far as to re-define the person’s sense of self or role in life. As one patient 
explained: 
‘It has made me unhappy, definitely. It’s made me depressed, it’s made me unhappy, 
and sometimes I feel as if I’m not the person I used to be.’  
… 
‘Bronchiectasis…it takes it out of you, you know, you’re not exactly the same person 
at all.’ (P04 146-147; 605-626)  
The disease has transformed this patient’s sense of self. As Charmaz described, in 
chronic illness the unity between the body and self is disrupted and so peoples’ 
identities are reconfigured (Charmaz, 1983; Charmaz, 1995). As this lady described, 
with the onset of the disease, ‘you’re not exactly the same person’. Linked with this 
change in sense of self or identity were changes in how people felt they were viewed 
by others. Participants described many situations in which they had encountered 
stigma. This included both perceived stigma from strangers and enacted stigma from 
interactions with friends (Goffman, 1963). Firstly, a frequent reference to the stigma 
attached to having an audible cough, and as such a socially visible condition, was the 
belief that others assumed they must be a smoker and have COPD. This is 
mentioned both in terms of what others would think of them and the general public’s 
lack of understanding about bronchiectasis. This carer describes the experience of 
having a lung disease which is assumed to be something it isn’t:  
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‘I think there’s a stigma though, when you’re diagnosed, not just with bronchiectasis, 
they’ll say you’ve got COPD and the first thing they say is “Have you stopped 
smoking now?” He’s never smoked in his life.’ (C04 258-260) 
It was difficult for patients to manage this perception that others may assume they 
had a smoking related illness; that it was self-inflicted and they were therefore 
culpable. It has been described that conditions such as COPD that are liable to have 
been self-induced do not receive much understanding or sympathy (Williams, 1989; 
Williams and Bury, 1989). ‘Chronic lung disease’ has also been described as ‘anti-
social’ and ‘isolating’ (Toms and Harrison, 2002). Toms and Harrison’s small focus 
group study (n=7) included 2 patients with bronchiectasis and 5 with COPD. Within 
my interview data, having COPD is clearly viewed in a different ‘category’. Moreover, 
some patients made reference to the fact that their doctors had also assumed that 
they were smokers. Some had possibly misinterpreted the taking of a smoking history 
as an accusatory line of enquiry rather than a process of diagnostic elimination. This 
aside, however, the fact that patients were so frustrated with their doctors for 
seemingly not believing them demonstrates how significant the impact of this 
presumption of smoking status and culpability is for patients. One participant also 
described how this lack of culpability and often unidentifiable cause of bronchiectasis 
led to further uncertainty for her:  
‘I mean I’ve never smoked so it’s obviously not caused by, you know, self-inflicted, I 
mean…you had this sense of “What have I done?” Not “to deserve this”, because life 
isn’t fair I know that, but getting it round in my mind “What’s caused it?”’ (P05 592-
598) 
Having no certain cause for her condition seemed to lead to more emotional work. 
Knowing that she was not ‘to blame’ for her diagnosis did not alleviate her concern 
regarding causation, just eliminated one potential culprit.     
The sometimes public nature of symptoms led friends to offer lay diagnoses such as 
‘you sound as if you’ve got TB!’ (P13 145-146). Interactions with friends and family 
often led to patients encountering such enacted stigma. The same patient described 
another such encounter: 
‘A friend of mine, I visited her in the summer, and she said to me when I coughed – 
her husband was a doctor – she said “Your cough sounds like a death’s cough”.’ (P13 
114-116) 
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Note how, the description of ‘a death’s cough’ is situated in a context where the 
speaker is marked as having some medical credibility, albeit indirectly. The 
association of the cough of bronchiectasis with the negative description of a ‘death’s 
cough’ or ‘TB’ demonstrates both the social stigma associated with such a cough, 
and the accessibility of the symptoms to those around you. It is almost impossible not 
to disclose such a diagnosis: the cough will do it for you. In order to ensure you are 
not considered to have a self-inflicted smoking related condition, a contagious illness, 
or a fatal disease, it is imperative to openly discuss the fact that you have 
bronchiectasis, both with those you may wish to, and others that you may not. The 
impact that this has on people psychologically and socially is significant.  
Additionally, one patient described self-stigma when relating to her experiences in 
childhood of elderly men coughing and spitting in the street, saying:  
‘To me bringing up phlegm makes me feel dirty…it’s not womanly is it?’ (P04 156-
162)  
This led to her avoiding coughing or taking inhalers in public as she was always 
taught that coughing up phlegm was a disgusting thing to do and it was something 
she associated with ‘dirty old men’ (P04 155). For her, she now has the 
embarrassment of having an audibly productive cough and therefore a socially visible 
illness. Having bronchiectasis had impacted upon her identity as a woman, and as 
someone who takes pride in their appearance and cleanliness. This embarrassment 
is something that has lessened with time since diagnosis, however, as she has 
begun to learn to live her life with bronchiectasis. This process of acceptance, or 
adaptation (Charmaz, 1995) has lessened the impact of bronchiectasis on her life, in 
particular in relation to social situations that used to lead to much embarrassment for 
her: 
‘It’s like part of my life now, part of my day. Go out with an inhaler, plenty hankies and 
your medication in your little bag and that’s it.’ (P04 378-379) 
This quote illustrates her adaptation in terms of learning to manage bronchiectasis 
and also how this adaptation along with passage of time has led to the normalisation 
of living with the condition. Being able to confidently manage her condition and cope 
with the changes it dictates has been fundamental to her learning to live with 
bronchiectasis. The potential for the various impacts of bronchiectasis to fluctuate 
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over time throughout the patient journey is inevitable. It was evident however that all 
of the participants had developed, or were beginning to develop, their own ways of 
dealing with their diagnosis and its implications. 
4.3 Developing support and coping mechanisms 
Patients and carers explained how they had developed their own support and coping 
mechanisms over time. It was through the use of these mechanisms that patients 
and their families managed ‘having the condition’. Central to this managing process 
are mechanisms of practical and emotional support, varying modes of reassurance, 
and the understanding of ‘normality’ for people with bronchiectasis. By developing 
good support or coping mechanisms, patients and their carers were able to lessen 
the impact or disruption that bronchiectasis presents. 
One of the key ways in which participants are supported is by other people around 
them. The main characters in these storylines were usually families, friends and the 
medical team. One patient, for example, found that her family’s support and 
reassurance have helped her significantly:  
‘My husband is good, my daughter’s good, my grandson, they are all pretty good with 
“come on, howay,” you know “don’t worry about anything, we are here for you. If you 
need anything, we’ll help you”.’ (P04 206-210) 
This practical and emotional support from her extended family had lessened the 
impact of bronchiectasis on her life, helping her to manage life with bronchiectasis 
and to develop an acceptance of her new condition. This support of family was a 
mechanism often used, and is in keeping with Bury’s descriptions of ‘mobilisation of 
resources’ (Bury, 1982). Resources often used alongside the support of family were 
the patients’ medical teams and other patients who had experienced similar issues.  
Bronchiectasis is a relatively rare condition when compared to asthma and COPD, for 
example. Often people had never heard of it before their diagnosis and hadn’t met 
anyone else with the disease. As noted above, making sense of what was ‘normal’ 
for bronchiectasis was central to being able to develop coping mechanisms. Being 
able to relate to others in a similar situation was therefore reassuring and facilitated 
an exploration of ‘normal’ experiences of bronchiectasis. This patient echoes the 
feelings of many participants when she describes how important it is to be able to 
understand one’s ‘new normal’ with bronchiectasis: 
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‘That’s a big part when you are chronically ill, having something to reassure you that 
that’s normal for your condition, or you need to get looked at. … It’s easy, say with my 
problems, for it to creep up on you, because it’s every day, you’re just sort of 
accepting that debilitation, and you don’t realise how small your world’s got until it’s 
more or less disappeared.’ (P12 370-376) 
This patient felt as though she had no idea what she should expect to happen, and 
as such had no sense of what should trigger her asking for help and what she should 
just accept as ‘normal for bronchiectasis’. By learning about themselves from other 
people’s experiences, participants were able to get a sense of what they should 
expect: which symptoms are normal for bronchiectasis, and which are not. Another 
patient echoed these thoughts about relating to others’ similar experiences: 
‘It is some normality to what you are feeling, cos even though it’s an illness and it’s a 
symptom … it’s normal for what you’ve got.’ (P03 394-396) 
The understanding of what is ‘normal’ for bronchiectasis, as this patient described, 
was key to several aspects of ‘coping’. Not only does it allow patients to learn when 
to worry about their symptoms and when to just ‘manage’, i.e. if their experiences are 
‘normal’, it also allows them to feel ‘normal’ in themselves. Knowing that others are 
experiencing the same symptoms and feelings assigns normality and validity to their 
own experiences.  
Additionally, being able to relate to others who had similar experiences generated a 
sense of solidarity when coming across stories of others who have the same 
condition, as this patient described: 
‘Because then you can recognise yourself. … So then you know you are not alone, 
some people have got the same problems.’ (P09 274-275) 
Being able to identify with others who have bronchiectasis was important to most of 
those interviewed. As we have established, such information about bronchiectasis is 
currently scarce, yet the importance of having such resources as a support 
mechanism was clear. Specifically, in terms of the use of information from others as a 
support mechanism, we have already shown the importance of prognosis to patients. 
It was often prognosis that people had sought reassurance about from others with 
bronchiectasis. This lady described her use of an internet forum for this purpose:   
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‘I had to think to myself “Right, it’s not going to get to that stage, I’m going to do the 
best that I can with it” you know, “if these people can live with it, I can live with it” you 
know, and there was loads and loads of suggestions and things what other people did 
and how they have coped, you know, and that really helped me to come to terms with 
it.’ (P04 260-64)  
This patient demonstrated the need for reassurance as a mechanism of support, and 
the importance of the experiential expertise of those offering that reassurance. For 
such a support mechanism to be effective, the user needs to know they can relate to 
the provider, that their experiences, and thus their methods of coping, could mirror 
their own. This clear use of information seeking as a form of reassurance, further 
confirms that a sound information resource could act as a support mechanism for 
patients and carers.  
Finally, in addition to normalising bronchiectasis, patients also wanted to maintain 
some sense of what they previously knew as ‘normal’ in their lives. Patients and 
carers described the efforts they made to combat the physical and emotional impacts 
of the disease in order to try to feel ‘normal’. As described earlier, this lady described 
how she tried to keep a sense of normal routines in her life:   
‘Some days I can’t be bothered to get dressed but I push myself to get dressed cos I 
want some normality in my life.’ (P03 383-385)  
Even though she barely had the energy to complete a simple task of daily living, she 
attached much significance to doing so. By making such an effort to get dressed she 
could feel as if she was ‘normal’. Despite the obvious impacts of bronchiectasis, 
people want to try to live as ‘normal’ a lifestyle as possible, whilst still acknowledging 
and understanding the ‘new normal’ of living with bronchiectasis. Establishing their 
own support and coping strategies empowered patients to move towards regaining 
control over the aspects of their lives that bronchiectasis impacts upon and start to 
play an active role in managing their condition.  
4.4 Taking back control and developing active partnerships 
Patients and their carers wanted to become a member of the team that has 
responsibility for their future - to be able to play an active role in the management of 
their condition. Being able to take back some control over the condition in this way, 
rather than bronchiectasis controlling their lives, was of great importance. Arriving at 
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this point of the patient journey took a variable amount of time, and acceptance of the 
diagnosis seemed to be an integral part of the process.  
One patient with longstanding disease explained that it had taken her a long time to 
accept her diagnosis. This initial lack of acceptance seemed to have impacted upon 
her ability to take control of her condition. She talked about this almost conscious 
decision not to accept things as ‘stubbornness’: 
‘It was probably a few years after the diagnosis that I sort of woke up and smelt the 
coffee type thing.  
IV: So it took a few years to kind of learn how to manage things? 
Yes, purely because I was stubborn, I think that’s got a lot to do with it with me.’ (P03 
256-263) 
Patients felt that once they were more accepting of their diagnosis, they were able to 
play a more active role in its management. This process of acceptance and 
adaptation helped patients to learn to live with and manage their condition, which in 
turn allowed them to maintain an element of control over their situation.  
Acceptance also seemed to influence participants’ development of a sense of 
responsibility for their own health. This was referred to by most as if it was a 
conscious decision or even an obligation; often in the later stages of their journey 
since symptom onset. Wanting to have such responsibility, or be part of an active 
partnership with the medical team, included wanting to do additional things beyond 
medical treatments to try to improve their condition and thereby lessen the impact of 
bronchiectasis on their lives. Learning about what they could possibly do to help 
themselves was of real importance to participants. The examples of diet or lifestyle 
were often given as factors participants would hope to be able to change in order to 
live with their condition in the optimal way. This patient was one of many who 
described why this was so important:  
‘How to help it … so you can sort of say “Right well I will do my bit”.’  (P02 75-94) 
Feeling as though they were playing an active role in keeping themselves well was a 
way of both being an active member of the team and exerting some control over their 
lives. They already knew that bronchiectasis is an incurable condition, so they began 
to focus more on making the most of their situation. It seemed diet and exercise were 
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things patients and carers felt they could realistically influence, and by doing so they 
could again take some responsibility for their health. Perhaps focussing on diet and 
exercise allows control over something that is actually controllable, unlike their 
diagnosis. One patient specifically stated that there should be advice given to new 
patients about taking control yourself: 
‘There should be one part where it is saying that it cannot be cured, so you’ve got to 
help yourself, making you aware of pulling yourself together … like it’s not the end of 
the world.’ (P04 586-599) 
This lady thought having that advice early on would help people to acknowledge the 
active role that they need to play in taking control of their condition and learning to 
accept their diagnosis. This patient’s description highlights both the practical and 
psychological elements of this process, with reference to the requirement for you to 
‘help yourself’ and ‘pull yourself together’. Although both require active participation, 
they describe very different aspects of self-help.  
Questions about how to self-help also extended to carers, who wanted to know what 
role they could play within the team. Clearly being able to have this active input is 
important to both patients and carers alike. One carer explained why she wanted to 
know about what she could do:   
‘I do know that it’s a progressive complaint and that it won’t get any better, but on the 
side of like, caring, it’s hard to see him struggling and if there was anything that we 
could do to, to help...’  (C01 134-136) 
As per the feelings of patients themselves, this carer acknowledged the incurable 
nature of the condition, yet still wanted to know more about how she could help, what 
other avenues she could pursue to cushion the impacts of bronchiectasis on their 
lives. Another carer echoed this lady’s sentiment of knowing there is maybe little they 
can do to influence the disease process, but wanting to know what (if anything) it was 
possible to have an influence on:  
‘I think the main crux of it is you want to make sure there’s nothing you do that is 
making it any worse, and you want to know if there is anything that can make it better, 
that you have that information, and you can do it.’ (C09, 571-574) 
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Again, this fits with both patients and carers wanting to exert any potential control 
they could have over the disease course; to be aware of and make any feasible 
changes that they can.  
To reiterate the sense of responsibility amongst patients and carers, in some cases 
the query about what ‘could’ be done, despite the fact that bronchiectasis is an 
incurable condition, was also described as what ‘had’ to be done. These descriptions 
were almost of an obligation or duty, rather than just a personal sense of wanting to 
take responsibility. One patient described her duty to: 
‘Just try and keep well really.’ (P03 25-27)  
This was a specific effort that she, amongst other patients, felt she needed to make 
to ensure that she remained as healthy as possible, rather than just describing 
‘wellness’ as something beyond her control. This sense of duty to be well and need 
for control again extended to carers. In addition to having to keep up with the daily 
treatment regime and monitoring for signs of infection there were other 
responsibilities, such as:  
 ‘We have to keep you fit’ (C04 533) 
This carer felt duty bound to keep her husband ‘fit’. This was again meant as 
exercise and diet related fitness rather than ‘wellness’ or health. An aspect of care 
that it was possible for her to try to influence. 
An area of perhaps more clarity or certainty than this concept of self-help, was self-
management of bronchiectasis. Many patients had started to self-manage, having 
developed skills of symptom recognition through experience rather than precise 
medical instructions. Although the medical team will give advice about how to 
recognise changes, the predictors of impending exacerbation are personal and 
individual, so beginning to recognise one’s own warning signs is a crucial step in 
beginning to self-manage. Patients talked of how they had learned over time to 
recognise symptom changes and their early indicators of exacerbations. One lady 
described this process as: 
‘Trial and error I think!’ (P03 214) 
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Although she had learnt about action to take from the medical team, understanding 
triggers for taking action had to be gained through experience. Most patients had 
learned when to take action in terms of treatment adjustments over time. Rather than 
simply being a ‘passive’ patient, awaiting direction from the medical team, this 
reinforced their role within an active partnership. One participant described in a 
slightly different way how she had learnt this art of self-management - ‘studying 
herself’:  
‘I studied myself as well. Every time it was hot weather I got a really bad lung 
infection...I had to learn myself because I can’t every minute go to see the doctor … 
so I have to study how to balance my life.’ (P09 21-37)  
By monitoring her own bodily responses to environmental triggers she had learnt how 
to adapt to manage her condition better. Again this demonstrates patients’ sense of 
wanting to play an active role in their own management, the sense of some degree of 
responsibility for their own health and the desire (or indeed practical requirement) for 
a degree of independence.  
A potential factor influencing this need for independence is ease of access to trusted 
healthcare services. To be an active partner within the healthcare team, one has to 
have some sort of relationship with the rest of the team. Although most described a 
positive relationship with their secondary care team and easily accessible advice or 
appointments, the degree of interaction with their primary care service was not 
always the same. Several interviewees described a lack of faith in their GP, and a 
sense that bronchiectasis was not something that their GP knew a great deal about. 
It seemed that GPs maybe have a diminishing role with time since diagnosis. This 
could be due to a stronger relationship being formed with the secondary care team, 
and perhaps the changing nature of patients’ needs over time.  
The feeling of not being listened to when explaining their symptoms prior to diagnosis 
was described by several patients. This again may contribute to a less positive 
relationship with their GP once a diagnosis has been made, with people preferring to 
deal only with the doctor or hospital that succeeded in diagnosing their condition 
having listened to their stories. The trust now embedded within that relationship is 
key to their working within this active partnership, and directly influences their views 
on credibility of information given. Being their trusted healthcare professional 
automatically lends credence to any information you impart. Having this connection 
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with credible information is the final and fundamental part of the process of learning 
to live with and manage bronchiectasis that I will describe.     
4.5 Connecting with information 
The crux of the interview schedule was to explore and understand the unmet 
information needs of patients and their carers. As such, discussion within the 
interviews covered information needs and how these were, or might be, addressed. 
This theme describes patients’ and carers’ experiences of information and the 
different ways in which they ‘connect’ with information. Connecting with information 
describes triggers, approaches and barriers to information seeking, in addition to 
preferred contents and format. Centrally, it is how people connect with information 
that will govern whether it is of any use, or has any influence upon them.  
4.5.1 Triggers and reasons for seeking information 
It was clear that patients and carers needed to have a trigger or reason to be seeking 
information, to have an unanswered question for example, or an ongoing concern. In 
this sense, timing was everything, with the need to access information being directly 
related to the individual’s current circumstance. One key time-point that was 
discussed by patients and carers was the time of diagnosis. The more longstanding 
patients often commented that they would have liked to have had more information at 
their time of diagnosis. As we have established above, an issue often at the forefront 
of people’s minds when receiving such a diagnosis, and indeed throughout their 
experience of living with bronchiectasis, is that of prognosis. One patient described 
how this was really the only thing that she had a pressing need to find out more 
about: 
‘I didn’t really look up a lot, only enough to satisfy my mind that I’m not going to die, I 
can live with it, get on with it.’ (P04 288-289) 
Once she had established her likely prognosis her main concerns were answered 
and she therefore didn’t feel she was lacking information. The trigger to seek 
information - an unanswered question - was no longer there. Prognosis specifically, 
however, was a topic of interest to patients at all stages of the journey since 
diagnosis. Although initially broad concerns about prognosis may be addressed, as 
things change over time more reassurance may be needed. Participants often 
reported development of a new symptom as a likely reason to seek information about 
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their condition again. At its outset, a new symptom will not necessarily have a clear 
cause and thus is not always immediately aligned to a specific condition. A patient 
may either have a number of diagnoses, or just simply not know if a particular 
symptom should be attributed to bronchiectasis or not. Seeking information about this 
new symptom enabled patients and carers not only to understand the symptom, but 
also to attempt to attribute it to one particular condition. Is this a symptom that is 
normal for bronchiectasis, or is this a new problem? Making sense of symptoms 
through this use of information seeking enabled patients and their carers to assess 
the ‘normality’ of their symptom dependent on its likely cause. As has been 
established, this understanding of normality is essential to the process of learning to 
live with bronchiectasis. When a patient’s experience of their known illness breached 
expectations in terms of symptoms, new treatments or change in personal 
circumstance, this generation of new, or revised, information needs prompted further 
seeking. 
A further time point that was felt to be important was during an exacerbation. Again, 
this was a change in the norm triggering new enquiries. Some mentioned they felt it 
would be useful to be able to access information if in hospital with an exacerbation, 
or upon discharge: 
‘If something comes through saying “You’ve had 10 days in hospital, however, you’re 
still not well and you should really be doing this, or not doing this just yet” and I think 
then, it might sink home to them … “change your diet” or “try a little exercise”, you 
know, remind them about their breathing exercises. Because I think once they’re out 
of hospital, it’s like they forget everything, they think “That didn’t happen, I’m back 
home now”, I think maybe a little prompt.’ (C04 568-581) 
This was felt to be both a time when questions are likely be raised and also a time 
when people may be receptive to new information. Having an admission to hospital is 
likely to be a situation that could generate new information needs and be a trigger to 
seek answers. It may also be a time during which having the right information could 
make a difference in terms of taking actions and responsibility for one’s own health.  
4.5.2 Barriers and reasons not to seek information 
Acceptance of the diagnosis of bronchiectasis seemed to have the potential to play 
opposing roles in information seeking. As discussed within the review of the literature 
in Chapter 2, information is not always actively sought, and at times, is actively 
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avoided (Maslow, 1963; Case et al., 2005). As I have also established within this 
cohort, some patients found that they didn’t want to look up anything about 
bronchiectasis at first, until they had developed an acceptance of their condition. In 
this scenario, a lack of acceptance could be considered to be a barrier to information 
seeking. For others, however, information seeking played a significant role in coming 
to terms with having bronchiectasis, and it is known that information seeking can be a 
key coping strategy (Lambert and Loiselle, 2007). Either way, it is apparent that the 
seeking of information plays a significant part in the development of these coping 
mechanisms, so any barriers or reasons to not seek information will directly impact 
upon this process.   
Barriers to information seeking can be quite simple and obvious. One very practical 
barrier brought to light was poor eyesight. Some found smaller text very difficult to 
read, which needs to be taken into consideration with the development of any 
information resource. Poor hearing was raised as another sensory barrier to 
receiving information. Participants described how listening to information was often 
more useful than reading something as you could make decisions about whether 
something was of importance or not based upon tone of voice and time spent 
discussing different matters. Seeing someone speaking was very important. Having 
information in unsuitable formats would clearly impose additional barriers, and 
optimising accessibility is vital. 
Some interviewees considered their lack of use of a computer or the internet as a 
barrier to information seeking. Some liked the idea of a web-based resource and 
reacted very positively to the example websites shown to them in the interviews, yet 
didn’t feel that this was a format of information that they would realistically be able to 
access. Age was indirectly implicated as a barrier to information access with 
interviewees often being of the opinion that a website would not be used by more 
elderly patients. People described this both with respect to themselves, and also in 
general terms, as if speaking for ‘imagined others’; older patients that would not use 
the internet. This conclusion, however, is not in keeping with previous work I carried 
out in a bronchiectasis clinic which established that over 90% of a sample surveyed 
had internet access, with ages ranging up to 90 years (unpublished data). 
Additionally, within the data described here, age of participant was not seemingly 
linked with internet access. Interestingly, one of the interviewees who had actually 
gleaned most of her information from the internet felt that this would not be the best 
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format for her, as she didn’t feel she was a confident user. Whatever one’s preferred 
style or format of resource, not having access to a suitable resource that you feel 
confident using is clearly a potential barrier to obtaining information.  
Suitability of resources is key to their uptake. As reported by Harland and Bath, 
(2008) having user-centred rather than system-centred resources allows for 
individuals’ needs to be taken into account. Leydon also described how information 
needs differ amongst patients with cancer and explored their reasons for not seeking 
information (Leydon et al., 2000). Not being able to find information set at the right 
level, or finding contradictory resources was an issue for my participants. Some felt 
that searching online for information could be confusing, with conflicting advice 
found. Patients described how there were some very basic information resources 
available and then some very clinical resources, but that there was very little middle 
ground. This highlighted a need to ensure that the developed resource was accurate, 
yet also accessible to patients with differing levels of health literacy and information 
requirements.  
Information requirements are bound to differ between individuals, and also to vary for 
an individual at different time points. Having a resource that is presented in such a 
way that users can look at specific information they do want, and not at things they 
would rather not know about, is important. Whilst some people want to learn as much 
as they can about their condition, fear of what one may read or a feeling of 
‘ignorance is bliss’ was also described by both patients and carers:  
‘If he read about it he would dwell on the bad bit, you know what I mean, whereas I 
would get my frame of mind in, if it gets to the bad bit I’d be able to cope cos I know 
what’s coming. But he’s the opposite way round, he doesn’t want to know the bad bit.’ 
(C03 628-631) 
This carer demonstrates how this is a very personal stance, with some wanting to 
know what the future held, and others preferring to just deal with things as they come 
along. The differing opinions here will always remain. Having the information 
available is clearly necessary, yet it is also necessary to avoid the creation of 
additional barriers for those only seeking specific information within their boundaries 
of comfort. To be able to choose or filter which sections of information one looks at is 
clearly important.   
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Another aspect to consider when assessing ‘suitability’ of a resource is that in order 
for a user to connect with information, they need to consider it credible. Apparent 
untrustworthiness of a resource, therefore, is an obvious barrier to its use. A variety 
of issues with the use of internet resources have been discussed by Henwood 
(2003), with trustworthiness being one of them. Zulman presented trust as an issue 
for older users of the internet when accessing health information resources (Zulman 
et al., 2011). For my interviewees, trust emerged as an issue for many people when 
accessing information, regardless of their age. In the main, this related to online 
information seeking. Having a credible information resource was of great importance 
to people; yet finding such a thing through your own self-directed seeking was 
problematic: 
‘I’ll be honest it’s mostly the NHS sites I go onto, because I think “well at least I know 
they are genuine sites” type of thing, where some of them you go on and you think 
“well, no I don’t think that’s right”.’ (P03 140-142) 
As this patient described, participants were often unsure of how to judge credibility of 
the available information and wanted to be advised about which websites to use or 
avoid. Being directed to a trustworthy resource by one’s medical team for example, 
or the website having recognised markers of credibility, would make people more 
comfortable using the information within it. As we have learnt, developing a 
partnership with trusted professionals is of great importance. If an information source 
is created, endorsed, or recommended by your trusted professional, it automatically 
becomes one to trust.  
4.5.3 Approaches and sources 
Participants varied in their approaches to information seeking. One thing that stood 
out, however, was the need for convenience, or ease of access. Several of the 
interviewees described how they would not go ‘out of their way’ to seek information. 
Many had only seen the BLF leaflet which was often handed to patients in person 
when attending clinic, requiring no self-directed seeking. Patients and carers valued 
convenience and information resources that fit in with their lifestyle. This may be due 
to a lack of inclination to put in any effort to seek information or may simply be people 
being realistic about what they would get round to doing. Again, triggers to seek 
information play a role here, as without such triggers or questions, why would effort 
be made to search for answers?  
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The convenience or effort factor also influenced the sources used. Again, this 
naturally differed for different people, depending on their specific circumstances. 
Within this cohort, the vast majority felt that an online approach to information 
seeking was the most straightforward. There were participants, however, who 
described alternative approaches and sources that were more convenient for them. 
One patient, who was a retired nurse, described looking in the medical textbooks that 
she still had at home and when she started coming into the ward regularly she looked 
at the information leaflets available there. These were convenient ways to access 
information that was already there for the taking. She did however, as with many 
participants, have a hierarchy and method in her information seeking. Any queries 
not answered by these sources she would save and either look up online when she 
was using the internet for other reasons, or write down and ask when attending her 
appointments. This process of upgrading the approach or source of information was 
commonly deployed, with participants’ own doctor usually at the top of the chain. 
Another participant described opportunistic information seeking. He stated that he 
would ask his doctor, but only if he was there anyway, or if he saw someone in the 
street using an inhaler he might ask them about how they find it and see if they have 
anything in common. He only described picking up information by chance and stated 
that he had never really actively sought any information beyond these personal 
interactions:  
‘I haven’t thought about it at all, like looking into it.’ (P02 141-153)  
He did not consider that he had made an active decision to seek information in this 
way, but had chanced upon various bits of information opportunistically. In keeping 
with this, he also thought that television was a good source of information, as he 
tended to spend most of his day watching it. Again this confirms that for a resource to 
have maximum uptake, it needs to be accessible in a variety of ways, to try to 
accommodate the ‘easiest’ route for the majority without excluding the minority. For 
different people, this pathway of least resistance will vary.  
Importantly, patients mentioned that their families had a role in information seeking. 
In some cases, it was only really family members who sought additional information, 
with the patient themselves not doing so. Having the input of both patients and their 
families is clearly critical in developing a resource that meets the needs of those who 
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will be accessing it, whether they be patients, carers, family or friends. Convenience 
and suitability is key.    
4.5.4 Content, style and format 
To enhance discussion around preferences of content, format and style of 
information, interviewees were shown examples of information resources about other 
medical conditions. They were shown websites, leaflets and a patient information 
DVD. This was to prompt views on presentation and layout of information, rather than 
the content itself. In terms of format, participants often expressed an interest in the 
DVD, commenting that information delivered audio-visually was better than written 
information alone. Watching or listening to information seemed to be universally 
preferred to reading text, or at least seen as an enhancement, as these participants 
described: 
‘It’s people talking; it seems to sink in a bit better … it makes you listen … more than 
just reading it in a booklet.’ (P01/C01 670-685)  
Their description suggests that reception and even retention of information could be 
improved by such a mode of delivery. Several suggested however that a DVD is not 
something that they would really refer back to as they would a booklet, yet obviously 
one could re-watch a DVD as many times as desired. Perhaps the effort or time 
thought to be involved in ‘watching a DVD’ is greater than simply getting out the 
booklet for a quick look at the section that you have a current query about. So, 
although the DVD as a mode of delivery was highly praised, most added that a 
booklet would be useful to have in addition. The participants’ preference for the DVD 
was really the format and presentation, rather than the device itself. In fact, many 
acknowledged that the DVD was fast becoming outdated and little used. It was the 
use of ‘video’ within the DVD to deliver information that was liked. Clearly this is 
something which can easily be incorporated into a website for example, and is not 
exclusive to the use of a DVD.  
The video content that was praised specifically was that of other patients telling their 
stories. Talking was an important feature, particularly when considering the 
experiences of other patients, with this type of information seeming to be much more 
accessible when delivered as a video: 
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‘I don’t know much so if I see a video like that, of people talking and learn about 
myself through that video, so I know which one is similar to my symptoms…when you 
see that, when they talk like that, then you know.’ (P09 326-31)  
This lady reflects the views of many of the participants, who valued being able to 
relate to other people’s experiences in the process of learning to live with 
bronchiectasis. Drawing on how other patients came to terms with their condition may 
aid this process in others, and having this in a format based upon a personal 
interaction, i.e. a video, may optimise its usefulness. In essence, presenting 
information in a way which people can really relate to is a priority, as this patient 
described: 
‘that’s a good example, I think, of where you are just looking at the facts, any clinical 
facts about it, versus “what does it actually mean to a person who’s had it?” and that 
can be quite different.’ (P14 240-242) 
This patient concurred with the many participants who explained that having 
pathophysiological descriptions of the disease process as per a clinical textbook was 
of limited use. What they would like to see is information that is of use to them, that 
they can identify with. In particular, the youngest patient made reference to wanting 
to hear people his own age talking about their experiences so that he could relate to 
them, rather than more elderly people. A few expressed a fear of seeing people 
worse off than them, and explained that they would want to be reassured, not 
worried, when hearing other peoples’ stories. Providing accurate yet positive content 
was important to the majority of participants.  
Volume of information emerged as an issue when patients compared two different 
written information sources. One was a thicker booklet which they often referred to as 
‘the book’ and the other a leaflet, which was a single page of A4 paper folded over. 
When comparing the two, there were lots of differences including use of images and 
smaller sections with headings in the larger booklet, for example, but the 
unanimously stated fact was that ‘the book’ had more information. One patient 
compared the shorter leaflet to one she had previously read about bronchiectasis, 
stating that it had left her with unanswered questions. More information seemed to be 
better and the concise leaflet was thought to be inadequate. Despite the general 
preference for a greater volume of information, a few participants wondered if too 
much information could lead to unnecessary worrying. They thought that looking at 
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very detailed information could lead to people looking at things that were not relevant 
to them, and that a less detailed initial leaflet may be a better starting point. Several 
of this group wondered if a shorter information guide with access to a more detailed 
version, if and when desired, may be preferable. Allowing for such selectivity seemed 
to be an important feature within a resource.  
Clarity of both content and presentation was a major issue and was demonstrated in 
ways other than direct opinions of the example resources. Misunderstanding of 
‘jargon’, for example, was often raised in interviews and frequently related to copy 
letters from clinic. Several participants talked about the content of their letters and 
how they couldn’t understand the terminology used. In some cases, having this 
additional source of information, yet misinterpreting it, led to more anxiety rather than 
being a source of reassurance. A lack of jargon and clarity of explanations were key 
to information being usable. Even the pronunciation of the word bronchiectasis was 
raised as an issue, with patients often being embarrassed about their uncertainties 
surrounding this. Having the phonetic spelling clearly presented within the resource 
seemed be a simple step to eliminate this problem.  
Clarity was important for the presentation of information. Layouts with headings and 
diagrams seemed to be preferred for ease of reading, and the presence of extra links 
or advertisements on web pages were often a deterrent as this carer described:   
‘Not too many bits and bobs on the side’ (C04, line 946) 
She was not alone in considering that online information resources with lots of 
distracting features at the edges of the page were unhelpful. This seemed to stem 
both from a sense of them detracting from the main content, but also generated an 
element of distrust in the site. If they were advertising products for example, what 
were their motives? Was this information trustworthy, or was its provision simply a 
money-making exercise? Nettleton discusses how users account their trusting of 
online resources using a ‘rhetoric of reliability’ (Nettleton et al., 2005). This similarly 
includes the assessment of whether a resource seems to be ‘commercial’. In an 
American survey of trust and sources of health information, physicians emerged as 
the most trusted source, yet the internet was the most frequently first accessed 
source (Hesse et al., 2005). As credibility of information is so important, recognising 
any markers of unreliability is crucial to optimise usage. 
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For the resource to be effective the data described by ‘connecting with information’ 
needed to be central to design, content and development: incorporating features that 
would optimise users’ connection with the resource and thereby its benefit. 
Participants felt that being able to access more information, about what they want to 
know, would further enable them to take an active role in their own management. 
Participants wanted more information, and they wanted this to be information that 
would be of use to them. They needed information that could help to lessen the 
impact of bronchiectasis on their lives, allowing them to regain the all-important 
normality and control. 
4.6 Deviant case analysis  
During analysis of the data, as well as looking for common themes, I explored any 
potential deviant cases in order to improve validity and rigour and to explore these 
areas in more depth in future interviews. There are in fact only two points to raise. 
The first is a deviation from the commonly expressed desire to hear of other peoples’ 
experiences. There was only one participant who felt this would not be a useful 
exercise. He had been diagnosed with bronchiectasis 2 years ago, had an additional 
diagnosis of lung cancer, and had never attended the specialist bronchiectasis clinic. 
He lived with his sister who was his main carer, and interestingly shared his 
disinterest in hearing about other peoples’ experiences. Neither had actively sought 
any information about bronchiectasis, despite having unanswered queries. Both 
wanted information about what they could do to help themselves or things that may 
be of benefit to them, very much in keeping with other participants. When asked 
about hearing of other people’s experiences of bronchiectasis they were not keen: 
‘P01:  In hospital all the patients around you are all similarly affected. 
C01: Really poorly, some of them yeah. 
P01: And I dunno err I can’t say I would want to know all of their stories. 
IV:  Right, so how does that make you feel when you are in hospital with all the 
other patients? 
C01: Depressed!  
C01: He does get one or two bits of information, you know. 
P01: Oh yeah 
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C01:  Because I mean they do talk about their complaints, I mean because people 
do sort of say, ‘oh he is here for that’ and ‘for this’ and he does pick up bits of 
information about his own complaints. 
P01: But it’s not something I would want to talk about.’ (P01 C01 404-435) 
They described both a reluctance to hear of others’ experiences and a reluctance to 
interact with others by talking about these shared experiences. It is possible his 
additional diagnosis of lung cancer may have influenced his perception of whether he 
would benefit from listening to others’ stories. This patient did have severe 
bronchiectasis and additional complications. Given that his symptoms were possibly 
more severe than most others, his ability to relate to their experiences may have 
been diminished if he could not draw comparisons between their symptom level and 
his own. Making these comparisons could also have reinforced the severity of his 
own condition. This patient did unfortunately die a few months after the interview took 
place. There were participants with similarly severe bronchiectasis, however, who did 
want to hear about other peoples’ experiences and still felt they had something to 
gain by doing so. It is likely that there is an element of the patients’ character or 
nature influencing whether this would be a useful resource for them. The final line of 
the quoted interaction above: ‘it’s not something I would want to talk about’ is 
notable. It suggests that the reluctance to interact with such a style of information 
resource may be his own natural reticence to take part in a conversation that may 
involve talking about himself as well. It is possible that his own objections to sharing 
such information would influence his lack of desire to listen to someone else 
discussing their experiences. He went on to additionally suggest that patients’ views 
were inferior to that of a doctor:  
‘Well if you are gathering information you want to listen to the experts not the patients 
because patients can be, well funny, can’t they at times’ (P01 803-804) 
This stance again was in opposition to the other participants, who felt that hearing 
what others have been through was a valuable way to learn more about their 
condition and provided reassurance. This patient, however, seemed to think that this 
would not provide any credible information, yet burden him with other peoples’ 
problems rather than help him to put his symptoms into perspective. Although I 
pursued this in subsequent interviews, his remained an atypical view. It is also at 
odds with the literature describing this method of drawing on others experiences 
(Williams, 1984; Bury, 1991). When showing examples of patients discussing their 
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symptoms and disease journeys to those that had not yet heard other’s experiences, 
they stated that a patient’s perspective would be extremely beneficial to them in 
learning to live with their condition.  
The second deviance was regarding the optimal volume of information to receive. 
Volume was important, and the example information ‘booklet’ shown to participants 
within the interviews was preferred to the single page ‘leaflet’. One patient, however, 
stood out as having quite specific views on information format. This was based 
mainly on his personal experiences of providing information to executives. He 
seemed quite focussed on reducing information to an absolute minimum and keeping 
everything extremely simple. He also liked the idea of audio-visual information in 
keeping with other participants. Not quite in keeping with his views, however, he did 
like the example from the NHS website that has extensive text only content. The 
reason given for this was that it had plenty of ‘white space’ on the page. He felt that 
this meant it was clear, even though it didn’t seem to fit with his ‘keep it simple’ motto 
and had no audio or visual enhancements. His opinions regarding the more 
extensive booklet were based on his own principles of delivery of key points to aid 
retention, rather than a disagreement with the actual content. As such, the basis of 
his objection was in fact in keeping with others’ views, yet could be viewed as a 
deviance from the group’s preferences. The exploration of this matter of presentation 
and volume of information (and reasons behind opinions) in subsequent interviews 
proved to be very useful in terms of teasing out exactly what features of different 
examples people were drawn to. 
Both these described cases of deviance from the collective view have ensured rigor 
and thoroughness in my lines of enquiry within interviews. This has informed the 
development of the resource in terms of content and features, and also in 
understanding what it is that makes people ‘connect’ with information.    
4.7 Reflections on my role as interviewer 
It is possible, as discussed in Chapter 3, that my profession did influence what 
accounts participants were willing to give to a ‘doctor’ rather than a ‘researcher’. For 
the vast majority of the participants however I was not ‘their’ doctor and they did not 
withhold accounts of medical care they had been dissatisfied with for example. It is 
possible that participants felt more obliged to present to a ‘doctor’ as being someone 
who was seeking information about their condition and trying to help themselves. 
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There were interviewees, however, who did describe their lack of seeking. In reality, 
this willingness to be seen as a ‘good patient’ could be the case with any ‘researcher’ 
who is interviewing them. There may have been answers that were modified due to 
the fact that I was a doctor but arguably there may also have been answers that were 
only given because I was a doctor. Talking with a doctor, who has clinical knowledge 
about the condition you have, removed the need for certain explanations and created 
an instant understanding. To have this shared knowledge and understanding, albeit it 
from a different perspective, I believe played a role in enabling me to establish a 
good rapport with all the interviewees.  
There are many aspects of the interview data that I believe I have been able to 
engage with more productively due to my ‘insider knowledge’ both of the disease and 
the medical system. There have been comments made by participants that a non-
medical interviewer may not have picked up on, or not pursued, that could be critical 
to the understanding of the data. By having this added insight I have been able to 
explore and extend lines of questioning or conversation further than someone who 
does not have such an understanding. I have also been able to interrogate the data 
in more ways, picking up on certain areas of knowledge for example that were 
obvious to me as a doctor to be lacking in accuracy.  
Additionally, the majority of participants have asked medical questions which I have 
discussed further post-interview. Some misunderstandings for example had actually 
arisen from typographical errors in clinic letters and had led to much worry. In these 
instances getting a copy of the letter had done more harm than good in terms of 
understanding and reassurance. This led to my spending significant amounts of time 
going through and explaining the contents of these letters, which were often shown to 
me during the interviews. At the end of the majority of interviews I spent a significant 
length of time talking to the patients and carers and addressing any 
misunderstandings or concerns they had. This both made me feel I had done 
something useful for the participants in return for their time and participation, and it 
also seemed that patients and carers felt they had actually gained something more 
by taking part. They had been involved in the research, yet also had access to a 
bronchiectasis doctor during a less time pressured period than a routine clinic 
appointment.  
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I think overall that it was important for me to acknowledge and reflect upon my role 
and its potential influence on the data in order to have complete transparency of 
methodology. Although it implicitly will have affected the process, the impact upon 
the data, the analysis and the participants has many positives.  
4.8 Summary of interview findings 
In this chapter I have described the main themes emerging from the analysis of 
interviews with seventeen patients and nine of their carers. The core theme, ‘living 
your life with bronchiectasis’, is central to the understanding of the three further 
interlinking themes. A key finding within this core theme was that living with 
bronchiectasis means living with uncertainty. Having this diagnosis is a not a single 
time-point disruption of one’s biography, but generates the potential for an ever-
changing one. Although variations of biographical disruption have been extensively 
described (Dingwall, 1976; Bury, 1982; Corbin and Strauss, 1985; Corbin and 
Strauss, 1987; Sanders et al., 2002; Williams et al., 2009), the concept that to have a 
diagnosis of bronchiectasis is to embark upon an uncertain future direction 
represents a novel finding. Being able to manage living with bronchiectasis does not 
simply involve learning what medical treatments are required and making once only 
adjustments to one’s life, but learning to live with the changing ‘new normal’ 
presenting itself throughout the patient journey. This ability to cope with having a 
condition with an uncertain prognosis is a complex process as I have explored, and 
involved deployment of numerous coping and support mechanisms. I will discuss the 
concept of biographical disruption and associated literature with respect to a 
diagnosis of bronchiectasis in more depth in the final discussion chapter of the thesis.  
Part of learning to live with bronchiectasis was the desire to regain control over the 
condition. Incorporated within this process was a sense of duty to self-help. This has 
links with both Parsons work in relation to the sick role, and the concept of the duty of 
a patient, or the duty to be well (Greco, 1993). What my data has shown, is that this 
duty extends to carers, with family members also describing a sense of responsibility 
for ‘their’ patient’s health and wellbeing. Both patients and carers wanted to take any 
helpful action they could and become part of the team working towards optimising 
their health and prognosis. It is important to note that the vast majority were keen to 
play an active role in their own care, wanting to find out what they could do to help 
their situation. It is possible that this represents a more motivated group, as having 
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volunteered for research about patient information, they may naturally be people who 
are interested in information. Although some were more motivated or proactive than 
others, there were none within this cohort that were against taking an active role. 
Patients and carers want more information about bronchiectasis, and this information 
needs to have a format, content and style that users will connect with. Some 
information needs were fairly explicit, yet some have been gently teased from the 
data within more general discussions about experiences of living with bronchiectasis. 
Information seeking has been shown to provide reassurance; to be a fundamental 
support mechanism for patients and carers. Incorporating the multiplicity of factors 
required for a ‘useful’ and credible resource identified within this data provided an 
opportunity to produce a universally accessible and functional resource. This unique 
insight into the experiences and needs of those who are actually living with 
bronchiectasis was key to the co-development of the novel user-driven information 
resource that is described in the following chapter. 
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Chapter 5 Results 2: Co-development of a novel patient information 
resource 
Drawing on the findings of the interviews described in the previous chapter the co-
development process of a novel user-driven information resource began. Building on 
the understanding achieved through the exploration of patients’ and carers’ needs 
and preferences, a resource designed to inform, engage and reassure was 
produced. This information resource was then used as an intervention within the 
subsequent study, Bronchiectasis Information and Education: Feasibility study and 
evaluation of a novel resource (The BRIEF Study, Chapter 6). In this chapter I 
describe how the interview findings informed the resource design, the co-
development process and the resultant information resource.  
5.1 Exploring available resources: searches and interviews  
During preparation for the interviews with patients and carers, I carried out 
background research into the bronchiectasis patient information resources that were 
readily available in the public domain. A tabulated summary (Table 4) shows some of 
the resources easily found by searching online in the UK for ‘bronchiectasis 
information’ and ‘patient information bronchiectasis’. When searching I used the 
search engines Google and Bing and the search terms stated were searched for 
separately. Searching for ‘bronchiectasis information’ using Google revealed 
1,330,000 results and ‘patient information bronchiectasis’ revealed 938,000 results. 
Searching using Bing revealed 600,000 and 500,000 respectively. This includes all 
languages and all types of resources. The tabulated summary simply provides an 
overview of a selection of those resources available in English that were within the 
first few pages of search results. This was not therefore a systematic review, but was 
intended to reflect what patients may be able to readily access. There are additional 
resources (in English) that I was aware of, yet did not readily appear on UK 
searching without more specific search terms. Some of these have been reviewed by 
a patient team for the European Lung Foundation (ELF) (Table 5). 
Notably, since this search was first carried out at the time of the interviews and 
resource development process, a few years have passed and the figures I have 
provided here are for the more recent search in February 2017. As time has gone on 
more resources about bronchiectasis have become available. To my knowledge, 
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however, there remain no resources currently available that have been as rigorously 
researched, developed, tested and evaluated in the way that the resource detailed in 
this chapter has. 
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Table 4. Available information resources (English language). 
Resource  Provider Description 
https://www.blf.org.uk/support-for-you/bronchiectasis  British Lung Foundation Online and booklet version available. Quite brief 
information about bronchiectasis (900 words). 
Participants felt was too little information.  
http://www.nhs.uk/Conditions/Bronchiectasis/Pages/Diagnosis.aspx  National Health Service Quite lengthy online information (3,600 words). Lots of 
text on the page to scroll through plus extra items 
alongside which put some participants off. 
http://patient.info/health/bronchiectasis-leaflet  Patient (patient and 
professional information 
provider) 
Online text. Lots of adverts alongside. Includes 
discussion forum. 
http://www.bronchiectasishelp.org.uk/  Written by a patient with 
bronchiectasis  
Patient’s perspective with input from professionals. 
Basic information. Not text-heavy. No Adverts 
https://www.nhlbi.nih.gov/health/health-topics/topics/brn  National Heart Lung and 
Blood Institute (USA) 
Well organised sections. Quite a bit of information and 
text (4,500 words). No Adverts. 
http://www.bronchiectasis.info/  Run by patients with 
bronchiectasis  
Discussion forum and online community rather than 
an information resource. 
https://en.wikipedia.org/wiki/Bronchiectasis  Wikipedia Text and images. Not always considered credible.  
https://medlineplus.gov/ency/article/000144.htm  US National Library of 
Medicine 
Small amount of basic information (570 words). 
http://bestpractice.bmj.com/best-practice/pdf/patient-
summaries/531907.pdf  
British Medical Journal Concise information (1200 words) no adverts. 
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Table 5. Other available information resources. 
Resource  Provider Description 
https://www.chss.org.uk/documents/2013/08/c4_bronchiectasis-
pdf.pdf  
Chest Heart and Stroke 
Scotland 
In depth information as a downloadable 
PDF. Some contribution from patients. (Not 
in existence at the start of this work.) This 
was considered the best open access 
resource in an unpublished patient survey. 
(Conducted by ELF, personal 
communication.) 
https://www.youtube.com/watch?v=7OOvfsTtTYM  BLF online presentation and 
question and answers with 
consultant and 
physiotherapist. 
YouTube video of presentation slides and 
audio. Patient questions and answers.  
http://www.webmd.boots.com/a-to-z-guides/bronchiectasis  Boots Online text information (1300 words). Lots of 
adverts on the page and unrelated images 
which some find off-putting. 
http://www.bronchiectasis.scot.nhs.uk/  NHS Lothian and input from 
patients with bronchiectasis  
Online information with input from patients 
(Approximately 3,000 words plus written 
patient stories). (Not in existence at start of 
this work) 
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As confirmed by these searches, when looking online for ‘bronchiectasis information’ 
there would seem at first glance to be numerous resources available to patients. 
Their usefulness or appeal to patients, however, was still unclear. As described in the 
previous chapter, patients were often confused about which sites they should look at 
when presented with such search results. Determining credibility was a necessary 
step in the selection process. Being affiliated with a well-known lung charity or the 
NHS were factors that frequently influenced a resource being used or trusted. The 
actual content of the resource was obviously also a factor once that initial criterion 
had been met. The interview data confirmed that having long documents of text 
containing medical jargon, for example, was off-putting, as was having 
advertisements on a website. Despite this apparent wealth of available information 
online, patients and carers still felt that there was a lack of credible and user-friendly 
information. To create an accessible, trustworthy resource containing information that 
users wanted, rather than just information that providers have decided they should 
have, were key objectives of the development process described in this chapter.  
During the interviews, examples of styles and formats of information resources about 
conditions other than bronchiectasis were shown to participants to prompt 
discussions. These included websites, a DVD, a booklet and a short leaflet. 
Participants’ views about various features of information resources were considered 
within the analysis of the interviews. This incorporated both specific views on the 
example resources and general discussion around information needs. As described 
in Chapter 4, analysis of the qualitative data highlighted many aspects of patients’ 
and carers’ experiences of living with bronchiectasis that needed to be woven into 
the novel resource design. This was not simply a list of facts to be included, but use 
of the new found insight into their experiences of bronchiectasis and approaches to 
information use. This approach enabled design of the information resource in a 
format that aimed to engage users and facilitate their understanding. In Chapter 2, 
the literature supporting such an understanding of the needs of the patient group and 
developing information to meet those needs was discussed (Leydon et al., 2000; 
Case et al., 2005; Lambert and Loiselle, 2007). The benefit of user-centred 
approaches and co-development were also discussed (Harland and Bath, 2008; 
Patient Information Forum, 2013). As described in the methods in Chapter 3, the first 
step in this process was to discuss an overview of the interview findings and initial 
concepts for the novel resource with a group of patients and carers.   
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5.2 Workshop 1: Confirmation of themes and refinement of ideas and 
concepts 
The first workshop was attended by 5 patients with bronchiectasis and 2 carers. As 
described in the methods (Chapter 3) some participants had taken part in an 
interview and others had not. I facilitated the session along with a specialist 
bronchiectasis nurse. A topic guide was used as I aimed to cover quite a lot of 
material in the session (Appendix 11). I described the interview findings to the 
workshop attendees and showed them a list of the four main emergent themes and 
their relevant subthemes as detailed in the topic guide. Participants discussed these 
themes and how they could be incorporated into patient information within a website 
or booklet. Their views overall confirmed the interview findings, yet this further and 
more focussed consideration helped to refine my initial ideas about how these 
findings would influence the resource design. Interestingly, in keeping with the main 
emergent theme of the interviews, participants spent a lot of time discussing their 
own experiences of living with bronchiectasis and their own needs in terms of 
information and resource provision. This interaction between the participants was 
also concordant with the desire to relate to others’ experiences identified within the 
interviews. Being given such a space in which to discuss their shared experiences 
was clearly welcome (Figure 4 (used with permission)). 
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Figure 4. Workshop 1. 
 
5.2.1 Resource format 
One key area arising from the interview analysis was the format of the resource. The 
group concurred with the interviewees: a website and a substantial booklet (rather 
than a single page leaflet) would be the preferable ways to present the information. 
The use of video clips with professionals, patients and carers was also confirmed to 
be a relevant and important way of delivering additional information. The consensus 
was that the use of video clips should be incorporated into a website rather than a 
DVD. DVDs were felt to be outdated and little used. Although there was the risk of 
exclusion of those without internet access, it was felt that such video content could 
be additionally supplied on request, should there be demand for it. This approach 
was agreed to be the most consistent with our findings on preferences and the most 
economical use of funding. Cost is clearly an important consideration when 
developing information resources for use within a budget constrained NHS.  
5.2.2 Resource homepage, front cover and title 
The next step in this co-development process was to try to reach an agreement on 
what the front page of a booklet or website should look like. This was important to 
ensure early engagement with an information resource, as patients reported a 
significant rejection rate based upon website homepages. For this purpose I had 
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created a very basic template with removable sections using features from the 
interviews that had been identified as important to patients and carers (Figure 5). 
These included components such as the title choice and a choice of images that 
users could potentially relate to. Affiliations that may inspire trust and engagement 
were also found to be important in the interviews and were included as options. 
Figure 5. Workshop 1 template use. 
 
Participants then discussed which elements they felt should remain or be removed: 
which added to the resource, and which were superfluous to requirements. For 
example, one feature I had included on the front page template was the phonetic 
spelling of bronchiectasis (brong-kee-ek-tuh-sis). In keeping with the interview 
findings, several workshop participants were, or had been, unsure of how to 
pronounce bronchiectasis:  
‘P21: The way that you put, the way that you pronounce it. Because I can never say 
that word. I’ve always said “bronchiexi-whatsit”. But that’s helpful actually. 
F:  And then do you think that’s something you would put, like, on a front page of 
the website, or would you have that somewhere else? 
P21: No, put it on the front page. 
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P20: Yeah. 
P19: If it’s on the front you know exactly what it is.’ (FG1, 1854-1873) 
Even those that didn’t specifically mention the importance of pronunciation did 
sometimes mis-pronounce it. One participant had wondered whether it was the same 
as bronchitis, as it sounded the same. Although this may seem like a minor point, this 
was considered an important element of the website homepage. Simply putting the 
phonetic spelling to aid with pronunciation could help a lot of patients feel more 
confident about this and save them the embarrassment and confusion that some 
participants had experienced.  
As an example of a feature that was not chosen to be included, I had suggested as 
potential options for the front page some images of a pair of lungs and a doctor. On 
discussion, participants felt that overall these added little to the homepage in terms of 
giving information or fitting with the overall design theme and purpose. The decision 
was therefore made that these would not be included on a final version, as they may 
be considered to be ‘cluttering’ the page rather than improving it.    
I also began discussions about the title choice included within the template by asking 
what people thought of the proposed title ‘Living your life with bronchiectasis’, and 
whether it should be changed or simply be entitled ‘Bronchiectasis information’ for 
example. Participants felt that the choice of title was good: 
‘C11: No, I think living with is good. Personally, I think that’s what you want.  
P22: Yes, because that’s what we are doing, we are living with it. So I think that’s 
very appropriate. 
P18: And it’s positive isn’t it?’ (FG1 2107-2112) 
This is exactly why the proposed title had been created: to portray a positive 
message, how one can still live life with bronchiectasis. Patients and carers were 
very clear that they wanted positivity within any information received so to ensure this 
was embodied within the title of the resource was crucial. By using the interview data 
I had created this title to portray the purpose and nature of the information and to 
capture the essence of the interview findings. The agreement of the workshop 
participants that this met requirements confirmed that my translation of these findings 
into an engaging title had been effective.  
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Another key outcome was to design the resource to ensure credibility; to encourage 
potential users to look at and trust the resource. A range of logos were included in 
the template: those for Newcastle University, Newcastle upon Tyne Hospitals NHS 
Foundation Trust, NIHR and the BLF. Participants felt these were essential to include 
on a front page, and that the NHS logo itself was the most likely to inspire trust. It 
was agreed that all logos used would remain at the bottom of the front page to 
optimise initial engagement. This decision reflected both the interview and workshop 
findings that users are more likely to engage with and trust ‘authentic’ information 
resources from trusted organisations.   
5.2.3 Resource contents: sections and headings 
Moving on to the content of the resource, I then shared with the group draft content 
headings based upon the interview findings (Appendix 12). We initially discussed 
which elements required a prominent position within an information resource, and 
which could possibly be omitted or repositioned. The content headings had been 
based on the findings of the interviews, to try to ensure that sections of information 
were organised and titled in a way that users could relate to. By reviewing these 
provisional section headings and the concepts for their content within the workshop 
we were able to refine this further as a group. For example, I had included a section 
about the ‘medical team’ which I proposed would include a description of each 
member of the team that someone with bronchiectasis was likely to see. The aim was 
to explain the role of the multidisciplinary team, and the ways in which they can help, 
so that people would know what to expect, and who to turn to. I suggested that this 
would be a combination of both text and video clips, with each team member making 
a short video clip describing their role. Participants felt that this was useful, but 
maybe could be presented slightly differently:  
‘C11: It’s also useful to know that there is a whole team to deal with this. If you are 
going in and see five, “Oh crikey there’s five or six things wrong with me…It’s 
not just the one” 
Co-F: Can I ask you a question? So P21, when you see the term there, ‘The medical 
team’ what does that make you think of? 
P21: Well as an ex-nurse, I would automatically think doctors, nurses, physios…. 
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P19: …So instead of putting it as ‘medical team’, could you not put, ‘People who 
you are likely to see’? Because medical, you think, surgical…Or it’s going to 
be invasive… 
F: Yes, that’s a good idea.’ (FG1 2471-2507) 
By understanding users’ reactions to the proposed presentation of this section, I was 
able to change it to be entitled ‘People you may need to see’. I then described who 
the potential people involved would be alongside a video clip of each individual 
explaining their role (respiratory consultant, respiratory physiotherapist, specialist 
nurse, continence nurse, lung function technician, dietitian). By using these templates 
of initial ideas within the workshop, it was possible to tease out more subtle 
requirements for acceptability to users. 
Similar subject areas were identified as important to the workshop participants as 
had been with the interviewees. Workshop participants also wanted to receive 
‘useful’ information: information about things that would help them, or things they 
could do to help themselves. Again, nearly all used diet and lifestyle advice as 
examples. Prognosis also came up again as an important subject area to be 
included. This is something that was clearly required to feature within the resource as 
accurately as possible, yet in a way that would offer hope and positivity. In terms of 
format, it was felt that explanations about a complex subject such as prognosis may 
be better achieved through the use of video to complement written information. 
Having video clips of professionals and also patients, both new and old, talking about 
their experiences and how their lives have or have not changed was also thought 
likely to add credibility and be more engaging than written descriptions alone.  
By discussing the proposed sections and contents we were able to review which 
elements were agreed to be important components of the resource. By discussing 
proposed ways of sectioning different aspects of information, and how each section 
should be titled and organised, we began to build a much clearer picture of how the 
contents would look. The views of participants in this first workshop built upon and 
reaffirmed the findings of the interviews. This new knowledge made it possible to 
begin to develop a first prototype of the novel user-driven resource. 
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5.3 Prototype development  
Once the findings of both the interviews and the first workshop had been assimilated, 
I had an initial meeting with a media production company and my supervisory team to 
discuss content and design of the agreed resources: a website and a booklet. We 
discussed concepts and ideas behind the resource, and the key requirements. 
Although I was responsible for production of the content of the booklet and website, 
the actual website construction and design was developed in conjunction with the 
media company based on my explanations of what we were aiming to achieve. I 
gave details of the title, sections required, what needed to be on the homepage, 
navigation features that had been highlighted as important, images and login 
requirements, to name but a few. I briefed them on the opinions of users of some of 
the available resources tabulated above to aid with the design and conceptualisation 
of our planned resource. I also explained to them the findings of the interviews, and 
some of the typical experiences of people living with bronchiectasis, so that they 
understood the potential resource users. The media designer then spent time 
creating a few options in terms of design and layout and a variety of images to 
potentially be used on the homepage.  
Whilst this was being done, I began to develop the written, video and image content 
of the website in a structure that was in keeping with my qualitative findings and the 
workshop discussions. Transcripts and written analyses were used to facilitate this as 
described in the methods in Chapter 3. Additionally, members of the multidisciplinary 
bronchiectasis care team each contributed to their own expert sections. I held 
discussions with the members of the bronchiectasis MDT about the findings of the 
interviews and workshops and how they might present information relevant to their 
expertise in keeping with these findings. Each then provided their version of 
information, which was usually the information they would give to a typical patient 
when seeing them on a clinical basis. This ensured that the information provided 
would meet the needs identified, yet also be presented by an expert in that field in a 
way which would reflect information received when attending a specialist clinic. By 
using the whole team, as would be done in a clinical setting, the resource was further 
shaped and developed around the users’ identified needs and ensured that any 
additional content thought fundamental to their specialist area was included. Content 
was written or edited by me and my clinical supervisor and also reviewed by 
contributors, potential users and independent reviewers. This rigorous process of 
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peer review was important to ensure that the information provided was accurate, un-
biased and of high quality. 
Video clips were recorded by me using a camcorder. Videos of healthcare 
professionals were recorded within clinic rooms, and patients and carers were given 
the option of recording theirs either at home or at the hospital or university sites. Only 
1 participant opted to film at the hospital as this was more convenient for her, others 
were recorded in participants’ homes. I gave all contributors a briefing about what 
was required (topic matter and duration) in advance, but all content was decided by 
the person being recorded. The clips were not edited and patients, staff and carers 
gave their stories in their words. I did not know in advance what they had planned to 
say and they were not scripted. I felt this was the most honest and realistic way to 
record the video clips so that users could potentially more easily relate to them.  
Written and video content was then uploaded to the website by both the design 
company initially, and then by me once I had completed training in the content 
management system. This meant that I was able to make amendments as required 
throughout the development process and create logins for new reviewers and users. 
This training was essential to ensure that I could have ownership of the resource and 
promptly fix any issues as they arose. 
5.3.1 Prototype content and organisation 
Rather than setting the resource out in a traditional textbook layout: causes, 
investigations, symptoms and so on, (which I had learnt to be contrary to users’ 
desires for a resource) I focussed on addressing the main issues within the data. I 
grouped the information into 5 main sections, each of which had a relevant group of 
subsections (Table 6). 
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Table 6. Website section and subsection headings. 
Main Heading Learn 
 
Treatment 
 
Help and 
Advice 
 
Carers 
and 
Families 
 
Research 
 
Subheadings Getting a 
diagnosis 
 
Why have I got 
bronchiectasis? 
 
What is wrong 
with my lungs? 
 
What symptoms 
might I get? 
 
What is the 
prognosis? 
 
What does this 
mean for my life 
now? 
What  
 
People you may 
need to see 
Treatments 
Treating chest 
infections 
Managing 
breathlessness 
Treating 
coughing blood 
New drugs and 
research 
Recognising 
symptoms 
Self-
management 
Active 
partnerships 
with your team 
Understanding 
your clinic letter 
Diet, exercise 
and lifestyle 
advice 
Coping and 
support 
Patient 
experiences 
Useful links 
How you 
can help 
How you 
may feel 
What 
research is 
being 
done? 
What is 
being done 
in my local 
area? 
How can I 
get 
involved? 
 
The groupings were based upon discussions within the interviews and workshop and 
also which subsections ‘naturally’ went together. One feature that was clearly in 
demand was for users to be able to look at the information they wanted to look at, 
and not have to look at other information that may not be relevant or of interest to 
them. For this resource to be a quick and simple way for users to access information 
specific to their needs at a given time was clearly important. In order to enable this, 
many of these listed subsections were also subdivided again, to facilitate ease of 
searching for (and possibly avoidance of) specific information. Detailed contents and 
menu tabs, inter-section links and straightforward navigation systems were 
incorporated into the resource for this purpose also.  
As an example of information content, prognosis and disease trajectory was a topic 
raised by many. This was included in the ‘Learn’ section (Table 6). I wanted to cover 
this topic in a way that would address the prognosis concerns that people have 
described, rather than just giving medical evidence and figures. This needed to serve 
as reassurance to patients rather than create more confusion and concern. 
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Specifically, it was clear from the data that participants were comfortable with the 
term ‘prognosis’ but that this should also be addressed by quoting things patients 
have actually said in interviews: ‘How will I live with this?’ and ‘What does this mean 
for my life from now on?’, in addition to facts about prognosis and symptoms. This 
written information was complemented by videos from patients explaining how they 
have coped after a diagnosis, and a video from a consultant explaining more about 
prognosis. Wording this in ways that linked directly with discussions had within 
interviews and workshops ensured that users would be able to relate to the 
information and experiences described.  
Another section ‘Help and Advice’ facilitated incorporation of general diet and lifestyle 
advice, a topic of concern to many, in a similarly positive way. This section 
additionally enabled promotion of the importance of doing physiotherapy regularly by 
emphasising the benefits they should feel. Also included was advice about changes 
in symptoms to facilitate self-management, emphasising how this could help their 
condition remain stable. All advice was given in such a way that related back to the 
findings of the qualitative interviews, with a view to making this resource relevant and 
‘useful’ to users. 
The actual content of information and the way in which it was presented has been 
influenced by all of the interview and workshop data and the relevant literature 
described in Chapter 2. As described in Chapter 4, one of the primary purposes of 
information seeking seemed to be to somehow lessen the impact of bronchiectasis. It 
was therefore crucial that the resource was developed in a style that would enable 
users to easily see that this resource could help them to understand their concerns 
and consequently may lessen the impact that bronchiectasis is having on their life. 
The fact that potential users would have differing levels of clinical support 
emphasises the importance of universal accessibility to user-friendly information 
beyond the clinic experience. 
5.3.2 Key points for resource development 
Alongside the development of the actual content, format and presentation of the 
resource, there were other important points that arose during discussions and 
analysis of data. Many of these have been described already, yet for clarity, I have 
tabulated a summary of some of the general points that were important to take into 
account in order to optimise information delivery, uptake and benefit (Table 7).  
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Table 7. Resource general principles 
 
General Principles 
 
The resource should be positive yet realistic 
 
Clarity: black on white, no jargon, Easy Read principles. 
 
Detailed contents and navigation: what you view is up to you. 
 
Booklet to accommodate those who do not want ‘too much information’. 
 
Placement is key to maximising value: most are ‘opportunistic seekers’. 
 
Trust: needs to be endorsed or recommended. ‘NHS’ logo essential. 
 
Multi-format: website, video content, booklet. 
 
Accessibility: incorporates all above points 
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I have also presented some examples of specific points that clearly needed to be 
included (Table 8). These summaries were used to confirm the important features 
and principles with the co-development group, including the media team. For them to 
be clear about exactly what we were aiming to achieve was vital to being able to 
move forwards with developing a high quality resource in keeping with our findings. 
These points, along with the section headings given above began to give a better 
picture of how we envisaged the prototype. By using these as a framework, the 
prototype information resource could be constructed. Once the prototype had been 
completed, further workshops were held to review and refine the resource.
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Table 8. Specific examples of resource content and features 
Specific examples of content and features to be included 
Phonetic spelling to aid pronunciation on front page (brong-kee-ek-tuh-sis) 
‘Understanding your clinic letter’ picture of example letter and links to key 
words and sentences e.g. terminology, imaging and lung function. This was 
commonly misunderstood as learned from interview data.    
Clearly distinguish from COPD and asthma and lack of connection with 
smoking and explain what and why doctors will ask (not accusatory). This 
was clearly an issue for patients who had never smoked yet were repeatedly 
asked if they had. 
Explaining common misconceptions – is bronchiectasis contagious or 
smoking-related? 
Explain conditions it may be linked with 
Drugs and side effects and other management: physiotherapy, pulmonary 
rehabilitation, transplant (emphasise rarity so as not to cause unnecessary 
worry). 
Research and the future: links to what is happening locally if want to get 
involved. 
FAQs and expert advice – participants would appreciate an ‘email and 
answer’ section but wouldn’t be practical at this stage. Initially just FAQs as 
determined by interview data. 
Have a variety of patients and carers giving their experiences in terms of 
reactions to diagnosis, and how they manage on a daily basis to give hope 
and positivity. Incorporate people’s reactions and management strategies 
relating to interview findings of biographical disruption and flow.   
Prognosis: include videos of participants recalling thoughts at diagnosis and 
now, how changed over time. 
Self-management tips, as with above, to aid readers to feel empowered to 
‘take back control’ or form an ‘active partnership’ including others’ 
experiences and symptom recognition – incorporate ‘normality’ and put into 
context ‘Put it into their daily lives so that you really understand’ (C09 434). 
Advice about playing an active role. This seems to particularly relate to diet 
and lifestyle advice. 
Practical advice e.g. holiday insurance. 
Links with other trusted online resources. 
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5.4 Workshops 2 and 3: Refining the resource 
Workshops 2 and 3 focussed on patients and carers reviewing the resource 
prototype and finalising ideas on content of the overview booklet to accompany the 
website. A concise topic guide was used for these sessions (Appendix 13). 
Workshop 2 was attended by 5 patients and 1 carer, and was facilitated by me and a 
specialist bronchiectasis nurse. Workshop 3 was attended by 1 patient and 1 carer 
and facilitated by me.  
Prior to workshops 2 and 3, all contributors to the website had the opportunity to give 
feedback and suggest changes to the prototype, and the prototype site had also 
been reviewed by a patient representative from the British Lung Foundation and a 
number of ‘expert’ patients. During the workshops, participants were shown the 
prototype website. It was made clear to them that this was a starting point and the 
purpose of the session was to get their views and feedback and make any necessary 
alterations. They were shown example sections chosen by me, and the participants 
also selected sections they particularly wanted to look at. I gave demonstrations of 
how to navigate through the site and participants could try this for themselves. The 
extensive review of the prototype began with discussion of the website home page 
and their reactions to it.  
5.4.1 Homepage 
The appearance of the home page was our starting point. At that stage in the 
development process, there were 2 potential options for how the homepage could be 
set out (Figure 6, Figure 7). The images show the website when viewing on a PC 
(main image) or mobile device (image the the left of main image).  
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Figure 6. Website homepage option 1. 
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Figure 7. Website homepage option 2. 
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A lot of importance was attached to the images that would be on the homepage as 
they were felt to be representing bronchiectasis and people who may have it. The 
participants wanted to portray a positive image, as per the interview findings. There 
was one participant who initially felt that the images were not representative of 
someone with bronchiectasis. He wondered if someone wearing an oxygen mask 
should be portrayed. A discussion ensued and the consensus was that the majority 
of people with bronchiectasis will be well most of the time, and that this is what 
should be represented. All agreed (including the participant who raised the original 
suggestion of including an oxygen mask) this was preferable to presenting the ‘worst 
case scenario’ which does not fit the need for a positive approach that users had 
expressed, nor does it represent the majority of people with the condition:   
‘P27:  When I’m well, I’m well, and I look well. 
… 
P24:  I mean that’s one of the reasons why I stopped reading stuff from the internet 
about bronchiectasis… ‘cause there’s a lot of doom and gloom. And you, you 
read it, and you come off and you think, “My God!” You think that y- your life’s 
over, but I suppose them pictures show that you don’t have to be – it doesn’t 
have to be a life debilitating illness…You can still have a quality of life at the 
same time. 
… 
P26: I think you need to start with where the mean is, so they will be the majority of 
people looking…I think on the first screen you want to capture the presence of 
the main group of people.’ (FG2 336-429) 
Building on this point, some participants had concerns that the man shown in option 
2 (Figure 7) looked like he might be wearing a dressing gown and that this was not 
an ideal image to portray. On the basis of these discussions we were able to make 
changes to the homepage and alter it to include an image which fitted with an 
‘average’ patient with bronchiectasis: a middle-aged woman who looks well.  
Also agreed to be important features of the homepage were the phonetic spelling of 
bronchiectasis, logos and contact details that confirm credibility, easy menu options 
to allow swift access to the area of information required, and a video clip explaining 
the purpose of the website and how it had been developed. The final website 
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homepage incorporating these features was created with all these points taken into 
consideration (Figure 8).  
Figure 8. Final version website homepage. 
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5.4.2 Section contents and navigation 
When talking generally about the site content, participants agreed again that the title 
of the site was positive, as was the web address: www.bronchiectasis.me. This 
domain name was considered carefully before purchasing for the site. They also felt 
the positive message of coping with bronchiectasis came across throughout the site. 
Discussion about sections of the website ensued and useful changes were able to be 
made to make navigation and searching more straightforward. Participants gave their 
views on the way that sections were ordered, and the organisation of menus to the 
side of the screen that intended to make looking at specific subsections of a page 
much easier. For example, the Help and Advice section (Figure 9).  
Figure 9. Help and Advice section. 
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To make it easier to narrow down exactly which aspect users wanted to look at, we 
had a side menu including recognising symptoms, self-management, diet and 
lifestyle advice and so on. Not all sections of the website can be discussed in depth 
here, but all were reviewed and revised as per discussions within the workshop. 
For a more in depth look at the website content, a PDF version of the site is included 
as an appendix (Appendix 2). The website can also be viewed at 
www.bronchiectasis.me. People opting to enter the feasibility study without internet 
access were given the PDF as an alternative to viewing the website. Unfortunately 
this did mean they were not able to access the video content, nor the interactive 
content such as the example clinic letter. Although this was an incomplete and less 
than ideal way of accessing the information contained within the resource, it did 
serve as a next best option for those wanting to engage with the information and 
enter the feasibility study.   
5.4.3 Final revisions 
In workshop 3, participants were shown the further revised version of the website 
with the final homepage (Figure 8) and asked to look through the site and give their 
feedback. Participants felt that the revised images were positive and likely to appeal 
to users. They also concurred that having the explanatory video on the homepage 
was a good way to both get across a message in a different format, and introduce 
what could be expected within the site, as many more video clips are used 
throughout.  
During workshop 3, minor errors such as typing errors and non-functioning links were 
also identified and final revisions were facilitated. The overall view was extremely 
positive: 
‘I think it looks really professional…and I think you should be very proud of yourself…I 
think that would have answered everything I wanted to know and…I think a lot of it 
would have reassured me. And I think you’ve done a good job in sort of saying, ‘This 
isn’t necessarily going to happen’.’ (P28, FG3 1438-1454) 
This participant had a relatively new diagnosis, and had found that previous online 
searching for information had been very frightening when not knowing what 
information was reliable, and what she should believe. It was very reassuring to hear 
that the resource I had co-developed with patients and carers based upon the 
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interview findings and workshops would have met the needs of a new patient such as 
her. This was further confirmation that the development methods had allowed me to 
meet the aims I had set.   
5.4.4 The overview booklet 
Following this third workshop, the website in its final version was again reviewed by 
patients, an independent respiratory physician and all contributors. We then further 
discussed and finalised the contents of the booklet. This was to be a 14 page glossy 
booklet with a similar front page to the website homepage. The ‘essential’ contents to 
be included within this booklet were determined by both discussions within the 
interviews and workshops, and feedback from patient reviewers and healthcare 
professional that contributed to the information resource. The booklet was presented 
in a similar style, and quotes from participants aimed to replace the videos used on 
the website. Only a limited amount of information could be included within the 
booklet, so focussing on what was important was crucial. Again the contents were 
added by me based upon the website content, and the design company organised 
the layout options which I reviewed. The prototype was then reviewed by 
contributors, patients, carers and an independent respiratory consultant as per the 
website. Amendments were made and a final version agreed. A PDF of the final 
booklet is included as an appendix (Appendix 1). 
5.5 Summary  
The process of resource co-development took approximately 8 months. This included 
development time, filming, content writing and revision and re-design in between 
workshops and reviews. This process was informed by concurrent analysis of 
workshop discussions and transcripts and by referring back to the interview data 
analysis. Being able to co-develop the resource with patients and carers in this way 
meant that potential users influenced the development process and end products 
directly, in addition to the resource being designed around the qualitative interview 
findings. All reviewers felt that a useful, positive, credible and informative resource 
had been developed. The resource seemed to both meet users’ requirements and 
incorporate insights into their experiences gleaned from analysis of interviews. The 
next step was for the resource to be used as the intervention within the BRIEF Study. 
The findings of the BRIEF study, including further resource evaluation, are described 
in the following chapter. 
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Chapter 6 Results 3: Bronchiectasis Information and Education: 
Feasibility and evaluation of a novel resource (The BRIEF Study) 
findings 
In this chapter I describe the findings of the Bronchiectasis Information and 
Education: Feasibility and evaluation of a novel resource (BRIEF Study, 
ISRCTN84229105). This reporting of results is in keeping with the newly published 
extension of the 2010 CONSORT statement for randomised pilot and feasibility 
studies (Eldridge et al., 2016). The methods and design of the study have been 
described in detail in Chapter 3, where the study protocol was presented. The 
findings of the qualitative interviews and the results of the resource co-development, 
which formed the intervention for this feasibility study, were described in Chapters 4 
and 5. The BRIEF study was a feasibility study, and therefore its primary purpose 
was to determine the feasibility of conducting a future definitive RCT based on this 
study design and protocol. In addition, I aimed to further evaluate the information 
resource that formed the intervention within the study. In this chapter I will present 
the results of the feasibility outcomes (detailing recruitment, retention and study visit 
completion) in addition to the baseline demographic data and descriptive analysis of 
the data collected at study visits. As this was a feasibility study, no formal statistical 
testing has been performed in keeping with the protocol and pre-written statistical 
analysis plan described in Chapter 3. (See also (Hester et al., 2016).) Participants’ 
views on the resource and the trial process were explored both in study 
questionnaires and a focus group at the end of the study. The outcomes of these are 
presented along with analytical data on the use of the website. Findings are 
discussed at the end of the chapter and then further in the overall discussion 
(Chapter 7) which concludes the thesis. 
6.1 Participants and recruitment 
As described in the methods (Chapter 3), potential participants were approached by 
their usual care team following review of case notes, usually at a clinic appointment. 
A participant information leaflet (Appendix 15) was given to them in person or 
agreement established to their being contacted for further information about the study 
by the research team. If participants had agreed to being contacted but the team 
were unable to contact them despite repeat attempts at postal and telephone contact, 
they were deemed ‘uncontactable’.  
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At study commencement, the aim was to recruit and randomise a minimum of 60 
patients, in keeping with recommendations for feasibility studies (Browne, 1995; 
Lancaster et al., 2004). Study recruitment was expected to take place over a period 
of just over 2 years, with projected patient accrual of 2-3 patients per month.  
Overall, 62 patients were randomised. As the aim was for 30 per arm, given the 
availability of potential participants, 62 were randomised to ensure follow up data was 
achieved for 30 participants per arm to facilitate estimation of sample size for a full 
study (Browne, 1995; Lancaster et al., 2004). Recruitment took place over a 16 
month period (the first patient was randomised on 10th June 2014, and the last on 
23rd September 2015), with a participant recruitment rate of 3.9/month (Figure 10). 
Recruitment target numbers were therefore achieved ahead of time.   
Figure 10. BRIEF Study cumulative number of participants randomised: original target compared to actual 
recruitment. 
 
 
6.1.1 Distribution of participants by randomisation strata 
Participants were randomised using random permuted blocks within strata by means 
of the Newcastle University online randomisation system. Randomisation was 
stratified according to gender. Overall more women were recruited than men, which 
had been anticipated in keeping with the patient demographic. There were equivalent 
male to female ratios in each group. The distribution of patients by randomisation 
strata is included in the table of baseline characteristics (Table 12).   
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6.1.2 Adverse events  
Within the control group there were two serious adverse events (SAE) unrelated to 
the study, one of which resulted in the death of the participant (Table 9). The latter 
event clearly resulted in the complete withdrawal of the participant. The participant 
with fractured ribs was able to continue with study visits, but was unable to perform 
the lung function tests at visit 3. 
Table 9. SAE summary table. 
group 
allocation 
Allocation 
date 
Date of 
initial report 
SAE 
Description 
Onset 
Date 
SAE 
reason 
Outcome 
of SAE 
Control 16/09/14 27/11/14 
Pulmonary 
embolus 
26/11/14 
Hospital 
admission  
Death 
Control 10/04/15 10/06/15 
Fractured 
ribs 
10/06/15 
Hospital 
admission  
Resolution 
with 
treatment 
 
6.1.3 Withdrawals and loss to follow up 
There was 1 withdrawal from the intervention group at day 15 due to personal 
circumstances (Table 10). The participant had an unexpected change in 
circumstances that they felt prevented them from continuing with study visits. Only 
visit 1 of 3 was completed. This was a complete withdrawal and as defined in the 
protocol (Chapter 3) consent was obtained to retain and use data up to the point of 
withdrawal but the participant was not followed up further within the study. Other than 
the death (detailed in 6.1.2) and this withdrawal, there were no further patients lost to 
follow-up.  
Table 10. BRIEF study withdrawals. 
group 
allocation 
 
Allocation 
date 
Date of 
withdrawal 
Withdrawal 
type 
Withdrawal reason 
Intervention 
 
30/09/14 14/10/14 Complete Change in personal circumstances  
 
6.1.4 Data collection, validation and analysis 
The trial protocol in Chapter 3 (Hester et al., 2016) describes the methods of data 
collection and the main features of the analysis. The statistical analysis plan 
(Appendix 28) describes, in more detail, the predetermined strategy that was used for 
the statistical analysis and presentation of data collected for The BRIEF Study.  
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The CONSORT Statement for Reporting Randomised Trials recommends that all 
analyses should be planned and outlined in a statistical analysis plan prior to the 
unblinding of the data so as to avoid any post hoc decisions which may affect the 
interpretation of the statistical analyses (Moher et al., 2010; Eldridge et al., 2016). 
The CONSORT statement also recommends that when writing research papers 
authors should specify whether analyses were planned or suggested by the data – 
planned analyses have greater credibility and are in line with Good Clinical Practice. 
A statistical analysis plan was therefore written (with advice from a statistician) for the 
BRIEF study prior to embarking upon any data analysis. Participants recruited to The 
BRIEF study were not blinded due to the nature of the intervention making this 
impractical. The research staff conducting study visits were also unable to be blinded 
to the allocation groups. The same principles have been applied for the purposes of 
analysis however, and those initially entering data into the database and cross 
checking with study files were not directly involved in the trial.  
Trial data was entered manually into the BRIEF study database by data managers at 
the study site. All data was originally hand written into each study record folder and 
entered into an excel database subsequently.  
The following checks were carried out before any analysis: 
 Treatment arm allocation as recorded in the randomisation log checked against 
that recorded in the CRF  
 Randomisation stratification variable as recorded in the randomisation log, 
checked against Visit 1 CRF  
 Age at randomisation ≥18 years (from randomisation log and CRF visit 1) 
 All dates examined to check timings and compliance with the protocol. 
 
Data analysis was performed as per the pre-written plan by me, the chief 
investigator. Due to the nature of both the intervention and the study (receipt of the 
intervention resource in a feasibility study with no additional funding for an 
independent data analyst), I was not blinded to the allocation groups either. Analysis 
was, however, performed on the fully anonymised data set using the pre-determined 
plan. 
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6.1.5 Definition of analysis sets 
Statistical analyses were based on the intention to treat principle with analysis sets 
based on the groups allocated at randomisation and all randomised participants being 
included in the analysis.  
No data were available at week 12 for participants lost to follow-up (n=2). Given this was 
a feasibility study, analyses of change data were based on the ‘Completers’ analysis set 
(Table 11). 
Table 11. Definition of analysis sets. 
Analysis set n Definition: 
Intention-to-
treat (ITT) 
62 
All randomised participants, retaining participants in their 
randomised allocation groups. 
Completers 60 
All randomised participants, retaining participants in their 
randomised allocation groups, who attended their final 
study visit at 12 weeks post randomisation. 
 
6.1.6 Patient flow 
Section 6.1 described recruitment, which was completed at a faster rate than 
expected. It had been anticipated that approximately 50% of those approached would 
ultimately be eligible or willing to enter. It is difficult to predict with certainty the 
number of patients screened who will be deemed ineligible or decline study entry. A 
recent review of influential RCTs found that only around half of trials report with 
sufficient detail to calculate a non-recruitment rate (Humphreys et al., 2013). A mean 
of 40.1% (SD 23.7%) non-recruitment was found amongst those studies reporting 
adequately. A conservative estimate of 50% non-recruitment was made ahead of this 
study. Of the 124 potentially eligible participants approached, 44 declined 
participation (35%), 15 were deemed uncontactable after repeated attempts to re-
contact following receipt of the patient information sheet (12%), and 3 deemed 
ineligible (2%). Overall therefore, exactly 50% of those approached were willing and 
eligible to enter the study, which was in keeping with what we had anticipated. The 
following CONSORT diagram further details patient flow through the study (Figure 
11).  
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Figure 11. BRIEF study CONSORT flow diagram. 
 
 129 
 
6.2 Participant characteristics 
Demographic and clinical baseline characteristics and trial stratification factors at 
randomisation were compared across treatment groups descriptively. For these 
baseline study entry characteristics, data for all participants has been included (ITT 
analysis set n=62). For data analysis beyond this point, only the data from ‘study 
completers’ (n=60, as defined in section 6.1.5) has been considered. Descriptive 
statistics were tabulated by treatment group and overall (Table 12).  
The majority of characteristics are reported as absolute numbers and percentages. 
Continuous data were examined graphically and described appropriately dependent 
on distribution. Consequently, age was reported as median and range, as were 
FEV1% predicted and time since diagnosis. To describe the population at baseline, 
features characterising individuals (e.g. age, gender); the nature of their disease (e.g. 
lung function, severity scores (BSI (Chalmers et al., 2014)), time since diagnosis, 
microbiology) and information seeking were recorded. It is anticipated in a 
randomised trial that baseline characteristics of the intervention and control groups 
would be very similar. For example, as shown in the table, median age is comparable 
between groups here. Gender is equal between groups, as randomisation was 
stratified by gender. However, with the small numbers involved and unequal splitting 
within some categories, some imbalance between groups in this study would be 
unsurprising. For example, it can be seen in the table that FEV1% predicted seems 
to be higher (75%) in the control group than the intervention group (67%). The clinical 
significance of this is hard to determine from one variable alone. The number of 
participants in the intervention group who have had bronchiectasis for more than 10 
years (17/32 (53%)) was greater than that of the control group (9/30 (30%)). Again, 
the clinical significance of this and its relevance to information use is hard to 
determine. It is possible that this could reflect a greater number with more severe 
disease in the intervention group, yet length of time since diagnosis and severity of 
disease do not necessarily go hand in hand. The majority of participants had 
idiopathic bronchiectasis in both groups.  
Notably, 28/30(93%) and 30/32 (94%) of the control and intervention groups 
respectively were recruited from the specialist bronchiectasis clinic. Only a minority 
were recruited from general respiratory clinics, which I will refer to again in the 
discussion. 9/30 (30%) of the control group, and 5/32 (16%) of the intervention group 
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had not actively sought information in the past, and a variety of methods of 
information seeking and access were described (Table 12). Overall, groups seem as 
balanced as expected given the small numbers. These characteristics allow a 
description of the groups at baseline. Variables described could potentially influence 
interaction with the intervention or health outcomes in a future definitive trial. No 
significance testing was carried out due to the randomised nature of the study 
(Altman, 1985; Roberts and Torgerson, 1999; Moher et al., 2010).  
Table 12. Baseline participant characteristics by allocation group (ITT analysis set). 
     Control group  
 
n=30 
Intervention group 
 
N=32 
Total 
 
n =62 
Gender 
Female 
Male 
 
18 (60%) 
12 (40%) 
 
20 (62.5%) 
12 (37.5%) 
 
38 (61%) 
24 (39%)         
Age (years) 
Median (range) 
 
65 (34-81) 
 
 65 (18-81) 
 
65 (18-81) 
FEV1 
(% predicted) 
Median (range) 
 
 
75(21-120) 
 
 
67(10-110) 
 
 
68(10-120) 
BSI score1 
Median (range) 
BSI Severity group  
Mild (score 0-4) 
Moderate (score 5-8) 
Severe (score >8) 
 
6(2-15) 
 
9(30%) 
14(47%) 
7(23%) 
 
7(2-14) 
 
13(41%) 
13(41%) 
6(19%) 
 
6(2-15) 
 
22(35%) 
27(44%) 
13(21%) 
Time since diagnosis 
(years) 
 
Median (range) 
> 10 
> 5 ≤ 10 
>1 ≤ 5 
>6 months ≤1 year 
≤6 months 
 
 
 
6(0.5-70) 
9(30%) 
5(17%) 
10(33%) 
5(17%) 
1(3%) 
 
 
 
15(0.25-70) 
17(53%) 
2(6%) 
6(19%) 
3(9%) 
3(9%) 
 
 
 
10(0.25-70) 
26(42%) 
7(11%) 
16(26%) 
8(13%) 
4(6%) 
Bronchiectasis aetiology 
Idiopathic 
Post-infection 
Secondary to chronic 
asthma/COPD 
 
Immune deficiency 
associated 
Other2 
 
 
12(40%) 
6(20%) 
 
7(23%) 
 
 
2(7%) 
3(10%) 
 
 
10(31%) 
11(34%) 
 
5(16%) 
 
 
1(3%) 
5(16%) 
 
 
22(35%) 
17(27%) 
 
12(19%) 
 
 
3(5%) 
8(13%) 
Exacerbations per year 
<3 
≥3 
 
13(43%) 
17(67%) 
 
10(31%) 
22(69%) 
 
23(37%) 
39(63%) 
                                            
1 Newcastle Bronchiectasis Severity Index, CT scoring not included 
2 Pink’s Disease, Rheumatoid Arthritis, Marfan’s Syndrome, Connective Tissue Disease, Wegener’s Granulomatosis. 
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     Control group  
 
n=30 
Intervention group 
 
N=32 
Total 
 
n =62 
Use of home intravenous 
antibiotics 
Y 
N 
 
 
8(27%) 
22(73%) 
 
 
15(47%) 
17(53%) 
 
 
23(37%) 
39(63%) 
Clinic attended 
Specialist 
General 
 
28(93%) 
2(7%) 
 
30(94%) 
2(6%) 
 
58(94%) 
4(6%) 
Prior bronchiectasis 
hospital admissions 
Y 
N 
 
 
16(53%) 
14(47%) 
 
 
25(78%) 
7(22%) 
 
 
41(66%) 
21(34%) 
Sputum microbiology 
Pseudomonas aeruginosa 
Other3 
Not colonised 
No samples 
 
8(27%) 
8(27%) 
13(43%) 
1(3%) 
 
9(28%) 
11(34%) 
11(34%) 
1(3%) 
 
17(27%) 
19(31%) 
24(39%) 
2(3%) 
Drug treatments 
Azithromycin 
Nebulised antibiotics 
 
10(33%) 
6(20%) 
 
18(56%) 
3(9%) 
 
28(45%) 
9(15%) 
Devices used to access 
internet/resource 
Mobile 
Tablet 
PC/laptop 
No access 
 
 
2(7%) 
13(43%) 
28(93%) 
0 
 
 
8(25%) 
10(31%) 
28(88%) 
1(3%) 
 
 
10(16%) 
23(72% 
56(90%) 
1(2%) 
Previous bronchiectasis  
information seeking  
None 
Paper 
Online 
In person 
 
 
9(30%) 
9(30%) 
14(47%) 
4(13%) 
 
 
5(16%) 
14(44%) 
16(50%) 
3(9%) 
 
 
14(23%) 
23(37%) 
30(48%) 
7(11%) 
 
                                            
3 Haemophilus influenzae, Klebsiella spp, Staphylococcus aureus, Serratia marcescens, Moraxella catarrhalis, Escherichia coli. 
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6.3 Analysis of feasibility outcome measures 
The primary outcome measures for the BRIEF study were those measuring 
feasibility. These criteria included:- 
 Participants’ willingness to enter the trial (consented participant to potentially 
eligible participants approached ratio). 
 Participant recruitment rate (as measured by the number of patients 
randomised divided by the length of the recruitment period). The recruitment 
period runs from the date that recruitment opened to the date of the last 
randomisation.   
 Participants’ acceptability of study design (as measured by the completion rate 
of participants in each randomised group, ‘study completers’).  
 Participant completion of required study forms and visits as per protocol. 
For the primary outcome measures all proportions/rates were calculated as defined 
(Table 13, Table 14). 
6.3.1 Willingness to enter and recruitment rate 
As described in section 6.1.6, willingness to enter the trial was as originally predicted. 
62/124 (50%) of potentially eligible participants approached entered the study. When 
removing the 3 ineligible participants, 62/121 (51%) of potential participants were 
consented and entered the study. Recruitment rate exceeded expectations, with 
recruitment to target numbers achieved ahead of time. A projected participant 
recruitment rate of 2-3 per month was surpassed, with an actual recruitment rate of 
3.9/month. 
Table 13. Participant recruitment. 
Outcome measure Result 
Willingness to enter trial (consented 
participants/ potentially eligible approached) 
62/121 (51%) 
Participant recruitment rate 3.9/month  
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6.3.2 Study completion rate 
Study completion rates were recorded as a measure of acceptability of the trial 
design to participants, which formed part of the assessment of feasibility. If the 
design of the study was acceptable to participants, a higher study completion rate 
would be anticipated. As described in sections 6.1.2, 6.1.3 and 6.1.5, there were just 
2 participants who did not complete the study (1 death and 1 lost to follow-up). There 
were therefore 60/62 (97%) participants in the ‘completers’ analysis set. One 
participant was lost from each of the randomisation groups, leaving a 97% study 
completion rate in both arms as shown (Table 14). In the study completers group, all 
participants completed the 3 required study visits as per protocol.   
Table 14. Study completion rates. 
 
 
Outcome measure 
(n=62 ) 
Control group n=30 Intervention group n=32 
Study completers 29/30 (97%) 31/32 (97%) 
 
6.3.3 Completion of study forms 
At each visit (as described in Chapter 3), a series of questionnaires were completed. 
Validated questionnaires were used, plus 3 unvalidated questionnaires, produced for 
use within this study. The unvalidated questionnaires consisted of the Bronchiectasis 
Knowledge Questionnaire (BKQ), the Resource Satisfaction Questionnaire (RSQ) 
and a postal questionnaire concerning symptoms and information use. The analyses 
of data within all study forms are described individually subsequently. For the 
purposes of determining feasibility, the completion rates of all questionnaires and 
lung function tests were examined.  
Completion of validated questionnaires and lung function tests 
Completion rates of validated questionnaires and lung function tests were excellent 
(Table 15). The Fatigue Impact Scale (Appendix 25), EQ-5D-5L (Appendix 26) and 
HADS (Appendix 24) were all fully completed by all study completers at each study 
visit. Lung function was omitted in one case in both the control and intervention 
groups, for clinical reasons. The SGRQ (Appendix 23) was well completed in both 
the control and intervention groups, with the omission of a few individual questions 
leading to an inability to calculate a total score for just 2/29 cases in the control group 
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(7%) and 1/31 in the intervention group (2%). When looking at the QOL-B 
questionnaire (Appendix 22), the figures for ‘Treatment burden’ seem at first glance 
to demonstrate a lesser completion rate for this section of the questionnaire (72% in 
the control group and 71% in the intervention group) compared to the very high 
completion rates for other sections. This in fact does not represent an issue with form 
completion. If patients are not taking any treatment, they do not score in this section. 
This is a feature of the questionnaire scoring system rather than an error or omission 
in completion. When looking back to the raw data and the paper questionnaires, all 
had been completed accurately. A summary of complete cases for the validated 
questionnaires and lung function is tabulated (Table 15). 
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Table 15. Summary of number of complete questionnaires and lung function at each study visit by randomisation 
group. 
 
Outcome 
measure 
 
Control group complete cases (n=29) 
Number (% rounded) 
 
Intervention group complete cases (n=31) 
Number (% rounded) 
  
V1 
 
V2 
 
V3 
 
Total 
complete 
at all 
visits 
 
V1 
 
V2 
 
V3 
 
Total 
complete 
at all 
visits 
 
FEV1 % 
predicted 
 
29(100)  
 
28 (97) 
 
28 (97) 
 
31(100)  
 
30 (98) 
 
30 (98) 
 
FIS:- 
Cognitive 
Physical 
Social 
Total  
 
 
29(100) 
29(100) 
29(100) 
29(100)  
 
 
29(100) 
29(100) 
29(100) 
29(100) 
 
 
29(100) 
29(100) 
29(100) 
29(100) 
 
 
31(100) 
31(100) 
31(100) 
31(100)  
 
 
31(100) 
31(100) 
31(100) 
31(100) 
 
 
31(100) 
31(100) 
31(100) 
31(100) 
 
EQ-5D-5L 
 
29(100) 
 
29(100) 
 
29(100) 
 
29(100) 
 
31(100) 
 
31(100) 
 
31(100) 
 
31(100) 
 
HADS 
 
29(100) 
 
29(100) 
 
29(100) 
 
29(100) 
 
31(100) 
 
31(100) 
 
31(100) 
 
31(100) 
 
SGRQ:- 
Symptoms 
Activity 
Impacts 
Total 
 
 
29(100) 
28(97) 
29(100) 
28(97)  
 
 
29(100) 
28(97) 
29(100) 
28(97) 
 
 
29(100) 
27(93) 
29(100) 
27(93) 
 
 
31(100) 
31(100) 
31(100) 
31(100)  
30(98) 
31(100) 
31(100) 
30(98) 
30(98) 
31(100) 
31(100) 
30(98) 
 
QOL-B:- 
Physical 
Role 
Vitality 
Emotion 
Social 
Treatment 
Burden 
Health 
Respiration 
 
29(100) 
29(100) 
29(100) 
29(100) 
29(100) 
23(79) 
 
29(100) 
29(100) 
 
29(100) 
29(100) 
29(100) 
29(100) 
29(100) 
25(86) 
 
29(100) 
29(100) 
 
29(100) 
29(100) 
29(100) 
29(100) 
29(100) 
26(90) 
 
29(100) 
28(97) 
 
29(100) 
29(100) 
29(100) 
29(100) 
29(100) 
21(72) 
 
29(100) 
28(97) 
 
31(100) 
31(100) 
31(100) 
31(100) 
31(100) 
27(87) 
 
31(100) 
31(100) 
 
31(100) 
31(100) 
31(100) 
31(100) 
31(100) 
26(84) 
 
31(100) 
31(100) 
 
31(100) 
31(100) 
31(100) 
31(100) 
31(100) 
27(87) 
 
31(100) 
31(100) 
 
31(100) 
31(100) 
31(100) 
31(100) 
31(100) 
22(71) 
 
31(100) 
31(100) 
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Completion of unvalidated questionnaires 
As described, 3 unvalidated questionnaires were also used within the study. Details 
of the data within these questionnaires is described in more detail in section 6.4.2 
Completion rates of these questionnaires were used as measures of feasibility and 
are described here.  
The Resource Satisfaction Questionnaire (RSQ) (Appendix 20) was completed only 
by the intervention group, and only at visits 2 and 3, as it detailed views and usage of 
the resource provided. This questionnaire had many individual questions. When 
looking at overall completion, 31/31 (100%) of those in the intervention group 
completed the form (Table 16). The breakdown of completion of individual questions 
is included as an appendix due to the volume of data (Appendix 29). 20/31 (65%) at 
visit 2 and 19/31 (61%) at visit 3 were completed without any omissions. It must be 
noted that the form was completed by all participants, but with omissions. Most of 
these consisted of a few unanswered questions, and it may be that these were felt 
not to apply rather than just having been missed. This was the first time that this 
questionnaire had been used, and as stated it is not a validated questionnaire. The 
main purpose of this questionnaire was to gain feedback on the resource, which is 
described further in section 6.5. 
The Bronchiectasis Knowledge Questionnaire (BKQ) (Appendix 21) was very well 
completed. Total completion rates at all 3 visits were 28/29 (97%) in the control group 
and 30/31 (97%) in the intervention group (Table 16). Omissions were minimal. The 
breakdown of completion of individual questions is supplied as an appendix 
(Appendix 30). 
The third unvalidated questionnaire was a postal symptom and information use 
questionnaire, completed monthly and returned in the post. Despite the additional 
effort required to complete and return this form, it was still well completed (Table 16). 
In the control group, 24/29 (83%) returned form 1, 27/29 (93%) returned form 2, and 
29/29 (100%) completed and returned form 3. In the intervention group, 30/31 (97%) 
returned form 1, 28/31 (90%) returned form 2 and 31/31 (100%) returned form 3. Due 
to the fact it was not the same participants who failed to return forms 1 and 2 each 
time, the total completing all 3 of their forms was slightly lower at 21/29 (72%) in the 
control group, and 27/31 (87%) in the intervention group. This is detailed again on a 
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per question basis as an appendix (Appendix 31). A summary of total form 
completion rates is tabulated (Table 16), with individual details appended as detailed. 
Individual completion rates of forms are all above 90%. Even when looking at those 
completing all forms at all visits, the lowest rate is 72%. These rates are very 
reassuring in terms of assessing feasibility for a future trial.  
Table 16. Summary of completion and return of unvalidated questionnaires. 
 
Outcome 
measure 
 
Control group complete cases (n=29) 
Number (% rounded) 
 
Intervention group complete cases (n=31) 
Number (% rounded) 
 
V1 V2 V3 
 
Total 
completing 
at all visits V1 V2 V3 
 
Total 
completing 
at all visits 
 
RSQ      31(100) 31(100) 31(100) 
 
BKQ 29(100) 28(97) 29(100) 28(97) 31(100) 30(97) 31(100) 30(97) 
 
Postal 24(83) 27(93) 29(100) 21(72) 30(97) 28(90) 31(100) 27(87) 
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6.4 Analysis of secondary outcome measures 
The secondary outcome measures recorded were as listed:- 
 Forced Expiratory Volume in 1 second (FEV1)  
 Number of unscheduled visits to primary or secondary care 
 Exacerbation frequency  
 Quality of life – Bronchiectasis (QOL-B) (Quittner et al., 2014) 
 St George’s Respiratory Questionnaire (SGRQ) (Wilson et al., 1997) 
 Hospital Anxiety and Depression score (HADS) (Zigmond and Snaith, 1983) 
 Fatigue Impact Score (FIS) (Fisk et al., 1994) 
 EQ-5D-5L (Herdman et al., 2011) 
 Bronchiectasis Knowledge Questionnaire  
 Resource Satisfaction Questionnaire 
 Postal symptom questionnaire  
Secondary outcome measures were recorded at study visits as per the study protocol 
(Chapter 3). The actual completion rates of the questionnaires listed and lung 
function tests were used as measures of feasibility and acceptability of the study 
design as described. The outcome measures themselves were chosen as measures 
that would be used in a definitive trial of the information resource, to measure impact 
of the intervention. FEV1, number of unscheduled visits and exacerbation frequency 
would be used as measures of disease stability. QOL-B and SGRQ are quality of life 
scores specific to bronchiectasis and respiratory conditions respectively. HADS is 
used to measure anxiety and depression, known to be prevalent in bronchiectasis, as 
is fatigue, measured by the FIS. EQ-5D-5L was recorded as a quality of life score 
that could be used in a definitive trial to estimate any health economic benefit. 
Recording use of and satisfaction with the information resource would enable 
assessment of the intervention and any refinements needing to be made to this. This 
is of use both within this feasibility study as an evaluation of the resource and in a 
future definitive trial. Knowledge of bronchiectasis was also assessed, using a 
questionnaire developed for this purpose. It had not been validated, yet there are no 
other validated knowledge questionnaires for use in bronchiectasis. In a future trial, 
some assessment of knowledge would be important when measuring impact of the 
intervention.  
In accordance with recommendations for the analysis of feasibility studies (where a 
formal power calculation is not carried out) the data analysis of these measures was 
descriptive and statistical comparisons between the randomisation groups were not 
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undertaken (Lancaster et al., 2004; Thabane et al., 2010). All summaries were 
interpreted cautiously because of the size of the study and the possible imbalance in 
pre-randomisation baseline covariates. Due to the nature of the intervention 
adherence to protocol was not assessed. 
6.4.1 Analysis of validated outcome measures 
Lung function tests and validated secondary outcome measures for study completers 
were described at baseline. Baseline data were examined graphically and due to 
distribution, median and range are presented for complete cases at baseline (Table 
17).
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Table 17. Baseline data for validated outcome measures. 
  
Control group (n=29) Intervention group (n=31) 
  
N (complete 
cases at all 
time-points) 
baseline Median 
(range) 
N (complete 
cases at all 
time-points) 
baseline Median 
(range) 
EQ-5D-5L4 
Index Value 
Vas 
 
29 
29 
 
0.8 (0-1) 
70 (30-100) 
 
31 
31 
 
0.7 (0.1-1) 
65 (20-95) 
SGRQ5 
Symptoms 
Activity 
Impacts 
Total 
 
29 
27 
29 
27 
 
61 (21-93) 
59 (12-100) 
29 (0-83) 
49 (17-86) 
 
30 
31 
31 
30 
 
74 (12-91) 
60 (0-100) 
36 (5-65) 
48 (10-88) 
QOL-B6  
Physical 
Role 
Vitality 
Emotion 
Social 
Treatment Burden7 
Health 
Respiration 
 
29 
29 
29 
29 
29 
21 
29 
28 
 
53 (0-100) 
73 (7-100) 
44 (0-100) 
92 (44-100) 
67 (0-100) 
78 (22-100) 
50 (0-83) 
62 (11-100) 
 
30 
30 
30 
30 
30 
22 
30 
30 
 
53 (0-100) 
73 (7-100) 
44 (0-77) 
92 (25-100) 
63 (8-100) 
78 (22-100) 
42 (0-92) 
52 (19-100) 
HADS8 
A 
D 
 
29 
29 
 
5 (1-13) 
3 (0-12) 
 
31 
31 
 
6 (0-14) 
4 (0-8) 
FIS9 
Cognitive 
Physical 
Social 
Total 
 
29 
29 
29 
29 
 
5 (0-34) 
12 (0-38) 
11 (0-71) 
30 (0-143) 
 
31 
31 
31 
31 
 
6 (0-21) 
12 (0-32) 
11 (0-47) 
31 (0-93) 
FEV1 (%predicted) 28 77 (21-120) 30 67 (10-110) 
                                            
4 EuroQol 5D 5L: self-reported health status (Index Value range: VAS range: 0-100%)  
5 St George’s Respiratory Questionnaire: Scores are expressed as a percentage of overall impairment 
where 100 represents worst possible health status and 0 indicates best possible health status. 
6 Quality of Life – Bronchiectasis: Scaled score 0-100, higher scores= better quality of life 
7 Treatment burden is not scored if participant is on no treatment hence apparent lower n. 
8 Hospital Anxiety and Depression Score: Anxiety 0-21, depression 0-21. 11+ significant 
9 Fatigue Impact Scale: Cognitive: 0-40, Physical: 0-40, Social, 0-80, Total 0-160. Higher score=bigger 
impact of fatigue.  
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For validated questionnaires scored using provided calculators, pre-determined rules 
for missing data were followed. For those questionnaires that were either unvalidated 
or had no pre-defined rules for dealing with missing data; missing data points were 
treated as such. Missing data due to participant non-completion of study 
questionnaires were not imputed and therefore the analyses of change data were for 
complete cases (i.e. those participants completing the particular outcome/ 
questionnaire at each of the specified time-points) on an outcome by outcome basis. 
Numbers of complete cases and descriptive analysis of baseline and change data is 
tabulated (Table 17, Table 18) and each measure described individually. 
EQ-5D-5L 
This is a brief questionnaire consisting of 5 dimensions (mobility, usual activities, self-
care, pain/discomfort and anxiety/depression) (Appendix 26) (Herdman et al., 2011). 
Participants rate these each on a scale of 1-5. An index value is calculated from 
these scores and in addition a self-scored measure of health on a visual analogue 
scale (VAS) labelled from ‘worst health you can imagine’ to ‘best health you can 
imagine’. All questions are answered as the participants health is ‘today’. In addition 
to assessing quality of life, this scale allows estimation of health economic evaluation 
for a future trial. If patients’ understanding and self-management are improved by an 
intervention (the information resource) then this could facilitate a reduction in service 
use and consequent reduction in costs to the NHS. For the purposes of this study, 
feasibility outcomes were looked at, and data described to aid in planning a future 
trial, rather than attempting to assess any benefit at this stage. The EQ-5D-5L had a 
100% completion rate, completed by all participants at all visits in each of the 
randomisation groups (Table 15). Median score at baseline for the VAS was 70 (30-
100) in the control group, and 65 (20-95) in the intervention group, with an index 
score of 0.8 (0-1) in the control and 0.7 (0.1-1) in the intervention group (Table 17). 
Change data is also presented (Table 18). 
SGRQ 
The St George’s Respiratory Questionnaire is a quality of life and respiratory health 
questionnaire (Wilson et al., 1997) (Appendix 23). Scales differ for different questions 
in part 1, and in part 2 responses are mainly true or false. Scores are calculated 
using an official calculator tool. Scores are obtained for Symptoms, Activity, Impacts, 
and a Total score. Each score is expressed as a percentage of overall impairment 
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where 0 is the worst and 100 the best. Median (range) baseline scores (Table 17) 
and change data were recorded (Table 18). Completion rates were good for SGRQ, 
with 27/29 (93%) obtaining data complete enough to calculate a total score at all 
visits in the control group, and 30/31 (97%) in the intervention group (Table 15). 
Median total score at baseline in the control group was 49 (17-86) and 48 (10-88) in 
the intervention group. 
QOL-B 
QOL-B is a quality of life questionnaire specific to bronchiectasis (Quittner et al., 
2014) (Appendix 22). A score is calculated in 8 domains (physical, role, vitality, 
emotion, social, treatment burden, health and respiration) with no total score 
calculation. Scores are scaled 0-100, with higher scores indicating better health. As 
can be seen (Table 15), completion rates at all visits were 29/29 (100%) in the 
control group, and 30/31 (97%) in the intervention group, for all bar the treatment 
burden domain. This is a feature of the QOL-B scoring system, in that a treatment 
burden score is simply not generated if patients take no treatment. The lower 
‘complete case numbers’ of 21/29 (72%) and 22/31 (71%) reflect the number of 
generated scores for this domain. This does not therefore represent a problem with 
form completion, but the number of patients within each group who do not take 
regular treatment for bronchiectasis. Median (range) baseline scores (Table 17) and 
change data (Table 18) are summarised. 
HADS 
The Hospital anxiety and depression scale is a short questionnaire completed by the 
participants (Zigmond and Snaith, 1983) (Appendix 24). Completion of this form was 
100% at all visits in each randomisation group (Table 15). There are 7 questions 
relating to anxiety, each scaled response from 0-3, and the same for depression. 
Total scores for each domain range from 0-21. Higher scores represent worse 
anxiety or depression, with scores of 11 or more being clinically significant. As can be 
seen in the table (Table 17), median baseline scores for anxiety were 5 (1-13) in the 
control group and 6 (0-14) in the intervention group. Depression median baseline 
scores were 3 (0-12) and 4 (0-8) in the control and intervention groups respectively. 
All median baseline scores are below significance level.  
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FIS  
The fatigue impact scale is subdivided into cognitive, physical and social domains 
and then a total core is calculated (Fisk et al., 1994) (Appendix 25). The 
questionnaire consists of 40 questions with scaled responses indicating how much of 
a problem fatigue presents in different areas of one’s life. It is answered with the past 
4 weeks in mind. Total score can be from 0-160, with higher scores indicating a 
greater impact of fatigue. A score of 40 or more is considered to be significant. This 
questionnaire had 100% completion at all visits in both groups (Table 15). Baseline 
data show a median total score of 30 (0-143) in the control group and 31 (0-93) in the 
intervention group (Table 17). Change data are also tabulated (Table 18). 
FEV1 % predicted 
Spirometry was performed at baseline and visit 3. There was only 1 omission per 
group due to participants not being able to perform the test (Table 15). The Forced 
expiratory volume in 1 second (litres) and the percentage this volume was of the 
participants predicted ideal FEV1 were recorded (Table 17, Table 18). At baseline 
the median FEV1 % predicted was 77 (21-120) in the control group, and 67 (10-110) 
in the intervention group. There is possibly a slightly lower overall FEV1 % predicted 
in the intervention group at baseline, but no statistical significance can be attached to 
this. Change data is also presented (Table 18). 
Overall the quality of the data for the validated questionnaires is excellent: the number 
of complete cases is high, with over 97% of complete cases for each of the outcome 
measures. The majority of measures at baseline seem comparable between groups. 
The data demonstrates that for a large number of outcome measures there is 
enormous variation between and within participants. The change from baseline to 12 
weeks (and 2 weeks where applicable) was also summarised (Table 18). Data were 
again examined graphically and the majority of change data were approximately 
normally distributed, although for some variables the change data were slightly 
skewed. It was decided most appropriate to report the change data consistently as 
mean (SD) given the normal (or near-normal) distribution of data. Change data is most 
often symmetrical and presenting the data in this way allows it to be used if calculating 
a sample size for a future definitive study based on this feasibility study design. 
Although the validated outcome measure data at baseline have been described using 
medians and ranges in Table 9, they are summarised again using means (SD) so that 
the change summary measures can be interpreted in context. No further statistical 
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interpretation has been made of this basic change data nor of any apparent change 
within allocation groups given the fact that this cannot be meaningfully interpreted 
without further analysis and can be misleading (Vickers and Altman, 2001; Bland and 
Altman, 2011).
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Table 18. Summary of baseline and change data for lung function and validated questionnaires. 
 
 
 
 
 
 
 
 
n 
Control group n=29  
 
 
 
 
N 
Intervention group n=31 
Baseline 
mean (sd) 
mean change10 
 baseline to  
2 weeks (sd) 
mean change 
 baseline to  
12 weeks (sd) 
Baseline 
mean (sd) 
mean 
change 
 baseline to  
2 weeks (sd) 
mean change 
 baseline to  
12 weeks (sd) 
EQ-5D-5L11 
Index Value 
VAS 
 
29 
29 
 
0.75(0.24) 
68.6(18.5) 
 
0.01(0.17) 
-1.55(13.0) 
 
-0.50(0.19) 
0.48(16.2) 
 
31 
31 
 
0.70(0.23) 
65.4(18.0) 
 
0.06(0.13) 
5.97(12.0) 
 
2.11(11.7) 
-3.0(16.7) 
SGRQ12 
Symptoms 
Activity 
Impacts 
Total 
 
29 
27 
29 
27 
 
57.6(23.4) 
56.3(23.5) 
33.6(21.5) 
46.1(19.9) 
  
0.25(15.0) 
-4.85(13.4) 
0.02(11.3) 
-1.53(8.3) 
 
30 
31 
31 
30 
 
65.9(21.3) 
56.1(28.3) 
32.9(17.2) 
44.9(19.1) 
  
-7.89(25.7) 
-4.79(14.8) 
-3.06(13.0) 
-2.62(9.46) 
QOL-B13  
Physical 
Role 
Vitality 
Emotion 
QOL-B 
Social 
Treatment burden14 
Health 
Respiration 
 
29 
29 
 29 
29 
 
29 
21 
29 
28 
 
48.1(32.3) 
63.5(29.3) 
44.1(24.0) 
84.0(17.0) 
 
59.7(31.2) 
71.2(22.7) 
45.0(25.3) 
60.6(23.7) 
 
2.30(17.8) 
0.23(13.6) 
-1.53(18.5) 
1.05(14.9) 
 
-.077(22.1) 
-1.06(16.8) 
1.25(18.2) 
3.97(17.3) 
 
-3.85(16.7) 
1.32(17.6) 
0.38(16.9) 
-2.1(13.0) 
 
2.97(14.7) 
0.53(14.7) 
-0.10(13.0) 
3.6(16.3) 
 
30 
30 
30 
30 
 
30 
22 
30 
30 
 
51.6(35.1) 
64.9(25.8) 
43.7(22.4) 
85.0(18.6) 
 
58.1(22.8) 
71.7(21.6) 
44.0(24.3) 
54.3(22.8) 
 
3.11(16.2) 
5.33(18.7) 
4.44(18.4) 
4.44(15.3) 
 
5.37(17.2) 
2.02(14.8) 
7.04(15.8) 
9.7(14.6) 
 
-4.94(25.2) 
2.22(17.8) 
-0.74(21.0) 
2.22(10.2) 
 
3.14(19.0) 
1.01(14.1) 
3.06(18.4) 
6.3(16.8) 
HADS15 
A 
D 
 
29 
29 
 
5.69(3.87) 
4.52(3.61) 
 
-0.14(2.86) 
0.00(2.38) 
 
-0.31(3.11) 
0.14(1.76) 
 
31 
31 
 
5.87(4.01) 
3.81(2.33) 
 
-1.32(2.4) 
-0.10(1.7) 
 
0.44(6.6) 
2.12(13.2) 
 
 
 
                                            
10 A negative change indicates a numerical fall on average from baseline to 12 weeks. 
11 EuroQol 5D 5L: self-reported health status (VAS range: 0-100%)  
12 St George’s Respiratory Questionnaire: Scores a percentage of overall impairment .100 represents worst possible health status and 0 indicates best 
possible health status. 
13 Quality of Life – Bronchiectasis: Scaled score 0-100, higher scores= better quality of life 
14 Treatment burden is not scored if participant is on no treatment hence apparent lower n. 
15 Hospital Anxiety and Depression Score: Anxiety 0-21, depression 0-21. 11+ significant 
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n 
Control group n=29  
 
 
 
 
N 
Intervention group n=31 
Baseline 
mean (sd) 
mean change10 
 baseline to  
2 weeks (sd) 
mean change 
 baseline to  
12 weeks (sd) 
Baseline 
mean (sd) 
mean 
change 
 baseline to  
2 weeks (sd) 
mean change 
 baseline to  
12 weeks (sd) 
FIS16 
Cognitive 
Physical 
Social 
Total 
 
29 
29 
29 
29 
 
8.52(9.44) 
15.52(12.3) 
21.79(21.95) 
45.8(42.5) 
  
2.07(7.2) 
-1.69(5.6) 
-0.59(8.8) 
-0.21(18.3) 
 
31 
31 
31 
31 
 
7.55(5.84) 
12.9(8.18) 
15.7(13.4) 
36.2(26.0) 
  
1.26(5.7) 
0.39(6.9) 
2.72(12.9) 
2.70(19.7) 
 
FEV1 (%predicted) 28 72.6(26.7)  3.78(8.61) 30 63.7(23.8)  -0.78(10.1) 
 
FEV1 (Litres) 28 1.82(0.73)  0.08(0.23) 30 1.64(0.75)  0.23(1.15) 
                                            
16 Fatigue Impact Scale: Cognitive: 0-40, Physical: 0-40, Social, 0-80, Total 0-160. Higher score=bigger impact of fatigue.  
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6.4.2 Analysis of unvalidated questionnaires 
The BRIEF study used several unvalidated questionnaires as described. These were 
primarily used to assess participants’ engagement with such questionnaires for any 
future studies and to evaluate the resource. A secondary aim of the questionnaires 
was to develop some data on the participants’ knowledge about bronchiectasis, their 
current symptoms and use of healthcare services. Three questionnaires were 
produced and will be reported individually. Change data has not been formally 
calculated for these measures, but the results are described and tabulated below.  
The Bronchiectasis Knowledge Questionnaire 
The Bronchiectasis Knowledge Questionnaire (BKQ) is an unvalidated questionnaire 
created for use within this study (Appendix 21). There are no validated 
questionnaires assessing knowledge of bronchiectasis currently available. Given the 
lack of available materials, and the need to measure participants’ understanding of 
their condition, I opted to produce a questionnaire aiming to assess knowledge and 
understanding specific to bronchiectasis. The BKQ was additionally used to assess 
engagement with a knowledge questionnaire in the absence of an existing validated 
questionnaire. Although a formal questionnaire development process was not used 
(the BKQ was not piloted and validated prior to its use within this study), a rigorous 
and methodical approach was taken. Other validated respiratory knowledge 
questionnaires were used for reference. An example is the Bristol COPD Knowledge 
Questionnaire, which consists of 13 questions to be answered ‘true’, ‘false’ or ‘don’t 
know’ (White et al., 2006). However, this specific questionnaire was not suitable for 
direct use within our study with patients who have bronchiectasis. The questions 
within the BKQ were designed to reflect aspects of understanding about 
bronchiectasis that the specialist team and patients and carers had already identified 
as being important throughout the qualitative phases of this work. I began the 
development by creating a list of subject areas that were identified within interviews 
as areas that people wanted more information about, or had a lack of understanding 
of. I then formulated questions and had the questionnaire reviewed by members of 
the bronchiectasis service specialist team, including a bronchiectasis consultant and 
specialist nurse. Revisions were made based upon these discussions to both the 
question content and format. The questionnaire was then further reviewed by user 
representatives. The questions in the final version of the BKQ aimed to establish 
knowledge about areas considered (by users and professionals) to be relevant to 
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patients being able to understand and manage their condition appropriately. The aim 
was to assess knowledge and re-assess after use of the information resource. The 
BKQ is in 2 parts. The first part consists of 15 statements about bronchiectasis to 
which the respondent can select from 4 responses to grade their understanding of 
that issue. The second part comprises 11 questions to be answered true, false or 
don’t know. As the primary role of this questionnaire was to assess engagement, 
responses were summarised as numbers and percentages of participants giving 
each response at each study visit. Participants who did not complete each question 
at each visit were not excluded from this analysis as absolute numbers and 
percentages giving each response were recorded at each visit. Individual change 
data were therefore not calculated for this unvalidated questionnaire. The main 
findings are presented here and a summary of all question responses is tabulated 
and presented as an appendix due to the volume of data (Appendix 32). 
Completion rates and data quality for the BKQ were excellent. As the BKQ is an 
unvalidated questionnaire being used within a feasibility study, it is not possible to 
establish whether or not there are significant improvements in knowledge as a result 
of the intervention. However, increases in participants reporting understanding 
aspects of their condition ‘very well’ seem to be more obvious across study visits in 
the intervention group than the control group (Appendix 32). For example, ‘I 
understand what bronchiectasis is’ was graded ‘very well’ by 10/31 (32%) at visit 1 
rising to 22/31 (71%) at visit 3 in the intervention group. In the control group 
percentage understanding this ‘very well’ remained roughly the same: visit 1, 11/29 
(38%) and visit 3 10/29 (34%) (Figure 12).  
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Figure 12. Percentage understanding 'very well' what bronchiectasis is. 
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The percentage understanding ‘very well’ what their treatments were for increased 
from 13/31 (42%) to 22/31 (71%) in the intervention group, yet again remained the 
same in the control group: visit 1 17/29 (59%), visit 3 15/28 (54%) (Figure 13).  
Figure 13. Percentage understanding ‘very well’ what their treatments are for. 
 
The percentage understanding ‘very well’ what to do when having a bronchiectasis 
flare up rose from 17/31 (55%) to 25/31 (81%) in the intervention group, whereas the 
control group again remained the same (Figure 14). Importantly for this study, 
understanding ‘very well’ where to get more information rose from 9/31 (29%) to 
22/31 (71%) in the intervention group, and remained the same in the control group 
(Figure 15).  
This pattern can be seen for several questions, yet no statistical significance can be 
attached to this due to the nature of the study (feasibility study, not powered to detect 
such change) and the questionnaire (unvalidated). It also should be noted that there 
are other questions for which such patterns were not seen (Appendix 32).  
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Figure 14. Percentage understanding very ‘well’ how to manage a flare up. 
 
 
Figure 15.  Percentage understanding very ‘well’ where to find more information. 
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The postal questionnaire 
A postal questionnaire was sent out each month to study participants (Appendix 19). 
For postal questionnaire 1 (week 4) and 2 (week 8), they were asked to complete 
and return the 1 page document in a prepaid envelope. The third and final 
questionnaire was actually completed at the final study visit (week 12) rather than by 
post, which is reflected in the 100% completion rate for this third form. Overall the 
completion rates were excellent and above expected (Table 19), with a systematic 
review of postal questionnaires in studies reporting an average rate of 65% (Nakash 
et al., 2006). The same review reported that telephone follow up reminders and 
shorter forms improved completion and return rates, both of which were strategies 
used within this study.  
Table 19. Postal questionnaire completion rates. 
Return of postal 
questionnaires 
Control group(n=29) 
n (%) 
Intervention group (n=31) 
n (%) 
 
1  
2 
3 
 
24(83%) 
26(90%) 
29(100%) 
 
29(94%) 
30(97%) 
31(100%) 
 
The questionnaire had 3 sections, covering current level of symptoms compared to 
their usual, any additional treatments or medical advice required and use of 
information since their last visit. This was an unvalidated questionnaire developed for 
the purposes of this study and specific change data has not been calculated. Results 
are presented as numbers answering and rounded percentages. All responses are 
included. Main findings are presented here and again full summaries of responses 
are tabulated and presented as an appendix due to volume of data (Appendix 33). 
In the intervention group, at month 1, 25/29 (86%) reported having used the 
information, at month 2, 19/28 (68%), and at month 3, 24/31 (77%). This 
demonstrates that, overall, those who received the resource report using it, with the 
majority stating they used the resource weekly or monthly rather than daily. 
Interestingly, some participants in the control group appeared to answer in error to 
the questions about the information resource, claiming to have used the resource 
daily or weekly, despite being in the control group with no access to the resource. 
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This suggests in future studies the questionnaire needs to be further developed and 
piloted. Providing some explanation about which questions to answer, or indeed a 
questionnaire specific to each randomisation arm are possible considerations. 
The remainder of the postal questionnaire posed questions about health and service 
use specific to bronchiectasis. In a definitive trial over a longer follow up period, 
responses to questions about current level of symptoms could be used to identify the 
potential impact of the intervention on exacerbation rate and unscheduled use of 
healthcare services. In this feasibility study they were well completed, yet are not 
validated questionnaires. It is noteworthy that the reports are consistent with a high 
morbidity population with considerable numbers reporting seeking GP or specialist 
help. 
6.5 Resource evaluation 
Further aims of the study were to evaluate the resource that had been developed, 
and assess its acceptability for use. For this to be done, we asked for feedback from 
participants about the information package provided. The resource was in 3 main 
formats: website, overview booklet and PDF version of website for those without 
internet access. A questionnaire: The Resource Satisfaction Questionnaire (RSQ) 
(Appendix 20) was created for use within the study in order to ask questions about 
the resource and participants’ preferences. In addition, at the end of the study, 
participants (and their carers) were invited to a focus group to discuss both the 
resource itself and the trial process. Whilst the trial was running, the website use was 
also monitored using basic level analytics to determine page views, navigation 
through the site and attempts at access from those outside of the study.  
6.5.1 The Resource Satisfaction Questionnaire 
The RSQ was produced to enable feedback on the use of the resource from the 
participants within the intervention group only. As this relied upon their experiences 
of using (or not using) the resource it was not completed at the first study visit. A 
series of questions were asked about the use of the information provided and their 
opinions of it. Both scaled responses and free text were used within the 
questionnaire. For scaled response questions, options were: ‘strongly disagree’, 
‘disagree’, ‘neither’, ‘agree’ or ‘strongly agree’. For the purposes of summarising 
responses here, these have been further grouped into ‘disagree’ (‘strongly disagree’ 
and ‘disagree’ combined), ‘neutral’ or ‘agree’ (‘strongly agree’ and ‘agree’ combined). 
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This is an unvalidated questionnaire designed to provide feedback about the 
resource. All completed participant responses have been included for each visit 
within the summaries presented. Participants who did not complete each question at 
each visit were not excluded from this analysis, but absolute numbers and 
percentages giving each response were recorded at each visit. Individual change 
data were therefore not calculated for this unvalidated questionnaire. The main 
findings are presented here and summaries of all question responses are tabulated 
yet presented as an appendix due to the amount of data (Appendix 34, Appendix 35). 
About the information overall 
The completion rates were again excellent (100% of study completers, n=31), and 
87% reported that they had used the information provided (Table 20).
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Table 20. RSQ: overall use of information. 
 Numbers in 
intervention group 
completing 
questionnaire 
(n=31) 
Yes n (%) No n (%) 
Did you use the 
information provided? 
Visit 2 
Visit 3 
 
31 
31 
 
27(87) 
27(87) 
 
4 (13) 
4(13) 
 
Of those that used the information, 25/27 (93%) reported that they found it useful 
(Table 21). More than 80% thought that the information was easy to use, covered the 
topics they wanted and that the right amount was given. By visit 3, 18/28 (64%) felt 
that they were more able to manage their bronchiectasis. Over 50% had shared the 
information with their family. Interestingly, knowledge was reported to have improved 
in 22/27 (81%) at visit 2, but only 18/28 (64%) at visit 3 (Table 21). This could 
potentially reflect a reduction in use of the resource as time went on, or an 
interpretation of the question to mean an increase in knowledge since the last study 
visit rather than since the start of the study. It is also important to note that this is not 
looking at individual change on a case by case basis, but an overall number and 
percentage of the group who gave each response at each visit. Due to the small 
numbers involved and the unvalidated nature of the questionnaire it is therefore not 
possible to draw absolute conclusions from this.  
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Table 21. RSQ: Review of information resource overall. 
  
 Numbers 
completing 
questionnaire 
(n=31) Agree n (%) Neutral n (%) Disagree n (%) 
1. I found the 
information useful. 
V2 
V3 
 
27 
28 
 
25(93) 
26(93) 
 
1(4) 
1(4) 
 
1(4) 
1(4) 
2. My knowledge 
about my condition 
has improved. 
V2 
V3 
 
 
27 
28 
 
 
22(81) 
18(64) 
 
 
4(15) 
8(29) 
 
 
1(4) 
2(7) 
3. I feel more able to 
manage my 
condition. 
V2 
V3 
 
27 
28 
 
13(48) 
18(64) 
 
12(44) 
8(29) 
 
2(7) 
2(7) 
4. The information 
provided was easy 
to understand. 
V2 
V3 
 
 
27 
28 
 
 
26(96) 
25(89) 
 
 
0 
1(4) 
 
 
1(4) 
2(7) 
5. The right amount 
of information was 
given. 
V2 
V3 
 
 
27 
28 
 
 
24(89) 
23(82) 
 
 
2(7) 
4(14) 
 
 
1(4) 
1(4) 
6. The things I 
wanted to know 
about were covered.  
V2 
V3 
 
 
27 
28 
 
 
25(93) 
24(86) 
 
 
2(7) 
2(7) 
 
 
0 
2(7) 
7. My partner/family 
member/friend used 
the information. 
V2 
V3 
 
 
27 
27 
 
 
11(41) 
15(56) 
 
 
3(11) 
4(15) 
 
 
13(48) 
8(30) 
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About the website 
At study entry, those in the intervention group received a login and password to 
access the online version of the information resource (www.bronchiectasis.me) in 
addition to the overview booklet. More than 60% reported to have used the website 
(Table 22).  
Table 22. RSQ: Website use. 
 Numbers in 
intervention group 
completing 
questionnaire 
(n=31) Yes n (%) No n (%) 
I used the website. 
V2 
V3 
 
30 
28 
 
19(63) 
18(64) 
 
11(37) 
10(36) 
 
The full summary of responses has been tabulated as an appendix due to the volume 
of data (Appendix 34). Of note, 19/20 (95%) at visit 2 and 20/21 at visit 3 (95%) 
agreed that it was easy to find the sections they wanted to look at within the website. 
At visit 2, 90% of participants completing the questionnaire thought the video clips 
and diagrams were helpful. In addition 90% (18/20) stated that they found the login 
procedure easy to use. At visit 3, approximately 50% (11/21) reported that the 
website was their preferred version of the provided information. Response rates to 
individual questions can be seen in the appended table. Again, these are overall 
numbers and percentages for each question answered and do not look at change 
between visits for individual participants.  
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About the overview booklet 
Those in the intervention group also received a 15 page A5 sized information booklet 
about bronchiectasis to accompany the online information resource. At visit 2, 28/31 
(93%) reported to have used the overview booklet, and 24/31 (77%) at visit 3 (Table 
23). As discussed, this may reflect answering the question as ‘since last visit’ rather 
than since the start of the study.  
Table 23. RSQ: Booklet use. 
 Numbers in 
intervention group 
completing 
questionnaire 
(n=31) Yes n (%) No n (%) 
I used the overview 
booklet. 
V2 
V3 
 
31 
31 
 
28(93) 
24(77) 
 
3(7) 
7(23) 
 
Half of participants that completed the questionnaire reported that the overview 
booklet was their preferred version of the information resource, which is in keeping 
with the preferences reported for the website. The vast majority reported that the text 
was easy to read and it was easy to find the sections they wanted. The majority also 
reported having looked at the whole booklet rather than just certain sections. The 
detailed summary of these findings are tabulated as an appendix due to volume of 
data (Appendix 35).  
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About the PDF 
Within the website it was possible to download the text and images for each section 
as a PDF (Portable Document Format). This was offered as an option at entry to the 
study for those who did not have internet access. In the PDF version however, the 
video clips were obviously not able to be viewed and interactive features could not be 
used. Two participants chose this option of study entry.  
This section of the questionnaire sought feedback about the PDF version from those 
who had the PDF at entry to the study and to establish if participants used this 
function within the website. From the summary table (Table 24) it can be seen that 
the vast majority of participants did not use this facility.  
Table 24. RSQ: PDF use. 
  
Responders n Yes n (%) No n (%) 
I downloaded the PDF. 
V2 
V3 
 
30 
28 
 
4(13) 
6(21) 
 
26(87) 
22(79) 
I printed out the PDF. 
V2 
V3 
 
25 
24 
 
2(8) 
2(8) 
 
23(92) 
22(92) 
I received the PDF in place 
of the website at study 
entry. 
V2 
V3 
 
24 
20 
 
2(8) 
1(5) 
 
22(92) 
19(95) 
 
 
 160 
 
RSQ free text feedback  
At the end of each section of the RSQ, there was a space for participants to add free 
text comments or suggestions. This was not always completed but there was some 
very useful feedback. Positive feedback in free text is tabulated (Table 25). 
Table 25. RSQ free text positive feedback. 
 Positive Comments 
Regarding the use of 
video 
Enjoyed watching the video of patients 
 Video clips helpful. 
 Liked patient video clips. 
 Found videos comforting 
 Found videos of patients doing nebulisers useful 
 The videos were good 
 Confirmation of own self-management technique helpful also 
seeing other patients -same problems helpful. 
Regarding the website I will use the website in future especially as I will be out of the 
country for 2 months 
 Website excellent 
General overall views Quite happy with resources provided 
 
 Everything was clear and easy to understand 
 Thought good and clear, language good, easy to understand. 
 Well balanced 
 Well done 
 I can never have enough information 
Regarding use by 
family 
My youngest son has a better understanding of bronchiectasis  
 
The videos were commented on frequently and these were positive comments, the 
only negative comments concerning the video clips were that people would have 
liked to have seen more of them. In the main, negative comments seem to be about 
the access to the website (Table 26). These could reflect a lack of clarity with the 
access procedure, however 90% reported in the RSQ that the login process was 
easy to use. It is possible that they may reflect personal technical issues.  
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Any problems or suggestions for improvement were also recorded and tabulated 
(Table 26). This feedback was assimilated and reviewed in advance of the end of 
study focus group, to ensure any issues that had been raised were further explored. 
Table 26. Free text suggestions for improvement. 
 Problems or suggestions 
Regarding the use of video Would like more case studies 
 A patient sharing how to use the nebuliser would be more 
helpful than a technician showing how it works. 
 More patient stories 
 
Regarding the website Problems getting on to internet site 
 Unable to access website. 
 When scrolling down things disappeared but did come 
back.  
 Login email + password could be clearer 
 Patient unable to access website due to invalid password. 
Advice sought from Research staff 
 Could not access web on my computer 
 Could not get on website : - password 
General overall views I have not used the information provided due to hospital 
stay and work commitments 
 I find that now the information has stopped for me. I.e. 
there is nothing new to read about. 
Regarding use by family Family members not interested – just want me well, quite 
embarrassed about emotion and keep quiet about my 
condition 
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6.5.2 The end of study focus group 
Following the last participant’s last study visit, participants (and their carers) were 
invited to a focus group to strengthen data obtained from the RSQ, and to discuss 
the trial process. A pragmatic approach was taken to the purposive sampling for 
participant selection with a view to inviting a range of participants. In total, 11 people 
attended the focus group which was facilitated by me. There were 8 patient 
participants and 3 carers. There were a mix of male and female participants and 
carers from both the control and intervention group. One participant had no internet 
access and had elected to enter the study with the PDF version of the site. 
Participants had a range of ages and times since diagnosis.  
The focus group aimed to explore participants’ experiences of taking part in the 
BRIEF study and their views on the information resource. As with the interviews 
(Chapter 4), and to some extent the co-development workshops (Chapter 5), the 
main content of the discussion was in fact people’s experiences of living with 
bronchiectasis. I did have pre-defined questions that I wanted to address in the form 
of a topic guide (Appendix 27) and although I made repeated attempts to concentrate 
on these areas, the need of the participants to discuss amongst each other their 
shared experiences was clear, and tended to dominate the conversation. The focus 
group lasted for approximately one hour, and I used the booklet and the website to 
prompt discussion.  
Areas of discussion common to the interviews included delay to diagnosis, a lack of 
understanding of bronchiectasis amongst GPs and wanting guidance on 
management. There was relatively little discussion about the trial process itself, with 
participants reporting not having found it burdensome. Regarding the content of the 
information resource, participants commented that they had learnt new things, such 
as fatigue being a symptom linked with bronchiectasis, for example.   
Participants made positive comments about the booklet, including it being easier to 
have a quick look at, particularly if you didn’t have internet access. One participant 
talked about how he had given the overview booklet to his friend who had been 
diagnosed with bronchiectasis and that the friend had found it very helpful. They also 
thought it was a good resource for learning about how to find more information on 
bronchiectasis.  
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The website also received favourable reviews, in particular in comparison to other 
available resources as this carer stated: 
‘To answer your question about the website, because I’ve looked at other things, I 
think it’s clear, concise…it’s easier to understand…the thing that’s good about it 
you’ve got a carer’s perspective, you’ve got patient perspective, consultant and so 
on.’ FGC1 770-778.  
He qualifies his opinion by explaining that he has seen other resources and explains 
that he liked the fact that this information resource is both patient and carer-
orientated. Another participant echoed this saying that it would be useful for your 
family, particularly if you are too unwell to want to look at the information. Further 
positive features of the website that were identified were the videos; that you can’t 
mislay it like you could a leaflet; and that it is easier to update. 
There were some negative comments, including issues with passwords. Forgetting 
passwords or not being able to log on easily was clearly a barrier to use. These 
reflect the negative comments within the RSQ. Ease of access to the site was 
possibly an aspect that could be improved upon. 
6.5.3 Website analytics   
Google Analytics was used to perform basic web analytics for the website 
www.bronchiectasis.me. Each individual’s activity was not monitored, but this did 
allow an overall view of how and when the site was accessed, how long people 
stayed on the site, which pages had the most views and how users navigated the 
site.  
The website could be found using internet search engines, yet a password was 
required to access it beyond the homepage. The home page explained that the site 
was for use within a study and that access to the site for those not in the study was 
not possible. An email address was on this home page and I received multiple emails 
from people who had bronchiectasis both locally and from all over the world who 
wanted advice about their condition. I replied to emails detailing the study and 
advising people to see their own doctor. 
Looking at the web analytics, the countries of origin of those attempting access to the 
site included the USA, UK, Japan, Canada, Russia, Japan, Brazil, China, India, 
Australia, and many more. The ‘bounce rate’, i.e. those who exited the site on the 
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same page they entered it without looking around (presumed in the main to be due to 
inability to gain further access to the site due to a lack of password) was 68%. Over 
the duration of the study, there were 7553 sessions by 6456 users, with over 20,000 
page views. The average numbers of pages per session was 2.71, yet this will be 
skewed hugely by the number of those only viewing the home page. During this time 
period 13% of page views were from returning visitors to the site. We noted part way 
through the study that some page content could be read behind the pop up box when 
accessing a page other than the homepage via internet search engines. This was 
addressed by making the background page darker so that it was unreadable.  
When looking at the most popular pages within the site, it is possible to look at ‘user 
flow’. This shows how users navigate through the site, which pages they go to first 
and what they go to next, and how many drop offs there are at each step. An 
example snapshot of this is shown below (Figure 16).
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Figure 16. User flow for first 3 interactions with the site. 
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When looking over the flow analysis, it is clear that the pages about diet and lifestyle 
advice are the most popular, with ‘learning about prognosis’; ‘getting a diagnosis’; 
‘why have I got bronchiectasis?’; ‘what symptoms I might get?’ and ‘who might I need 
to see?’ also being very popular. Total numbers of page views for these pages are 
tabulated below (Table 27). This would include those that were ‘bounced’ from these 
pages. It is likely that people who attempted to look at the page after searching for 
example for ‘diet and lifestyle advice in bronchiectasis’ using a search engine form 
the majority of these. If one used a search engine to search for the above, one would 
be directed to the page, but a pop up asking for log in details would cover the screen. 
For this reason the bounce rate is also tabulated. Although this data does not 
accurately describe the use of the site for individual participants, to be able to capture 
the overall use, and worldwide searching for, or interest in, identifiable topics is of 
great value. 
Table 27. Website page views. 
Webpage Number of views Bounce rate 
Diet exercise and lifestyle 
advice 2061 32% 
What symptoms might I get? 835 32% 
Getting a diagnosis 764 45% 
Carers and families – how 
you can help 723 63% 
Treatments 628 30% 
What is the prognosis?  546 33% 
What does this mean for my 
life now? 536 35% 
People you may need to see 525 84% 
Why have I got 
bronchiectasis?  483 33% 
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6.6 Summary of the BRIEF Study findings and implications for future studies 
In this chapter I have presented the findings of the BRIEF study, including feasibility 
outcomes and evaluation of the resource. The successful recruitment process, high 
retention rate and excellent study form completion rates, indicate that it was feasible 
to conduct this pilot study, and that it could be feasible to conduct a full trial based on 
this study design. There are however always points to consider when assessing 
feasibility and moving from a pilot trial to planning a definitive trial (Thabane et al., 
2010; Bugge et al., 2013).  
The BRIEF study was a single centre trial, although participants could be recruited 
from two sites within the same trust. Recruitment was mainly from a specialist 
bronchiectasis clinic, with 94% of participants recruited from that clinic. Refusal rates 
of those approached did not differ according to clinic attended. Recruiting relatively 
small numbers of participants from the site where the research staff were working 
from a cohort of patients under specialist care went smoothly. For a larger, 
multicentre, definitive trial, recruitment may be more difficult. 
Research staff found the study straightforward to carry out, and found study visits 
easy to conduct. This is consistent with participants’ reports also. The excellent data 
quality shows that staff were able to follow protocol and complete study measures as 
required. The BRIEF study was feasible to conduct over a 3 month period and the 
data obtained could be used in the future to calculate a sample size and predicted 
recruitment time period for a definitive study. Planning a future study with an adaptive 
design may be useful, as the follow up period for the BRIEF study was only 3 
months, and change data over a longer period of time may need to be studied to 
establish if any change is maintained or ongoing. By using an adaptive design, data 
could be collected part way through, for example at 6 months and sample size 
requirements re-assessed.  
Given the short time duration of the BRIEF study, some outcome measures such as 
lung function and antibiotic use could be affected by the specific months during which 
participants entered the trial. For example, if a participant tends to exacerbate more 
in the winter than summer, and also if they were exacerbating at the time of study 
entry. Randomisation, however, used random permuted blocks within strata, and 
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therefore study entry time would be expected to be balanced between the control and 
intervention groups. Should a full trial be performed, however, the follow up period 
would need to be much longer. This would allow for measurement of change in 
outcomes such as exacerbation frequency for example, which would need to be 
recorded over a longer time period. For the purposes of this feasibility study, a 3 
month duration was a pragmatic and acceptable design.  
When considering the baseline data in the BRIEF study, the two groups are 
approximately comparable. There were more participants in the intervention group 
though who had had bronchiectasis for more than 10 years (17/32 (53%) compared 
to 9/30 (30%)). The number who had bronchiectasis for more than 5 years were 
more comparable between groups however with 14/30(47%) in the control group and 
18/32 (60%) in the intervention group. Time since diagnosis could potentially 
influence the type of information needs a person may have. During the interview 
process however, it was apparent that although some information needs do change 
over time, many unanswered questions were common to those who had both new 
and longstanding diagnoses. The numbers of those who had a relatively new 
diagnosis (<1year) were more even, 6/30 (20%) in the control group and 6/32 (18%) 
in the intervention group. If time since diagnosis was thought to be a potential 
confounder, stratification by time since diagnosis could be considered when planning 
a full trial. With larger numbers in a definitive trial however, it would be anticipated 
that the balance between arms for potential confounders would even out.   
In the Bronchiectasis Knowledge Questionnaire, there were some areas of 
understanding that seemed to improve over the visits for the intervention group. For 
the True/False questions, that seemed less apparent. It could be the design of the 
questions, or their content, influencing this. It is also possible that there are some 
areas that are amenable to knowledge gain through such resources, and others that 
may need face to face interaction. The questionnaires were not designed using a 
formal questionnaire development process and the fact that there were no validated 
questionnaires to be used is a limitation of the study. The BKQ was, however, well 
completed and as such seemed acceptable to users. It was reassuring to see that 
there seemed to be a trend towards an increase in participants’ understanding of 
their condition in the intervention group and a raised understanding of how to find 
more information. It is important to keep in mind however that these are not 
statistically significant changes and the questionnaires are not validated.  
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The findings of the BKQ are in keeping with the responses given in the RSQ. 
Feedback from the RSQ demonstrated a perceived increase in knowledge amongst 
those using the resource. This seemed to rise by visit 2 (2 weeks after receiving the 
resource) but then fall slightly by visit 3 (12 weeks after receiving the resource). This 
could represent a perceived plateau in knowledge gain if the question was 
interpreted as meaning an increase in knowledge since the last visit rather than the 
start of the study. This could strengthen the argument for a formal questionnaire 
development process, improving question wording and layout. It may simply 
represent a lack of knowledge retention if participants used the resource at the outset 
and then didn’t engage further with it. Exploring this further within focus groups could 
also facilitate a better understanding of question interpretation and improvements in 
questionnaire design. This point was not specifically discussed in the end of study 
focus group.  
In addition, with hindsight, to follow up on the question regarding understanding 
about treatments (which participants perceived to improve in the intervention group) 
a useful question could have been: ‘are you now more likely to take your medications 
regularly’ as a marker of influence on adherence. Moving on to assessing the impact 
of a reported improvement of understanding in practical terms would be beneficial in 
a future study.  
The RSQ gave some very useful feedback about the resource. Interestingly, 
approximately half preferred the website and half the booklet. When looking at which 
was used the most however, the split was approximately 60/40 in favour of the 
booklet. There are clearly different features that were advantageous to different 
people with each format. It would seem that although the majority have internet 
access, this does not necessarily mean that it is their preferred version of the 
information resource. The PDF version however was little used, and only 2 
participants chose PDF entry to the study. In order to remain inclusive, having this 
option, however little used, was important with this being a feasibility study. 
Acceptability of different formats of the resource was a key finding. 
From the free text feedback about the resource, negative comments mainly 
highlighted technical access problems with the website. These may be specific to the 
user, but it could be that the login process was not as intuitive as we had hoped. For 
the purposes of the trial, in order not to compromise the trial integrity, the access had 
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to be password controlled. It is possible though that if the website was accessible 
without a password, uptake within the trial could have been improved upon. Certainly 
in terms of wider access, looking at the web analytics we can see that the majority of 
attempts at site access were bounced, and that the demand for access to the 
information world-wide was high. 
Further evidence of the demand for such a resource is that the British Lung 
Foundation have requested to use the booklet as the basis of their new and improved 
bronchiectasis patient information and encouraged me to openly publish the website 
for them to reference. Perceived by patients and carers as a highly credible resource 
provider, their use of this developed resource is a commendable outcome of this 
research. I will discuss this further in chapter 7 in terms of the potential impact of this 
work. 
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Chapter 7 Overall Discussion and Conclusions 
This thesis has highlighted the importance of healthcare information and described 
how bronchiectasis was, until quite recently, viewed as a relatively rare condition. 
Bronchiectasis has previously been somewhat neglected in terms of provision of 
information and education materials for patients and their carers. I have described 
the potential impact that an accessible, credible resource could have for those living 
with bronchiectasis, and how the needs of potential users had to be identified and 
understood in order to develop an effective and user-friendly intervention. Related 
issues surrounding information seeking, provision and development, and links with 
self-management have also been explored, both in the current literature, and in the 
interviews with patients and carers described in this thesis. The findings of these 
qualitative interviews provided new insight into the experiences and information 
needs of people living with bronchiectasis, and enabled the co-development of a 
novel information resource. During evaluation of this resource within the BRIEF study 
users reported it to be trustworthy and to meet their requirements; and the trial 
comparing its use to usual care was feasible to conduct. In this discussion, I will 
reflect upon the key findings and strengths and limitations of this work and also 
present its potential impact, recommendations for future research and my overall 
conclusions. 
7.1 The qualitative interviews: key findings 
At the outset of the interviews, the main focus was to establish the unmet information 
needs of patients with bronchiectasis and their carers. In total interviews with 17 
patients and 9 carers took place. A key finding was that during the interviews, 
information needs were almost invariably discussed in the context of their own 
experiences of living with bronchiectasis; the main emergent theme. I have therefore 
been able to understand and describe the physical and psychological impacts of the 
condition, and the biographical disruption and impact upon sense of self that 
bronchiectasis can present. I have also identified and described the ways in which 
people mobilise resources; develop their own support and coping mechanisms and 
develop active partnerships with the healthcare team. Not only have the interviews 
established the unmet information needs of this group, and how users ‘connect’ with 
information, but also their lived experiences of the disease. Developing an 
understanding of the participants lives and how they been affected by bronchiectasis, 
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laid the groundwork for understanding their interactions with information and how 
their needs could be met. To my knowledge, this is the first time that the experiences 
of those living with bronchiectasis have been explored and described in such depth; 
and the first time that requirements for information and education in the context of 
these experiences has been understood.  
7.1.1 Bronchiectasis as a biographical disruption 
The core theme within the interview data, ‘Living life with bronchiectasis’, described 
the lived experiences of patients with bronchiectasis and their carers and the physical 
and psychological impacts bronchiectasis had upon their lives during their journey 
since diagnosis. The ‘disruption’ that a diagnosis of bronchiectasis presents was 
particularly prominent within the data. As discussed in Chapter 4, to further 
understand the disruption that a diagnosis of bronchiectasis brings, I reviewed the 
key literature conceptualising the impacts of chronic illness. Of particular relevance to 
this thesis was Bury’s conceptualisation of chronic illness as a biographical disruption 
(Bury, 1982). Bury’s work built upon prior descriptions of chronic illness as a ‘critical 
situation’ (Giddens, 1979) and a ‘disruption’ (Dingwall, 1976) and descriptions of how 
it affects quality of life (Strauss and Glaser, 1975). Bury described chronic illness as 
an event that has three aspects of disruption: taken for granted assumptions and 
behaviours; the individual’s self-concept and biography, and their response in 
mobilisation of resources in an altered situation. He described how in patients with 
rheumatoid arthritis the insidious onset of symptoms often leads to patients 
dismissing them initially, yet as these progress their ‘common-sense assumptions’ fail 
to explain their experiences. Within my interviews, participants often reported having 
symptoms for a long time prior to diagnosis. This seemed in the case of 
bronchiectasis, however, to be a misinterpretation of symptoms by both patients and 
clinicians alike rather than a one-sided dismissal of their significance.  
Some of my participants, who had bronchiectasis symptom onset later in life, 
wondered if the symptoms were just a natural process at first, with some expectation 
of becoming breathless on exertion at a certain age. Studies in osteoarthritis and 
stroke have found that age does influence the presumption of symptoms being due to 
‘normal ageing’ (Sanders et al., 2002). Age can also mediate the impact of the 
diagnosis, with previous hardship and experiences of ill health seemingly modifying 
individuals’ responses (Pound et al., 1998). Studies of stroke and recovery have 
highlighted that age, co-morbidities and knowledge of their condition additionally 
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influence impact of the diagnosis (Faircloth et al., 2004). Many of the participants in 
my study had co-morbidities, and it is possible that dependent on the nature or 
relative severity of the co-morbidities, they could lessen the impact of bronchiectasis 
upon their lives. With bronchiectasis however, that relationship is often a changeable 
one. Bronchiectasis by its nature is a chronic condition that has periods of 
exacerbation and worsening: there will be times when a co-morbidity seems to be the 
most impactful, interspersed with times when bronchiectasis causes the predominant 
‘disruption’. 
In contrast to Bury’s group of newly diagnosed patients with rheumatoid arthritis, my 
interview participants ranged from those with new to very longstanding diagnoses. 
Interestingly, their ongoing need for information (particularly about prognosis) further 
suggested that a diagnosis of bronchiectasis does not involve a simple, one step 
biographical disruption, but that the change in trajectory remained laden with 
uncertainty. Whilst arguably this may be the case for many long term conditions with 
variable disease course (including rheumatoid arthritis) my description specific to 
bronchiectasis with the emphasis on ongoing need for information represents a new 
finding. The disruption associated with a diagnosis of bronchiectasis is subject to 
repeated superimposition of further ‘shifts’, both temporarily and permanently. The 
diagnosis of a chronic condition such as bronchiectasis does not simply alter a 
patient’s biography, but opens the door to an uncertain future. This state of not 
knowing what the future may hold impacted upon patient’s journeys to acceptance 
and adaptation, with no assurance of what was around the next corner. Although 
patients and carers tried to accept a ‘new normal’, this ‘work’ often had to be done 
repeatedly.  
Early descriptions of the ‘work’ of managing chronic illness (Corbin and Strauss, 
1985) identified the three main types of work carried out by both patients and their 
partners as ‘illness work’, ‘everyday work’ and ‘biographical work’. Corbin and 
Strauss further described ‘biographical work’ as what people do to manage the new 
situation that they face when diagnosed with a chronic illness (Corbin and Strauss, 
1987). They proposed 3 dimensions to a person’s biography (‘conception of self’, 
‘biographical time’ and ‘conception of body’) as the components of the ‘biographical 
body conception chain’ which need to be reconstructed following a biographical 
disruption. Bury has referred to the process following the initial disruption at 
diagnosis or onset of disease as ‘explanation and legitimation’ (Bury, 1991). Patients 
 174 
 
want explanations for their symptoms both medically, and in context, perhaps with 
narratives from others or their own prior experiences (Williams, 1984). Within my 
interview data also, participants commonly sought such explanations from these 
sources, with a great emphasis on the importance of hearing stories of others’ 
experiences. These actions concur with Bury’s definition of the term legitimation: ‘the 
process of attempting to repair disruption, and establish an acceptable and legitimate 
place for the condition within the person’s life’ (Bury, 1991). This access to prior 
experiences (both their own and others’) is clearly an important part of attempting to 
repair this disruption. As described, in my participants with bronchiectasis this ‘work’ 
is more of an ongoing, developing and changing process due to the nature of the 
condition, with variations in levels of symptoms both on a long and short-term basis. 
In summary, there are many similarities to Bury’s work and further concepts of 
biographical disruption in my data. My concept of a diagnosis of bronchiectasis as a 
biographical disruption with further superimpositions of change seems to describe the 
experiences of patients living with bronchiectasis, and indeed their carers. 
7.1.2 Strengths and limitations of the interviews 
The analysis of the interview data has provided new insights into the experiences of 
those who are living with bronchiectasis and their carers. The inclusion of carers 
strengthened the data by ensuring that their views, experiences and specific 
information needs were also explored and incorporated into the resource 
development. By describing the experiences of carers this study has added to our 
understanding of the lives of those who are affected by bronchiectasis. By using the 
methods outlined in Chapter 3, including the consideration of the approach to the 
interviews when exploring information needs and seeking: ‘talking whilst looking’ (Lee 
et al., 2016), and the use of maximum variation purposive sampling, the depth of 
understanding of the needs of participants was optimised. By exploring deviant 
cases, further rigour was added. My role as a bronchiectasis doctor and interviewer 
additionally added strength to the qualitative interviews and the analysis of data 
arising from them as described in both the methods and interview results chapters. 
Critically, having an understanding and knowledge of bronchiectasis enriched my 
interaction with participants and added insight to my interrogation and understanding 
of the data.  
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As with all studies, there are limitations to consider. The limitations I would like to 
discuss pertaining to these interviews relate to sampling. All patients were recruited 
from one hospital trust, as this was a single centre study. Had time and resources 
allowed, I would have aimed to have recruited participants from different centres to 
enable an exploration of any potential differences in experiences and information 
needs relating to the clinical contact they had. Because this was a single centre 
study, and as such the group of potential participants had already been reduced, 
purposive sampling was used in order to obtain a maximum variation sample. 
Participants were recruited from a specialist bronchiectasis clinic and several general 
respiratory clinics, each run by a different consultant. The aim of this approach was 
to recruit patients with different experiences of healthcare services and information 
provision. Although the sample was varied, it could (as always) have been more so. 
When looking at the overall group of participants, 11 patients were recruited from the 
specialist bronchiectasis clinic, and 6 from general respiratory clinics (Table 3). This 
was a good mix, yet still the majority had already been attending a specialist service 
and receiving bronchiectasis specific information from a consultant with an interest in 
patient education within this setting. As discussed in the methods (Chapter 3) the aim 
had been to ensure that participants had different experiences of provision of 
information by their clinical teams, as this might influence their needs. In order to 
improve upon this in the future, recruitment would be from different hospital trusts, 
ideally in different geographical locations.  
Another focus with further sampling would be to aim to recruit some much younger 
patients. Although the ages ranged from 33 to 78, and the median age of 65 was 
representative of the wider patient group in general, having the views of those under 
25 for example would be interesting. Given the saturation of data within this sample, 
it may be that views would not differ, but bronchiectasis is a condition that can be 
diagnosed in childhood. There are patients of all ages living with bronchiectasis. To 
have the views of young adults or even children (and their parent carers) would 
enrich the data further, both by understanding the lived experiences of younger 
people with bronchiectasis, and exploring their information needs. It may be that 
information needs do not differ, but preferences in terms of format and delivery may 
vary. In particular moving forwards, for such a resource to be developed or expanded 
upon with younger adults or children in mind, it is bound to take on a different form. 
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Having the input of children and their parents would be vital in ensuring that this 
could be extended to meet their needs. 
The social circumstances of participants could also be considered in more depth. 
Although I recorded occupation or education as a basic indicator, as well as home 
circumstances, this was done at the interview stage rather than as part of the 
sampling process at first. I was mindful, however, from the pilot exploratory interviews 
I had previously conducted, that I needed to try to sample a group with differing 
social backgrounds, aware of the influence this could have upon information needs 
and access. Within the sampling strategy for the interviews described in this thesis I 
aimed to broaden the variation within the group and achieved this. In further work, 
having a multi-centre study recruiting from different geographical areas would enable 
a much broader variation in social backgrounds within the cohort.  
In summary, analysis of these interviews has enabled the first in-depth description of 
the experiences of both patients and carers who are living with bronchiectasis and 
the biographical disruption that this presents. The information needs of patients and 
carers, and how these could be met have been explored and described. The 
relationship between the need for information and their lived experiences has been 
understood. My role as interviewer and data analyst, the rigorous methods used and 
the maximum variation sample achieved has added depth to this understanding. The 
consequent confidence in this new found understanding has enabled the effective co-
development of the novel information resource.      
7.2 The co-development of a novel information resource: key findings 
The data obtained from the interviews both enhanced understanding of the 
experiences of those living with bronchiectasis, and informed co-development of the 
patient-driven information resource. By having a user-driven development process, 
built upon a careful and analytical assessment of experiences, preferences and 
needs, a resource that met potential users’ requirements was created. 
The methods described in Chapter 3 were carefully considered when planning the 
approach to developing a novel information resource. The aim was that this resource 
would meet users’ needs, facilitate an improvement in their knowledge and 
understanding, and ultimately have the potential to improve self-management and 
health outcomes. Having such a solid framework: the interview data, to build the co-
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development process upon, significantly enhanced the end product. The subsequent 
co-development itself was an iterative process, with the series of 3 user workshops 
influencing ideas and concepts. Affirmations, adaptations and revisions allowed the 
generation of a resource that had genuinely been driven and developed with the user 
group.  
As had been identified within the interview data, users wanted to have information 
that would be ‘useful’ and would help them, or allow them to help themselves. They 
wanted to be able to access the specific information that they needed at that time. 
They did not want to trawl through pages of information about bronchiectasis in order 
to find the one piece of information they were interested in. They did not want to look 
at websites that they did not trust, that were advertising products or that were not 
presented with clarity. By having an understanding of these key participant 
preferences, and an understanding of how people did or did not ‘connect’ with 
different information resources, the creation of an ‘ideal’ resource was facilitated. In 
Chapter 2, I described the literature supporting the use of development processes 
that involve and are centred on potential users (Harland and Bath, 2008; Patient 
Information Forum, 2013). The literature also supports understanding users’ needs 
and developing information to meet those needs (Leydon et al., 2000; Case et al., 
2005; Lambert and Loiselle, 2007). By planning this series of workshops with patients 
and carers, and working with a multidisciplinary team of expert and lay contributors, 
the development process was a smooth and logical one. Allowing time in between 
workshops to read and then re-read transcripts and confirm views and discussions 
enabled changes and revisions to be made. By having users’ views on all aspects of 
the resource I was able to optimise achievement of the desired aims. As described, 
the final version of the information resource consisted of a website 
www.bronchiectasis.me and a 14 page booklet entitled ‘Living your life with 
bronchiectasis’.  
7.2.1 Strengths and limitations of the resource co-development 
The patient-driven, user co-development approach to the production of this resource 
has been key to its success. The strengths of this resource are due to its 
development process. Establishing users’ needs using qualitative interviews prior to 
the commencement of development is a major strength. Not only has this resource 
been co-developed with patients and carers but its content, format and presentation 
is entirely based upon an understanding of users’ experiences and needs. 
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Furthermore, through an understanding of patients’ needs, patient information 
provision on a routine clinical basis can also be improved. For example, one issue 
that I identified is the misinterpretation of copy clinic letters sent to patients in the 
post. The provision of a ‘plain English summary’ to patients following clinic 
appointments could aid understanding and consequently any required action. This is 
unlikely to be possible for every letter written given the volume of work it would 
generate, but it could be feasible to put this at the end of letters to new patients for 
example. Links to the relevant sections of the information resource could be included 
within letters so that patients can review this if they need further clarification.  
There are some potential limitations with the design of this development process and 
consequently the resource itself. By recruiting patients and their carers to a study 
concerning information provision it is possible that the group self-selected as a group 
who have an interest in patient information. The sampling process aimed to recruit a 
maximum variation sample, yet it is possible that those who did not have an interest 
in information would naturally decline entry to the study. This may well limit the 
inclusion of the views of those who are not interested in engaging with information, 
and thus limit the ability to develop a resource that would appeal to this ‘hard to 
reach’ group. Against this theory however, there was a very high uptake rate 
amongst those invited to enter the study (17/22, 77%), and amongst those 
interviewed were several who had not actively sought information before. By gaining 
an understanding of the views of this purposively sampled group, the needs of the 
wider patient group have in theory been accommodated. The review and co-
development process further refined the resource to ensure that this was the case, 
as did the evaluation process within the feasibility study. Despite the possible lack of 
inclusion of the views of harder to reach users, all efforts have been made to make 
this resource as widely accessible and user-friendly as possible. 
Another point to consider is that the resource was not developed based on a specific 
theory of behaviour change from the outset. The theory behind this resource was that 
basing it upon the experiences and needs of potential users and developing it with 
users, would be an effective way to optimise engagement and effect. The information 
resource is not simply a factsheet. It has been designed to facilitate understanding, 
address identified issues, and reinforce potential impacts of actions on health. 
Clearly, one way to develop such a resource would be to base it upon specific 
behaviour change techniques (Michie et al., 2005; Abraham and Michie, 2008), and 
 179 
 
interestingly it can be seen that many elements of the resource are actually aligned 
with such theory. For example, there are several video demonstrations within the 
resource, and instructions on how to perform certain tasks such as chest clearance. 
This provision of instruction and demonstration of behaviours is in keeping with 
social-cognitive theory (Bandura, 1977). In addition there is information on behaviour-
health links and consequences of actions or inactions, in keeping with an information-
motivation-behavioural skills model (Fisher and Fisher, 1992).  Although the resource 
is primarily an information resource rather than a self-management ‘programme’, it 
contains information about self-management and self-help. The aim was that by 
having information about self-management (which was amongst the identified 
needs), along with all the other needs-driven information within the resource, patients 
and carers would be able to improve their knowledge and understanding of their 
condition, their treatments and what they could do to help themselves. The 
methodological approach taken to the production of this user-driven and co-
developed information resource has ensured that each element of the resource has 
been influenced by the theories, literature, and interview data relevant to it.  
The understanding of patients and carers’ experiences of living with bronchiectasis, 
and their requirements for information has enabled the co-development of a novel 
resource that meets users’ needs. By developing, designing and formatting the 
information in such a heavily researched and considered way, a resource that aims 
to optimise engagement and impact has been created.  
7.3 The BRIEF Study: key findings 
The BRIEF study aimed to determine feasibility of conducting a future definitive trial 
of the described novel information resource. A definitive trial would aim to assess the 
impact of the information resource on users’ understanding, ability to self-manage 
and health outcomes. Any potential health economic benefits could also be assessed 
in a future study. Due to the expense and numbers involved in such definitive trials, 
feasibility studies are considered an essential requirement for the planning of future 
trials (Thabane et al., 2010). Safety of interventions, and feasibility of recruitment and 
trial conduct can be established. For the BRIEF study, establishing such feasibility 
and evaluating the novel intervention were key outcomes. The CONSORT extension 
to randomised pilot and feasibility studies guideline was followed (Moher et al., 2010; 
Eldridge et al., 2016) to ensure adequate reporting of the trial.  
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The BRIEF study was feasible to recruit to and was conducted to time and target. 
Recruitment took place over a period of 16 months, at a rate of 3.9 
participants/month. 62 participants were recruited to the trial, with only 1 death and 1 
loss to follow-up. Study form completion rates were excellent as detailed in Chapter 
6. Many of the questionnaires used achieved 100% completion rates. The postal 
questionnaires had slightly lower completion rates, but were still in excess of 
published average postal questionnaire return rates of 65% (Nakash et al., 2006). 
Data quality was exemplary with very few missing data or errors. It is important to 
note however, that such data integrity could drop in a multicentre design.  
Pre-defined feasibility outcomes (Chapter 3, Chapter 6) were therefore met. 
Willingness to enter the trial was within predicted numbers and the recruitment rate 
was above expected. Study design was acceptable as judged by study completion 
rates, qualitative feedback in the end of study focus group, and the completion of 
study forms as per protocol. On the basis of these findings it can be concluded that 
this study was feasible to conduct. This is key when designing a definitive, larger, 
multicentre trial based upon this study design, yet there are additional points to 
consider when moving from pilot to definitive studies (Thabane et al., 2010; Bugge et 
al., 2013). Specifically for the BRIEF study, points to consider for further planning 
would include the ability to recruit from different centres, planning required follow-up 
time, retention rates with a longer study follow-up time and changes to study design 
to improve chances of recruiting adequate numbers. Planning a definitive trial with an 
adaptive design would allow for re-assessment of required sample size part way 
through data collection, for example at 6 months. It is likely that for some outcomes 
such as frequency of exacerbations, a much longer follow up period, of at least a 
year would be required, given the likely number of exacerbations per year, and the 
seasonal variation that can occur (Bibby et al., 2015). Based on the findings of the 
BRIEF study, this study design is acceptable and feasible to conduct, and could be 
easily adapted to plan a future definitive trial.  
7.3.1 Evaluation of the novel resource within the BRIEF study: key findings 
Evaluation of the intervention itself took place as part of the BRIEF study. A 
questionnaire created for use within the study assessed users satisfaction with the 
resources provided. A focus group at the end of the study also explored participants’ 
(and carers’) views on the resources. Further analysis was possible through the use 
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of Google Analytics, to establish use of the website www.bronchiectasis.me beyond 
users’ reports.  
Feedback in the questionnaire identified that participants used the resource (87%), 
and found it useful (93% of users). In addition there was a suggestion of an 
improvement in perceived understanding of bronchiectasis, its treatments and where 
to find more information amongst the intervention group. Users highlighted their like 
of the video clips within the website, particularly those depicting other patients’ 
stories. Interestingly, the website and the overview booklet had equal numbers 
preferring one or the other. When reporting which format they had used the most, 
however, 60% said the booklet. There were different reasons to explain this, some of 
which concurred with the prior interview data. The ability to use the booklet as a 
quick reference was reported as useful, and the website, although preferred by half, 
had some problems reported. When looking though the problems highlighted in the 
free text questionnaire data, it seemed access or ‘logins’ had been problematic for 
some. It was unclear whether this was an issue with the website or the users’ 
devices, yet is clearly an area for improvement. If there were issues with access to 
the website, rectifying these could potentially lead to an increase in the proportion of 
users preferring the online version. 
By using the data obtained via website analysis, numbers accessing the site and 
most popular pages to view were confirmed. This proved to be a further method of 
data triangulation, as the pages viewed most frequently were in keeping with those 
that had been identified within the interviews and co-development process to be most 
important to users. They were also consistent with the identified key information 
selected to be included within the overview booklet. This evaluation proved to be very 
useful both in obtaining feedback about the resource and re-confirming prior 
qualitative findings. The fact that the demand for access to the site was shown to be 
high worldwide has also confirmed findings that patients want to be able to access 
credible bronchiectasis information resources. Further positive evaluation of the 
resource has been made by the British Lung Foundation. To have this request for 
use of the information resource by an internationally recognised provider of lung 
disease information adds confirmation that a high quality resource has been 
successfully developed.   
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7.3.2 Strengths and limitations of the BRIEF study 
As highlighted within Chapter 6, this is the first trial of a bronchiectasis information 
resource that has been based upon qualitative exploration and understanding of 
users’ needs and experiences. Patients and carers were involved in the study and 
intervention design from the outset, in addition to an independent user 
representative. A study protocol was produced in keeping with the MRC guidelines 
for evaluating complex interventions (Medical Research Council, 2000) and this was 
published and made openly accessible (Hester et al., 2016). Findings have been 
reported in keeping with the CONSORT guidelines (Moher et al., 2010; Eldridge et 
al., 2016) and a pre-defined statistical analysis plan was used when analysing data. 
As with any study, however, there are some limitations to consider. 
The first concerns blinding. This was a feasibility study, with limited funding and a 
sample size of 62. Due to the nature of the intervention, patients could not be blinded 
to whether or not they were receiving the resource to use whilst in the study. As the 
research staff conducting study visits needed to provide access details and support 
to those within the intervention group, they too were unblinded. It should be 
considered whether blinding of the data analyst is possible, and some argue that this 
should be possible in almost all cases (Polit, 2011). The BRIEF study however was 
being conducted during my doctoral research fellowship, and although some initial 
data entry was done by a data manager within the research team, all data checking 
and analysis was my responsibility. In order to check data accurately and effectively, 
it was not possible to be blinded to allocation groups. For example, some 
questionnaires were only completed by the intervention group, and I was directly 
involved in all study processes, and solely responsible for data analysis. In order to 
ensure data was analysed without bias, and was not influenced during analysis, a 
pre-defined analysis plan was written with advice from a statistician prior to data 
analysis. This analysis plan is attached as an appendix, and was strictly adhered to 
(Appendix 28). The analysis plan was included in the published study protocol 
(Hester et al., 2016). It should also be noted that outcomes for the feasibility study 
were in the main concerning response rate and recruitment rather than looking for an 
effect in the intervention group. For a future definitive trial, blinding of the data analyst 
should be aimed for. The lack of blinding in the BRIEF study, however, should not be 
considered to have influenced data analysis and outcomes. 
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The second limitation concerns both the definition and monitoring of exacerbations. 
There is no current gold standard for objectively measuring what constitutes an 
exacerbation in bronchiectasis. The BRIEF study did not have a protocol definition of 
exacerbations. At the first study visit, the number of exacerbations participants had in 
the preceding 12 months was recorded. This was done by patient recollection and 
case note review. During completion of study questionnaires, patients were also 
asked to recall numbers of exacerbations or courses of antibiotics since their last 
visit. This was done over a short time period. During a trial with a longer time period 
between study visits, GP and hospital notes may need to be relied upon more for 
accurate recording of events. Due to the potential burden of a daily symptom diary 
(as identified by patient reviewers of the study design), we opted to ask patients to 
record such details on a monthly basis. As this study did not aim to impact upon 
participants symptoms, this was felt to be adequate recording, and could be used to 
consider any potential ascertainment bias when planning a future study. In a 
definitive trial of this intervention however, improvements in self-management and 
consequently disease stability would be assessed. When adapting this study design 
for a future trial, a protocol definition of an exacerbation, and more rigorous reporting 
of events would be preferable. This could include, for example, electronic symptom 
diaries.  
Although numbers of courses of antibiotics would be important information to collect 
within a definitive trial, it would be difficult to use as a primary outcome measure. As 
the intervention would aim to improve participants’ recognition and management of 
exacerbations, this could lead to an increase in number of antibiotic courses taken (if 
a participant had previously been under-recognising treatment requirements), yet for 
others it may lead to a reduction (if they had previously been reacting to ‘normal’ 
variations in symptoms unnecessarily). Measuring change in number of courses of 
antibiotics therefore would be difficult to interpret with meaning. It is likely that 
exacerbation rate, along with a primary outcome measure of unscheduled healthcare 
visits (representing unpredicted and unmanaged exacerbations), would be the most 
accurate measure of improvements in self-management and health outcomes. This 
would be in conjunction with assessing knowledge and understanding of 
bronchiectasis. In order to more accurately report this, further work would need to be 
done to improve upon and validate the knowledge questionnaires used within the 
BRIEF study.  
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The third limitation relates to sample diversity. Although patients were recruited from 
all respiratory clinics within the trust, at 2 sites, the vast majority 58/62 (94%) were 
recruited from the specialist bronchiectasis clinic. This may be in part due to the fact 
that research staff familiar with all ongoing studies have a presence within the 
bronchiectasis clinic, reminding the clinical care team about recruitment, and being 
available to speak to potential participants if required. Recruitment from the general 
respiratory clinics relied upon the consultants delivering those clinics remembering to 
ask patients if they might be interested in hearing more about the study. Although 
consultants were reminded throughout the study by email, it may not have been at 
the forefront of their minds. As with all studies, ensuring adequate ‘advertising’ would 
have to be incorporated into future trial designs. By recruiting from all types of clinic, 
the aim was to have a patient group who had different clinical experiences and 
differing information provision. Although the majority had been to the specialist clinic, 
given the differing times since diagnosis, access to information from the clinic still 
varied.  
Also regarding sample diversity, patients’ backgrounds in terms of socio-economic 
status were not recorded in detail within the BRIEF study. This is something that 
could be considered in more depth if planning a definitive trial. Users’ backgrounds 
and educational level certainly have the potential to influence interaction with the 
resource. How users ‘connect’ with information was highlighted as important within 
the interview data, so establishing any additional social factors which may have an 
effect on this within a future trial would be useful. During the BRIEF study, although 
sampling included a range of patients (e.g. age, time since diagnosis, severity of 
disease), there are other factors such as this which were not heavily focussed upon.  
Another aspect of recruitment to discuss is that when approaching potentially eligible 
patients, a 50% consent rate was achieved. Although this was consistent with our 
predicted numbers, it is possibly slightly lower than could be anticipated. There are 
no definitive figures as to what to expect in this scenario, as there are many factors 
that vary between potential participant populations and different study requirements. 
A review of influential randomised trials reported a mean non-recruitment rate of 
40.1% (SD23.7%) (Humphreys et al., 2013). Rates vary hugely between studies 
however as described. The recruitment rate in the BRIEF study was lower than this 
reported mean, yet it is a small single centre study, not an influential RCT. There 
were no new treatments to potentially receive and it was not a heavily marketed 
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study. When compared to the recruitment rate for my qualitative interviews (17/22 
approached (77%)) the uptake rate of 50% is still much lower. It may be the nature of 
the BRIEF study compared to the interviews (12 week time period with 3 visits 
compared to a single, hour long interview) that seemed less appealing. For a 
definitive trial, follow-up time period would need to be longer still, so this is something 
that would need to be considered if it was a factor influencing refusal rates. It is also 
possible that recruitment was taking place within a group saturated with research 
study requests. There were several studies recruiting patients with bronchiectasis at 
the same time at the study centre and there are a finite number of patients with 
bronchiectasis. It may be that those approached had already been approached for 
entry into (or had entered) other studies and felt unable to enter another. Recruitment 
also took place at other general respiratory clinics within the single centre, yet few 
were recruited from outside of the specialist clinic. Although basic data was collected 
on reason for refusal and reported in Chapter 6, factors that may have encouraged 
participation were not explored, as this had not been written into the study design. In 
future studies, exploring this in more depth would be useful to influence future trial 
design. Importantly, however, recruitment was achieved to target numbers within the 
target timescale, and retention rates were excellent. Qualitative data collected within 
the end of study focus group also highlighted that participation was not considered to 
be burdensome, with no obvious areas for improvement. Those conducting study 
visits also found them straightforward.  
The final limitation I will discuss is the standardisation of ‘usual care’ for those 
randomised to the control arm. For the BRIEF study, it was decided that ‘usual care’ 
would be simply receiving no additional information resource, but making no 
restrictions on the information that could be otherwise used or sought. This is quite 
difficult to standardise, as each individual will have different clinical contact and 
information given, and different approaches to seeking or not seeking information by 
themselves. During design of the trial, one option considered was to provide those in 
the control arm with the current BLF bronchiectasis leaflet as a form of ‘usual care’. 
Ultimately this was decided against, as ‘usual care’ would not necessarily involve 
even the provision of this leaflet in some clinics. It was also assumed that all 
participants would already have different experiences of information provision prior to 
study entry. A simple example would be which clinic they attended, with the 
assumption that those attending a specialist clinic would potentially have access to a 
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level of information beyond that expected in a general respiratory clinic. This is not 
necessarily the case. Arguably, however, clinic attended, or prior information 
provision could be considered as a stratification variable during randomisation for a 
definitive trial if thought to be a potential confounding factor. Other related factors that 
could potentially influence outcomes or impact of an educational intervention could 
also be considered as stratification variables for a full trial. Examples could include 
prior access to information from a specialist clinician (as described above); time since 
diagnosis (which could influence the nature of information required); access to the 
internet (which could affect formats of resource able to fully engage with) and 
educational history or health literacy levels (which could influence both types of 
resources required and ability to engage with and understand them). Any factors felt 
to be relevant could be identified and used as stratification variables when planning 
recruitment and randomisation in a definitive trial.   
Accessing additional information resources during the BRIEF study was not restricted 
as this was felt to be difficult to do accurately. For those in the intervention group, 
looking at the resources provided could trigger seeking of further information 
elsewhere. For those in the control group, knowing they were not receiving the 
information resource could have triggered information seeking. The significant 
difference in information provision for the two groups within the trial however was the 
novel information resource. The ability to monitor additional seeking or provision of 
information is limited, and really has to be accepted as a variable which is not 
practicably controllable and reflects ‘usual’ patient practices. At study conclusion, all 
those who had taken part in the study (including those in the control group) were 
given access to the resource indefinitely. 
Despite the limitations of the BRIEF study, the design had a number of strengths and 
it was conducted successfully. The trial protocol underwent extensive peer review 
through NIHR during the doctoral research fellowship application process, and also 
during publication in Trials (Hester et al., 2016). The majority of the highlighted 
limitations are factors to consider for a definitive trial based upon this feasibility study. 
Resource evaluation and qualitative data added to the usefulness of this study by 
informing refinements to both the resource and trial design. For this feasibility study 
design to be adapted for a future definitive trial, changes would need to be made as 
discussed, and sample sizes calculated using the data presented. The indication is 
that a future multicentre study evaluating the impact of this resource on patient 
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understanding, self-management, health outcomes and health service use would be 
feasible to conduct.    
7.4 Overall impact and contributions to knowledge 
The mixed methodological approach used within this overall body of work has 
enabled the use of a combination of rigorous methods to achieve the aims and 
objectives set out at the start of this thesis:- 
1. To identify, understand and describe the information and education needs of 
patients who have bronchiectasis and their carers. 
2. To co-develop a high-quality, patient-driven information resource for patients 
with bronchiectasis in accordance with themes identified in qualitative 
interviews, focus groups and workshops. 
3. To evaluate the resource and conduct a feasibility study to inform the decision 
of whether to proceed to a definitive randomised controlled trial examining the 
impact of the resource on users understanding, self-management, use of 
health care services and disease stability. 
Firstly, a deeper understanding of the experiences of those living with bronchiectasis 
has been achieved. The nature of the biographical disruption that bronchiectasis 
presents, and the ways in which people manage this and develop active partnerships 
with their healthcare providers has been described for the first time. The ways in 
which those living with bronchiectasis ‘connect’ with information has also been 
explored and described. This new level of understanding could facilitate 
improvements in partnerships between healthcare providers and those living with 
bronchiectasis. This new knowledge therefore stands to benefit patients, carers and 
healthcare professionals and has facilitated the co-development of a user-driven 
information resource.  
Secondly, the co-development of a novel information resource that meets users’ 
needs has resulted in a website and booklet based upon this new understanding of 
the experiences of those living with bronchiectasis. By understanding unmet needs, 
preferences and required purpose of information resources, high-quality, useful 
resources have been developed. By using the particular iterative processes and 
methods described, and evaluating along the way, it has been possible to produce 
resources that are engaging, credible and well-received. This is the first step towards 
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using such a resource to positively influence patients’ understanding, ability to self-
manage and healthcare service use. In addition to the impact for those with 
bronchiectasis, this methodological approach could be extrapolated for use within 
other chronic conditions, contributing to further research in the future. 
Thirdly, the feasibility of using a randomised controlled trial to assess the impact of 
the novel resources has been established in the BRIEF study. In order to conduct a 
definitive trial, more work would need to be done to adapt the BRIEF study protocol 
and estimate sample sizes required. The success of the BRIEF study is a strong 
indicator that with appropriate adaptation, this protocol and study design could be 
used in future work. Qualitative methods incorporated into the trial design have 
additionally yielded data that could further influence such adaptations. The protocol 
for the BRIEF study was published openly, so could also be used by researchers in 
other related fields to plan similar feasibility studies, or to adapt for use for a full trial. 
The questionnaires produced and used for the first time in this study, particularly the 
Bronchiectasis Knowledge Questionnaire, are another useful output. With further 
development and validation, these could be used as outcome measures in future 
work.  
The BRIEF study also provided detailed evaluation and qualitative data on the 
resources provided. This has both enabled confirmation of the effective use of the 
interview findings and co-development process, and facilitated further refinements to 
the resources. The website www.bronchiectasis.me and the accompanying booklet 
‘Living your life with bronchiectasis’ are tangible outputs of this research. The booklet 
is currently being used by the British Lung Foundation as the basis for their revised 
information resource (paper and online versions), which I have reviewed and 
amended for publication. Within their booklet, Newcastle University, Newcastle 
Hospitals Trust, NIHR and I will be acknowledged. The website developed for use 
within the BRIEF study is also currently under further development and has now 
been made openly available with the support of the Open Lab at Newcastle 
University. The BLF include the link to this website within their new information which 
will hugely increase anticipated traffic through the site. Having the resource used and 
endorsed by a charity with international recognition for provision of information on 
lung disease will hugely increase the potential impact it could have for users, and the 
number of people that will be signposted to the resource. This collaboration could 
also be a means of facilitating and disseminating future research. 
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As information seeking is often opportunistic, this raises the importance of placement 
and how best to make this available to patients. Aside from being available openly to 
any seekers of information online, to maximise value and uptake of the new resource 
it would make sense for it to be available in a clinical environment. Information 
received from patients’ own clinician’s tends to be trusted information. For details of 
this resource to be shared in clinic, on the ward and details given to patients within 
clinic letters of how to access the information would be a good step towards making 
the information accessible. The NHS trust in which this resource was developed are 
currently approving the booklet for use.  
There have been several contributions to knowledge and tangible outputs from this 
body of work, all in keeping with the aims and objectives at the outset. In order to 
maximise impact, all findings have been disseminated widely.  
7.5 Dissemination 
I have presented each stage of this work throughout my fellowship period. The work 
has been presented in a variety of settings, including Research Discussion Forums 
both within my host institute, the Institute of Cellular Medicine, and the Institute of 
Health and Society where I have formed strong connections on the basis of the 
nature of work undertaken. I have presented findings within the Newcastle upon Tyne 
Hospitals NHS Trust, both at medical meetings and also at an open educational day 
about bronchiectasis, attended by patients, carers and healthcare providers. This day 
was advertised within the local press and had over 50 attendees. Also locally, I have 
presented findings at the North East Bronchiectasis Research Interest Group 
meeting, attended by healthcare providers from around the region and a BLF 
representative.  
I have presented findings from all stages of this work at international conferences 
including the British Sociological Association Medical Sociology Conference, British 
Thoracic Society Winter Meetings and the first World Bronchiectasis Conference. 
I have published the BRIEF study protocol in Trials (Hester et al., 2016), and have 
three further papers in preparation:-  
 Bronchiectasis education: a review of patient information and education 
provision.  
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 Living life with bronchiectasis: A qualitative exploration of what it means to live 
with bronchiectasis for patients and carers.  
 The BRIEF study: Development of a novel educational intervention for patients 
with bronchiectasis based on a qualitative exploration of the unmet information 
needs of patients and their carers, and the outcome of a feasibility study 
comparing the intervention to usual care in bronchiectasis.  
In addition, the booklet produced during the research is currently being approved for 
use within the Newcastle Hospitals Trust and also being used by the BLF as 
described. By making the website openly available, and linking with the BLF, 
dissemination amongst the user group will be maximised. Both the booklet and 
website include details of the research involved in their production. All participants 
have also received summaries of findings. 
7.6 Recommendations for future research 
Potential future research building upon this work would include delivering a full trial to 
determine the impact of the developed resources. In order to carry out a definitive 
trial, adaptations would need to be made to the BRIEF study protocol in keeping with 
the discussion in this chapter and in Chapter 6. Sample size calculations would need 
to be made, and consideration of potential sites for a multi-centre study. Outcome 
measures would also need to be re-considered. Identifying an impactful primary 
outcome measure could be challenging. Whilst patient knowledge and understanding 
are important, measures of health stability and service use would be critical to 
assessing whether the intervention had an effect on health outcomes and any 
economic benefits. The feasibility of such a study in terms of recruitment on a much 
larger scale, costs involved and therefore funding required are important 
considerations. Securing funding for such a study is by no means guaranteed. Given 
these factors, in combination with the opportunity to make this information resource 
openly available to the user group through collaboration with the BLF, I opted to 
disseminate the resource for more immediate patient benefit rather than to proceed 
with a full trial at this stage.  
Even without delivering a full trial, however, future developments can still be made. 
The questionnaires used within the study could be re-assessed and further 
developed and validated. If proven to be useful measures, these could then be used 
within future trials to assess impact of information resources on patient knowledge 
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and understanding of bronchiectasis. The information resources themselves are also 
primed for further development. By extending the exploration of information needs 
and the co-development process to younger patients and even children, for example, 
an understanding of the experiences of younger people with bronchiectasis could be 
gained. This could facilitate the development of resources specific to their needs, or 
the adaptation of the current resource to incorporate age-specific sections. To take 
this a step further, the information needs of healthcare professionals managing 
patients with bronchiectasis, such as GPs, could also be explored and provided for.  
The website, which is currently under development to be made openly available, has 
great potential to be developed further. Although at first this will be set up as a ‘static’ 
site, further work could be done to make this much more interactive, facilitating 
research into users’ engagement with digital resources in bronchiectasis. One feature 
that was highlighted as being of use within the interviews, was the ability to ‘ask a 
question’ through a website. For the resource developed within this body of work, this 
was not a feasible option in terms of technical features of the site and monitoring and 
upkeep. In future work, this could be incorporated into the site, for example by asking 
users to register questions, which could be rated by the user group in polls. Other 
users can answer the questions, and professional answers could be added to the 
most popular questions on a weekly basis. This not only promotes ongoing 
interaction with the resource, but also offers an opportunity to gain further insight into 
users’ needs. This could inform its ongoing development, for example moving 
towards a patient self-management programme within the site if users identified this 
as an unmet need. It could also help to identify other potential research projects 
favoured by those living with bronchiectasis. By not having to ‘login’ to the site when 
it becomes openly available, access is bound to increase, and we already know that 
demand for access has been high. By asking those using the site to complete a 
registration process, informing users about future research and promoting best 
practice in management could be facilitated. The options for development are 
numerous, and potential for future, further impact is significant. 
7.7 Conclusions 
This thesis presents a first in-depth description of the experiences of those living with 
bronchiectasis, and the biographical disruption they face. This understanding of 
patients’ and carers’ experiences and unmet information needs has informed the co-
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development of a novel information resource. A pilot study comparing use of the 
resource to usual care has proven feasible to conduct and shown it meets users’ 
requirements. All aims outlined at the start of this body of work have been achieved. 
In addition, a highly rated booklet and website are being made openly available to 
patients and carers. Having these resources available for public use, and maximising 
promotion and accessibility through their adoption by the British Lung Foundation 
have enabled an immediate improvement in the provision of credible information 
resources for those living with bronchiectasis, and created a wealth of future options 
for development.    
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